_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,b1,b2,confirmids1,confirmids2,e1,e2,factor1,factor2,firstfactor,saveselectionids1,saveselectionids2,secondfactor,sentence,wordid1,wordid2,orig_b1,orig_b2,baseline-decision,orig_e1,orig_e2,relation,sent_id,orig_sentence,term1,term2
725373071,5/24/2015 21:19:45,1642777250,5/24/2015 21:19:28,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,112,39,,,118,48,ANGINA,ABCIXIMAB,unstable ANGINA:,103-112,19-30-36-39-49-56-60-76-67,controlled trial of ABCIXIMAB before and during coronary intervention,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study.,112,39,112,39,-1,118,48,TWrex-cause,800959,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study,angina,abciximab
725373071,5/24/2015 21:34:05,1642781849,5/24/2015 21:33:47,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,112,39,,,118,48,ANGINA,ABCIXIMAB,ANGINA:,112,39,ABCIXIMAB,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study.,112,39,112,39,-1,118,48,TWrex-cause,800959,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study,angina,abciximab
725373071,5/24/2015 21:45:22,1642785037,5/24/2015 21:44:10,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,112,39,,,118,48,ANGINA,ABCIXIMAB,refractory unstable ANGINA:,92-103-112,39,ABCIXIMAB,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study.,112,39,112,39,-1,118,48,TWrex-cause,800959,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study,angina,abciximab
725373071,5/24/2015 22:09:44,1642792612,5/24/2015 22:09:21,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,112,39,,,118,48,ANGINA,ABCIXIMAB,refractory unstable ANGINA:,103-112-92,39,ABCIXIMAB,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study.,112,39,112,39,-1,118,48,TWrex-cause,800959,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study,angina,abciximab
725373071,5/24/2015 22:51:04,1642806806,5/24/2015 22:50:47,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,112,39,,,118,48,ANGINA,ABCIXIMAB,refractory unstable ANGINA:,92-103-112,39,ABCIXIMAB,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study.,112,39,112,39,-1,118,48,TWrex-cause,800959,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study,angina,abciximab
725373071,5/24/2015 22:57:13,1642808569,5/24/2015 22:56:35,false,clixsense,1,26770238,CAN,ON,Ilderton,209.183.157.27,112,39,,,118,48,ANGINA,ABCIXIMAB,abciximab coronary intervention ANGINA:,39-67-76-112,39-103-112,ABCIXIMAB unstable angina:,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study.,112,39,112,39,-1,118,48,TWrex-cause,800959,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study,angina,abciximab
725373071,5/24/2015 22:57:22,1642808601,5/24/2015 22:57:10,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,112,39,,,118,48,ANGINA,ABCIXIMAB,ANGINA:,112,39,ABCIXIMAB,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study.,112,39,112,39,-1,118,48,TWrex-cause,800959,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study,angina,abciximab
725373071,5/24/2015 22:58:23,1642808765,5/24/2015 22:57:11,false,points4rewards,1,28703583,USA,,,97.73.85.52,112,39,,,118,48,ANGINA,ABCIXIMAB,refractory unstable ANGINA:,92-112-103,39-92-103-112,ABCIXIMAB refractory unstable angina:,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study.,112,39,112,39,-1,118,48,TWrex-cause,800959,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study,angina,abciximab
725373071,5/24/2015 22:58:32,1642808823,5/24/2015 22:57:46,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,112,39,,,118,48,ANGINA,ABCIXIMAB,refractory unstable ANGINA:,92-103-112,11-19-30-39-36,placebo controlled trial of ABCIXIMAB,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study.,112,39,112,39,-1,118,48,TWrex-cause,800959,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study,angina,abciximab
725373071,5/24/2015 23:02:06,1642809677,5/24/2015 23:01:49,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,112,39,,,118,48,ANGINA,ABCIXIMAB,refractory unstable ANGINA:,92-103-112,39,ABCIXIMAB,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study.,112,39,112,39,-1,118,48,TWrex-cause,800959,Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study,angina,abciximab
725373072,5/24/2015 21:05:09,1642772651,5/24/2015 21:04:46,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,132,112,,,139,116,COLITIS,ACID,ulcerative COLITIS.,121-132,112,ACID,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis.",132,112,132,112,-1,139,116,TWrex-cause,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis",colitis,acid
725373072,5/24/2015 21:05:27,1642772747,5/24/2015 21:05:09,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,132,112,,,139,116,COLITIS,ACID,COLITIS.,132,112,ACID,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis.",132,112,132,112,-1,139,116,TWrex-cause,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis",colitis,acid
725373072,5/24/2015 21:18:16,1642776740,5/24/2015 21:18:04,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,132,112,,,139,116,COLITIS,ACID,ulcerative COLITIS.,121-132,97-112-117-121-132,aminosalicylic ACID for ulcerative colitis.,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis.",132,112,132,112,-1,139,116,TWrex-cause,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis",colitis,acid
725373072,5/24/2015 21:31:46,1642780894,5/24/2015 21:31:22,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,132,112,,,139,116,COLITIS,ACID,ulcerative COLITIS.,121-132,95-97-112,5 aminosalicylic ACID,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis.",132,112,132,112,-1,139,116,TWrex-cause,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis",colitis,acid
725373072,5/24/2015 21:40:12,1642783544,5/24/2015 21:39:28,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,132,112,,,139,116,COLITIS,ACID,ulcerative COLITIS.,121-132,97-112,aminosalicylic ACID,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis.",132,112,132,112,-1,139,116,TWrex-cause,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis",colitis,acid
725373072,5/24/2015 22:07:59,1642791881,5/24/2015 22:07:44,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,132,112,,,139,116,COLITIS,ACID,ulcerative COLITIS.,121-132,95-97-112,5 aminosalicylic ACID,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis.",132,112,132,112,-1,139,116,TWrex-cause,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis",colitis,acid
725373072,5/24/2015 22:49:32,1642806432,5/24/2015 22:49:19,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,132,112,,,139,116,COLITIS,ACID,ulcerative COLITIS.,121-132,95-97-112,5 aminosalicylic ACID,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis.",132,112,132,112,-1,139,116,TWrex-cause,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis",colitis,acid
725373072,5/24/2015 22:53:18,1642807416,5/24/2015 22:52:34,false,points4rewards,1,28703583,USA,,,97.73.85.52,132,112,,,139,116,COLITIS,ACID,ulcerative COLITIS.,121-132,112-121-132,ACID ulcerative colitis.,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis.",132,112,132,112,-1,139,116,TWrex-cause,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis",colitis,acid
725373072,5/24/2015 22:54:46,1642807829,5/24/2015 22:54:26,false,clixsense,1,26770238,CAN,ON,Ilderton,209.183.157.27,132,112,,,139,116,COLITIS,ACID,acid for ulcerative COLITIS.,112-117-121-132,112-117-121-132,ACID for ulcerative colitis.,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis.",132,112,132,112,-1,139,116,TWrex-cause,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis",colitis,acid
725373072,5/24/2015 22:56:30,1642808390,5/24/2015 22:56:18,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,132,112,,,139,116,COLITIS,ACID,ulcerative COLITIS.,121-132,96-97-112,- aminosalicylic ACID,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis.",132,112,132,112,-1,139,116,TWrex-cause,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis",colitis,acid
725373073,5/24/2015 19:06:17,1642726441,5/24/2015 19:06:02,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,25,80,,,31,88,STROKE,WARFARIN,STROKE,25,80,WARFARIN.,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin.,25,80,25,80,-1,31,88,TWrex-cause,803834,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin,stroke,warfarin
725373073,5/24/2015 19:07:57,1642727151,5/24/2015 19:07:40,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,25,80,,,31,88,STROKE,WARFARIN,STROKE,25,80,WARFARIN.,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin.,25,80,25,80,-1,31,88,TWrex-cause,803834,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin,stroke,warfarin
725373073,5/24/2015 19:09:32,1642727837,5/24/2015 19:08:59,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,25,80,,,31,88,STROKE,WARFARIN,STROKE,25,80,WARFARIN.,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin.,25,80,25,80,-1,31,88,TWrex-cause,803834,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin,stroke,warfarin
725373073,5/24/2015 19:23:31,1642739511,5/24/2015 19:22:05,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,25,80,,,31,88,STROKE,WARFARIN,STROKE,25,80,WARFARIN.,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin.,25,80,25,80,-1,31,88,TWrex-cause,803834,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin,stroke,warfarin
725373073,5/24/2015 19:28:40,1642742293,5/24/2015 19:27:04,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,25,80,,,31,88,STROKE,WARFARIN,STROKE,25,80,WARFARIN.,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin.,25,80,25,80,-1,31,88,TWrex-cause,803834,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin,stroke,warfarin
725373073,5/24/2015 19:40:16,1642747640,5/24/2015 19:40:06,false,clixsense,1,31482589,NLD,,,31.201.11.16,25,80,,,31,88,STROKE,WARFARIN,STROKE,25,80,WARFARIN.,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin.,25,80,25,80,-1,31,88,TWrex-cause,803834,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin,stroke,warfarin
725373073,5/24/2015 19:45:11,1642749459,5/24/2015 19:44:44,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,25,80,,,31,88,STROKE,WARFARIN,STROKE,25,80,WARFARIN.,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin.,25,80,25,80,-1,31,88,TWrex-cause,803834,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin,stroke,warfarin
725373073,5/24/2015 19:45:13,1642749466,5/24/2015 19:44:55,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,25,80,,,31,88,STROKE,WARFARIN,The risk for STROKE,12-16-21-25,59-67-75-80,greatly reduced with WARFARIN.,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin.,25,80,25,80,-1,31,88,TWrex-cause,803834,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin,stroke,warfarin
725373073,5/24/2015 19:45:39,1642749658,5/24/2015 19:45:17,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,25,80,,,31,88,STROKE,WARFARIN,COMMENTARY The risk for STROKE in patients with AF can be greatly reduced with warfarin.,0-12-16-21-25-32-35-44-49-52-56-59-67-75-80,0-12-16-21-25-32-35-44-49-52-59-67-75-80-56,COMMENTARY The risk for stroke in patients with AF can be greatly reduced with WARFARIN.,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin.,25,80,25,80,-1,31,88,TWrex-cause,803834,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin,stroke,warfarin
725373073,5/24/2015 19:49:14,1642750802,5/24/2015 19:49:00,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,25,80,,,31,88,STROKE,WARFARIN,STROKE,25,80,WARFARIN.,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin.,25,80,25,80,-1,31,88,TWrex-cause,803834,COMMENTARY  The risk for stroke in patients with AF can be greatly reduced with warfarin,stroke,warfarin
725373074,5/24/2015 19:29:55,1642742940,5/24/2015 19:29:44,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,149,106,,,158,119,GONORRHEA,CIPROFLOXACIN,uncomplicated GONORRHEA.,135-149,94-101-106,single dose CIPROFLOXACIN,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea.",149,106,149,106,-1,158,119,TWrex-cause,803757,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea",gonorrhea,ciprofloxacin
725373074,5/24/2015 19:47:31,1642750227,5/24/2015 19:47:14,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,149,106,,,158,119,GONORRHEA,CIPROFLOXACIN,Comparative clinical efficacy of two different single - dose ciprofloxacin treatments for uncomplicated GONORRHEA.,47-59-68-77-80-84-94-100-101-120-131-135-149-106,47-59-68-77-80-84-94-101-106-120-131-135-100,Comparative clinical efficacy of two different single - dose CIPROFLOXACIN treatments for uncomplicated,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea.",149,106,149,106,-1,158,119,TWrex-cause,803757,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea",gonorrhea,ciprofloxacin
725373074,5/24/2015 19:47:52,1642750383,5/24/2015 19:47:09,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,149,106,,,158,119,GONORRHEA,CIPROFLOXACIN,treatments for uncomplicated GONORRHEA.,120-131-135-149,94-101-106-120,single dose CIPROFLOXACIN treatments,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea.",149,106,149,106,-1,158,119,TWrex-cause,803757,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea",gonorrhea,ciprofloxacin
725373074,5/24/2015 19:49:53,1642750920,5/24/2015 19:49:36,false,neodev,1,31743852,GBR,G5,Faversham,85.210.123.52,149,106,,,158,119,GONORRHEA,CIPROFLOXACIN,ciprofloxacin treatments for uncomplicated GONORRHEA.,120-131-135-149-106,94-101-106-120-131-135-149,single dose CIPROFLOXACIN treatments for uncomplicated gonorrhea.,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea.",149,106,149,106,-1,158,119,TWrex-cause,803757,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea",gonorrhea,ciprofloxacin
725373074,5/24/2015 19:50:17,1642751108,5/24/2015 19:49:57,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,149,106,,,158,119,GONORRHEA,CIPROFLOXACIN,GONORRHEA.,149,106,CIPROFLOXACIN,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea.",149,106,149,106,-1,158,119,TWrex-cause,803757,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea",gonorrhea,ciprofloxacin
725373074,5/24/2015 19:50:32,1642751208,5/24/2015 19:50:19,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,149,106,,,158,119,GONORRHEA,CIPROFLOXACIN,GONORRHEA.,149,106,CIPROFLOXACIN,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea.",149,106,149,106,-1,158,119,TWrex-cause,803757,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea",gonorrhea,ciprofloxacin
725373074,5/24/2015 19:51:05,1642751347,5/24/2015 19:50:53,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,149,106,,,158,119,GONORRHEA,CIPROFLOXACIN,GONORRHEA.,149,106,CIPROFLOXACIN,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea.",149,106,149,106,-1,158,119,TWrex-cause,803757,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea",gonorrhea,ciprofloxacin
725373074,5/24/2015 19:56:16,1642752869,5/24/2015 19:55:30,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,149,106,,,158,119,GONORRHEA,CIPROFLOXACIN,uncomplicated GONORRHEA.,135-149,106,CIPROFLOXACIN,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea.",149,106,149,106,-1,158,119,TWrex-cause,803757,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea",gonorrhea,ciprofloxacin
725373074,5/24/2015 20:10:21,1642756638,5/24/2015 20:09:54,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,149,106,,,158,119,GONORRHEA,CIPROFLOXACIN,GONORRHEA.,149,106,CIPROFLOXACIN,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea.",149,106,149,106,-1,158,119,TWrex-cause,803757,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea",gonorrhea,ciprofloxacin
725373074,5/24/2015 20:11:27,1642756938,5/24/2015 20:10:31,false,instagc,1,19740138,CAN,,,50.69.96.237,149,106,,,158,119,GONORRHEA,CIPROFLOXACIN,GONORRHEA.,149,106,CIPROFLOXACIN,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea.",149,106,149,106,-1,158,119,TWrex-cause,803757,"Aznar J, Prados R, Rodriquez-Pichardo A et al. Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea",gonorrhea,ciprofloxacin
725373075,5/24/2015 18:58:33,1642722718,5/24/2015 18:58:09,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,31,137,,,43,142,PERICARDITIS,LUPUS,"PERICARDITIS,",31,129-137,"(neural LUPUS),","Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",31,137,31,137,1,43,142,TWrex-cause,811434,"Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue",pericarditis,lupus
725373075,5/24/2015 18:58:38,1642722733,5/24/2015 18:58:20,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,31,137,,,43,142,PERICARDITIS,LUPUS,"PERICARDITIS,",31,137,"LUPUS),","Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",31,137,31,137,1,43,142,TWrex-cause,811434,"Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue",pericarditis,lupus
725373075,5/24/2015 19:01:01,1642723881,5/24/2015 19:00:55,false,neodev,1,32456300,USA,CA,Laguna Niguel,216.177.129.227,31,137,,,43,142,PERICARDITIS,LUPUS,"signs include pleuritis, PERICARDITIS, myocarditis, neurological changes",6-12-20-31-45-58-71,112-120-129-137-145-162-175,"seizure activity (neural LUPUS), gastrointestinal ulcerations, Raynaud's","Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",31,137,31,137,1,43,142,TWrex-cause,811434,"Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue",pericarditis,lupus
725373075,5/24/2015 19:01:05,1642723902,5/24/2015 19:00:36,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,31,137,,,43,142,PERICARDITIS,LUPUS,"PERICARDITIS,",31,129-137,"(neural LUPUS),","Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",31,137,31,137,1,43,142,TWrex-cause,811434,"Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue",pericarditis,lupus
725373075,5/24/2015 19:01:09,1642723937,5/24/2015 19:00:36,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,31,137,,,43,142,PERICARDITIS,LUPUS,"PERICARDITIS,",31,129-137,"(neural LUPUS),","Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",31,137,31,137,1,43,142,TWrex-cause,811434,"Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue",pericarditis,lupus
725373075,5/24/2015 19:07:29,1642726964,5/24/2015 19:06:35,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,31,137,,,43,142,PERICARDITIS,LUPUS,"PERICARDITIS,",31,129-137,"(neural LUPUS),","Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",31,137,31,137,1,43,142,TWrex-cause,811434,"Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue",pericarditis,lupus
725373075,5/24/2015 19:20:43,1642735763,5/24/2015 19:20:10,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,31,137,,,43,142,PERICARDITIS,LUPUS,"PERICARDITIS,",31,112-120-129-137,"seizure activity (neural LUPUS),","Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",31,137,31,137,1,43,142,TWrex-cause,811434,"Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue",pericarditis,lupus
725373075,5/24/2015 19:25:37,1642740702,5/24/2015 19:25:19,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,31,137,,,43,142,PERICARDITIS,LUPUS,"PERICARDITIS,",31,129-137,"(neural LUPUS),","Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",31,137,31,137,1,43,142,TWrex-cause,811434,"Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue",pericarditis,lupus
725373075,5/24/2015 19:26:34,1642741121,5/24/2015 19:26:08,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,31,137,,,43,142,PERICARDITIS,LUPUS,"PERICARDITIS, myocarditis,",31-45,112-120-129-137,"seizure activity (neural LUPUS),","Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",31,137,31,137,1,43,142,TWrex-cause,811434,"Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue",pericarditis,lupus
725373075,5/24/2015 19:27:39,1642741748,5/24/2015 19:27:08,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,31,137,,,43,142,PERICARDITIS,LUPUS,"signs include pleuritis, PERICARDITIS, myocarditis,",6-12-20-31-45,112-120-129-137-145-162-175,"seizure activity (neural LUPUS), gastrointestinal ulcerations, Raynaud's","Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue.",31,137,31,137,1,43,142,TWrex-cause,811434,"Other signs include pleuritis, pericarditis, myocarditis, neurological changes including behavioral changes and seizure activity (neural lupus), gastrointestinal ulcerations, Raynaud's phenomenon (present in about 20% of patients), and other problems caused by inflammatory changes of the blood vessels or connective tissue",pericarditis,lupus
725373076,5/24/2015 21:36:06,1642782350,5/24/2015 21:35:44,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,35,101,,,54,114,BACTERIAL VAGINOSIS,METRONIDAZOLE,BACTERIAL VAGINOSIS:,35-45,96-101,oral METRONIDAZOLE.,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole.",35 45,101,35,101,-1,54,114,TWrex-cause,803751,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole",bacterial vaginosis,metronidazole
725373076,5/24/2015 23:01:52,1642809629,5/24/2015 23:01:22,false,points4rewards,1,28703583,USA,,,97.73.85.52,35,101,,,54,114,BACTERIAL VAGINOSIS,METRONIDAZOLE,BACTERIAL VAGINOSIS:,35-45,35-45-101,Bacterial vaginosis: METRONIDAZOLE.,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole.",35 45,101,35,101,-1,54,114,TWrex-cause,803751,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole",bacterial vaginosis,metronidazole
725373076,5/24/2015 23:03:43,1642810206,5/24/2015 23:03:26,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,35,101,,,54,114,BACTERIAL VAGINOSIS,METRONIDAZOLE,BACTERIAL VAGINOSIS:,35-45,101,METRONIDAZOLE.,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole.",35 45,101,35,101,-1,54,114,TWrex-cause,803751,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole",bacterial vaginosis,metronidazole
725373076,5/24/2015 23:05:22,1642810655,5/24/2015 23:04:40,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,35,101,,,54,114,BACTERIAL VAGINOSIS,METRONIDAZOLE,BACTERIAL VAGINOSIS:,35-45,96-101,oral METRONIDAZOLE.,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole.",35 45,101,35,101,-1,54,114,TWrex-cause,803751,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole",bacterial vaginosis,metronidazole
725373076,5/24/2015 23:19:37,1642814314,5/24/2015 23:18:05,false,bitcoinget,1,28503763,USA,CA,San Francisco,107.217.186.64,35,101,,,54,114,BACTERIAL VAGINOSIS,METRONIDAZOLE,BACTERIAL VAGINOSIS:,35-45,96-101,oral METRONIDAZOLE.,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole.",35 45,101,35,101,-1,54,114,TWrex-cause,803751,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole",bacterial vaginosis,metronidazole
725373076,5/24/2015 23:20:57,1642814706,5/24/2015 23:20:39,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,35,101,,,54,114,BACTERIAL VAGINOSIS,METRONIDAZOLE,BACTERIAL VAGINOSIS: treatment with clindamycin,35-45-56-66-71,83-89-96-101-71,clindamycin cream versus oral METRONIDAZOLE.,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole.",35 45,101,35,101,-1,54,114,TWrex-cause,803751,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole",bacterial vaginosis,metronidazole
725373076,5/24/2015 23:27:19,1642816358,5/24/2015 23:26:49,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,35,101,,,54,114,BACTERIAL VAGINOSIS,METRONIDAZOLE,BACTERIAL VAGINOSIS:,35-45,101,METRONIDAZOLE.,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole.",35 45,101,35,101,-1,54,114,TWrex-cause,803751,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole",bacterial vaginosis,metronidazole
725373076,5/24/2015 23:53:07,1642823012,5/24/2015 23:52:58,false,neodev,1,30749660,USA,NC,Durham,24.211.188.217,35,101,,,54,114,BACTERIAL VAGINOSIS,METRONIDAZOLE,BACTERIAL VAGINOSIS:,35-45,101,METRONIDAZOLE.,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole.",35 45,101,35,101,-1,54,114,TWrex-cause,803751,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole",bacterial vaginosis,metronidazole
725373076,5/24/2015 23:53:46,1642823257,5/24/2015 23:52:51,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,35,101,,,54,114,BACTERIAL VAGINOSIS,METRONIDAZOLE,BACTERIAL VAGINOSIS:,35-45,96-101,oral METRONIDAZOLE.,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole.",35 45,101,35,101,-1,54,114,TWrex-cause,803751,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole",bacterial vaginosis,metronidazole
725373076,5/24/2015 23:55:10,1642823731,5/24/2015 23:54:44,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,35,101,,,54,114,BACTERIAL VAGINOSIS,METRONIDAZOLE,C. BACTERIAL VAGINOSIS:,32-35-45,96-101,oral METRONIDAZOLE.,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole.",35 45,101,35,101,-1,54,114,TWrex-cause,803751,"Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole",bacterial vaginosis,metronidazole
725373077,5/24/2015 20:27:46,1642760926,5/24/2015 20:27:35,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,85,55,,,94,67,PREGNANCY,METHOTREXATE,ectopic PREGNANCY.,77-85,55,METHOTREXATE,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy.,85,55,85,55,-1,94,67,TWrex-cause,803322,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy,pregnancy,methotrexate
725373077,5/24/2015 20:32:06,1642762155,5/24/2015 20:31:54,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,85,55,,,94,67,PREGNANCY,METHOTREXATE,PREGNANCY.,85,55,METHOTREXATE,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy.,85,55,85,55,-1,94,67,TWrex-cause,803322,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy,pregnancy,methotrexate
725373077,5/24/2015 20:33:55,1642762644,5/24/2015 20:33:17,false,instagc,1,19740138,CAN,,,50.69.96.237,85,55,,,94,67,PREGNANCY,METHOTREXATE,ectopic PREGNANCY.,77-85,55,METHOTREXATE,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy.,85,55,85,55,-1,94,67,TWrex-cause,803322,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy,pregnancy,methotrexate
725373077,5/24/2015 20:56:38,1642769634,5/24/2015 20:56:19,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,85,55,,,94,67,PREGNANCY,METHOTREXATE,DRUG THERAPY drug therapy methotrexate treat ectopic PREGNANCY.,0-5-37-42-55-71-77-85,0-5-37-42-55-71-77-85,DRUG THERAPY drug therapy METHOTREXATE treat ectopic pregnancy.,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy.,85,55,85,55,-1,94,67,TWrex-cause,803322,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy,pregnancy,methotrexate
725373077,5/24/2015 20:58:31,1642770254,5/24/2015 20:58:21,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,85,55,,,94,67,PREGNANCY,METHOTREXATE,PREGNANCY.,85,55,METHOTREXATE,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy.,85,55,85,55,-1,94,67,TWrex-cause,803322,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy,pregnancy,methotrexate
725373077,5/24/2015 20:58:35,1642770259,5/24/2015 20:58:25,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,85,55,,,94,67,PREGNANCY,METHOTREXATE,ectopic PREGNANCY.,77-85,55,METHOTREXATE,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy.,85,55,85,55,-1,94,67,TWrex-cause,803322,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy,pregnancy,methotrexate
725373077,5/24/2015 20:59:13,1642770462,5/24/2015 20:59:00,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,85,55,,,94,67,PREGNANCY,METHOTREXATE,PREGNANCY.,85,55-77-85,METHOTREXATE ectopic pregnancy.,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy.,85,55,85,55,-1,94,67,TWrex-cause,803322,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy,pregnancy,methotrexate
725373077,5/24/2015 21:05:56,1642772964,5/24/2015 21:05:06,false,neodev,1,17426565,CAN,BC,Burnaby,70.79.18.187,85,55,,,94,67,PREGNANCY,METHOTREXATE,ectopic PREGNANCY.,77-85,55,METHOTREXATE,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy.,85,55,85,55,-1,94,67,TWrex-cause,803322,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy,pregnancy,methotrexate
725373077,5/24/2015 21:08:59,1642774020,5/24/2015 21:07:54,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,85,55,,,94,67,PREGNANCY,METHOTREXATE,ectopic PREGNANCY.,77-85,55,METHOTREXATE,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy.,85,55,85,55,-1,94,67,TWrex-cause,803322,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy,pregnancy,methotrexate
725373077,5/24/2015 21:11:51,1642774842,5/24/2015 21:10:06,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,85,55,,,94,67,PREGNANCY,METHOTREXATE,ectopic PREGNANCY.,77-85,55,METHOTREXATE,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy.,85,55,85,55,-1,94,67,TWrex-cause,803322,DRUG THERAPY  Introduction  Consider drug therapy with methotrexate to treat ectopic pregnancy,pregnancy,methotrexate
725373078,5/24/2015 20:33:39,1642762564,5/24/2015 20:33:21,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,87,15,,,96,27,INFECTION,AZITHROMYCIN,INFECTION),87,15,AZITHROMYCIN,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses.",87,15,87,15,-1,96,27,TWrex-cause,803521,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses",infection,azithromycin
725373078,5/24/2015 20:59:38,1642770611,5/24/2015 20:59:27,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,87,15,,,96,27,INFECTION,AZITHROMYCIN,INFECTION),87,15,AZITHROMYCIN,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses.",87,15,87,15,-1,96,27,TWrex-cause,803521,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses",infection,azithromycin
725373078,5/24/2015 20:59:48,1642770712,5/24/2015 20:59:33,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,87,15,,,96,27,INFECTION,AZITHROMYCIN,gonorrhea and chlamydial INFECTION),62-72-76-87,15,AZITHROMYCIN,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses.",87,15,87,15,-1,96,27,TWrex-cause,803521,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses",infection,azithromycin
725373078,5/24/2015 21:02:31,1642771695,5/24/2015 21:02:06,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,87,15,,,96,27,INFECTION,AZITHROMYCIN,gonorrhea and chlamydial INFECTION),62-72-76-87,15-30-62-72-76-87,AZITHROMYCIN g gonorrhea and chlamydial infection),"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses.",87,15,87,15,-1,96,27,TWrex-cause,803521,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses",infection,azithromycin
725373078,5/24/2015 21:10:14,1642774340,5/24/2015 21:10:03,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,87,15,,,96,27,INFECTION,AZITHROMYCIN,chlamydial INFECTION),76-87,15,AZITHROMYCIN,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses.",87,15,87,15,-1,96,27,TWrex-cause,803521,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses",infection,azithromycin
725373078,5/24/2015 21:12:57,1642775286,5/24/2015 21:12:42,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,87,15,,,96,27,INFECTION,AZITHROMYCIN,gonorrhea and chlamydial INFECTION),62-72-76-87,15,AZITHROMYCIN,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses.",87,15,87,15,-1,96,27,TWrex-cause,803521,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses",infection,azithromycin
725373078,5/24/2015 21:18:11,1642776728,5/24/2015 21:17:27,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,87,15,,,96,27,INFECTION,AZITHROMYCIN,chlamydial INFECTION),76-87,0-15-28-30-32,"Alternatively, AZITHROMYCIN 2 g po","Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses.",87,15,87,15,-1,96,27,TWrex-cause,803521,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses",infection,azithromycin
725373078,5/24/2015 21:24:55,1642778735,5/24/2015 21:24:41,false,clixsense,1,26492726,GBR,C2,Halifax,2.103.117.226,87,15,,,96,27,INFECTION,AZITHROMYCIN,gonorrhea and chlamydial INFECTION),62-72-76-87,15,AZITHROMYCIN,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses.",87,15,87,15,-1,96,27,TWrex-cause,803521,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses",infection,azithromycin
725373078,5/24/2015 21:25:22,1642778876,5/24/2015 21:24:16,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,87,15,,,96,27,INFECTION,AZITHROMYCIN,gonorrhea and chlamydial INFECTION),62-72-76-87,15-28-30-32,AZITHROMYCIN 2 g po,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses.",87,15,87,15,-1,96,27,TWrex-cause,803521,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses",infection,azithromycin
725373078,5/24/2015 21:26:35,1642779281,5/24/2015 21:26:20,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,87,15,,,96,27,INFECTION,AZITHROMYCIN,chlamydial INFECTION),76-87,15,AZITHROMYCIN,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses.",87,15,87,15,-1,96,27,TWrex-cause,803521,"Alternatively, azithromycin 2 g po can be given (which covers gonorrhea and chlamydial infection) with metronidazole 2 g po, both in single doses",infection,azithromycin
725373079,5/24/2015 21:01:13,1642771256,5/24/2015 21:00:57,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,54,173,,,70,176,PHOTOSENSITIVITY,SLE,PHOTOSENSITIVITY,54,172,(SLE),"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",54,,54,173,1,70,176,TWrex-cause,813307,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias",photosensitivity,SLE
725373079,5/24/2015 21:01:44,1642771448,5/24/2015 21:01:15,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,54,173,,,70,176,PHOTOSENSITIVITY,SLE,PHOTOSENSITIVITY,54,152-158-172,Lupus Erythematosus (SLE),"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",54,,54,173,1,70,176,TWrex-cause,813307,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias",photosensitivity,SLE
725373079,5/24/2015 21:14:30,1642775698,5/24/2015 21:14:08,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,54,173,,,70,176,PHOTOSENSITIVITY,SLE,PHOTOSENSITIVITY,54,54,photosensitivity,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",54,,54,173,1,70,176,TWrex-cause,813307,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias",photosensitivity,SLE
725373079,5/24/2015 21:14:46,1642775769,5/24/2015 21:14:33,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,54,173,,,70,176,PHOTOSENSITIVITY,SLE,PHOTOSENSITIVITY,54,152-158-172-179-184-192-198-201,Lupus Erythematosus (SLE) and Variant Forms of Lupus,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",54,,54,173,1,70,176,TWrex-cause,813307,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias",photosensitivity,SLE
725373079,5/24/2015 21:26:49,1642779332,5/24/2015 21:26:09,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,54,173,,,70,176,PHOTOSENSITIVITY,SLE,pronounced PHOTOSENSITIVITY,43-54,152-158-172,Lupus Erythematosus (SLE),"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",54,,54,173,1,70,176,TWrex-cause,813307,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias",photosensitivity,SLE
725373079,5/24/2015 21:27:48,1642779592,5/24/2015 21:27:28,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,54,173,,,70,176,PHOTOSENSITIVITY,SLE,PHOTOSENSITIVITY,54,152-158-172,Lupus Erythematosus (SLE),"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",54,,54,173,1,70,176,TWrex-cause,813307,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias",photosensitivity,SLE
725373079,5/24/2015 21:28:03,1642779637,5/24/2015 21:27:51,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,54,173,,,70,176,PHOTOSENSITIVITY,SLE,PHOTOSENSITIVITY,54,152-158,Lupus Erythematosus,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",54,,54,173,1,70,176,TWrex-cause,813307,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias",photosensitivity,SLE
725373079,5/24/2015 21:59:48,1642789489,5/24/2015 21:59:18,false,neodev,1,31670127,USA,FL,Key West,162.233.108.112,54,173,,,70,176,PHOTOSENSITIVITY,SLE,PHOTOSENSITIVITY,54,143-152-158-172,Systemic Lupus Erythematosus (SLE),"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",54,,54,173,1,70,176,TWrex-cause,813307,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias",photosensitivity,SLE
725373079,5/24/2015 22:03:40,1642790591,5/24/2015 22:03:25,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,54,173,,,70,176,PHOTOSENSITIVITY,SLE,PHOTOSENSITIVITY,54,152-158-172,Lupus Erythematosus (SLE),"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",54,,54,173,1,70,176,TWrex-cause,813307,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias",photosensitivity,SLE
725373079,5/24/2015 22:07:59,1642791885,5/24/2015 22:06:25,false,neodev,1,24628757,CAN,,,107.179.231.99,54,173,,,70,176,PHOTOSENSITIVITY,SLE,PHOTOSENSITIVITY systemic or cutaneous lupus erythematosus,54-95-104-107-117-123,152-158-172-209-221-143,Systemic Lupus Erythematosus (SLE) and porphyria,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias.",54,,54,173,1,70,176,TWrex-cause,813307,"Unless the cause is obvious, patients with pronounced photosensitivity should be evaluated for systemic or cutaneous lupus erythematosus (see  Systemic Lupus Erythematosus (SLE)  and  Variant Forms of Lupus ) and perhaps porphyria (see  Porphyrias",photosensitivity,SLE
725373080,5/24/2015 19:01:54,1642724188,5/24/2015 19:01:37,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,62,99,,,75,111,BLASTOMYCOSIS,DERMATITIDIS,BLASTOMYCOSIS,62,99,DERMATITIDIS.,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis.,62,99,62,99,1,75,111,TWrex-cause,811519,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis,blastomycosis,dermatitidis
725373080,5/24/2015 19:03:03,1642724815,5/24/2015 19:02:22,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,62,99,,,75,111,BLASTOMYCOSIS,DERMATITIDIS,BLASTOMYCOSIS,62,87-99,Blastomyces DERMATITIDIS.,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis.,62,99,62,99,1,75,111,TWrex-cause,811519,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis,blastomycosis,dermatitidis
725373080,5/24/2015 19:03:33,1642725094,5/24/2015 19:03:19,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,62,99,,,75,111,BLASTOMYCOSIS,DERMATITIDIS,BLASTOMYCOSIS,62,87-99,Blastomyces DERMATITIDIS.,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis.,62,99,62,99,1,75,111,TWrex-cause,811519,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis,blastomycosis,dermatitidis
725373080,5/24/2015 19:04:01,1642725327,5/24/2015 19:03:42,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,62,99,,,75,111,BLASTOMYCOSIS,DERMATITIDIS,pulmonary and extrapulmonary BLASTOMYCOSIS,43-47-62-33,87-99,Blastomyces DERMATITIDIS.,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis.,62,99,62,99,1,75,111,TWrex-cause,811519,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis,blastomycosis,dermatitidis
725373080,5/24/2015 19:14:15,1642729876,5/24/2015 19:14:01,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,62,99,,,75,111,BLASTOMYCOSIS,DERMATITIDIS,extrapulmonary BLASTOMYCOSIS,47-62,87-99,Blastomyces DERMATITIDIS.,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis.,62,99,62,99,1,75,111,TWrex-cause,811519,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis,blastomycosis,dermatitidis
725373080,5/24/2015 19:23:50,1642739747,5/24/2015 19:23:38,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,62,99,,,75,111,BLASTOMYCOSIS,DERMATITIDIS,extrapulmonary BLASTOMYCOSIS,47-62,87-99,Blastomyces DERMATITIDIS.,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis.,62,99,62,99,1,75,111,TWrex-cause,811519,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis,blastomycosis,dermatitidis
725373080,5/24/2015 19:27:51,1642741870,5/24/2015 19:27:38,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,62,99,,,75,111,BLASTOMYCOSIS,DERMATITIDIS,extrapulmonary BLASTOMYCOSIS,47-62,87-99,Blastomyces DERMATITIDIS.,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis.,62,99,62,99,1,75,111,TWrex-cause,811519,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis,blastomycosis,dermatitidis
725373080,5/24/2015 19:34:26,1642745197,5/24/2015 19:34:08,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,62,99,,,75,111,BLASTOMYCOSIS,DERMATITIDIS,pulmonary and extrapulmonary BLASTOMYCOSIS,33-43-47-62,76-83-87-99,caused by Blastomyces DERMATITIDIS.,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis.,62,99,62,99,1,75,111,TWrex-cause,811519,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis,blastomycosis,dermatitidis
725373080,5/24/2015 19:34:40,1642745287,5/24/2015 19:33:48,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,62,99,,,75,111,BLASTOMYCOSIS,DERMATITIDIS,pulmonary and extrapulmonary BLASTOMYCOSIS,33-47-62-43,87-99,Blastomyces DERMATITIDIS.,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis.,62,99,62,99,1,75,111,TWrex-cause,811519,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis,blastomycosis,dermatitidis
725373080,5/24/2015 19:35:18,1642745536,5/24/2015 19:35:08,false,clixsense,1,6417722,USA,MI,Taylor,99.170.106.105,62,99,,,75,111,BLASTOMYCOSIS,DERMATITIDIS,pulmonary and extrapulmonary BLASTOMYCOSIS,33-43-47-62,87-99,Blastomyces DERMATITIDIS.,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis.,62,99,62,99,1,75,111,TWrex-cause,811519,423  Blastomycosis  Treatment of pulmonary and extrapulmonary blastomycosis caused by  Blastomyces dermatitidis,blastomycosis,dermatitidis
725373081,5/24/2015 19:01:15,1642723985,5/24/2015 19:00:50,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,153,70,,,170,79,CHRONIC HEPATITIS,RIBAVIRIN,CHRONIC HEPATITIS C:,153-161-171,70,RIBAVIRIN,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.",153 161,70,153,70,-1,170,79,TWrex-cause,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial",chronic hepatitis,ribavirin
725373081,5/24/2015 19:01:53,1642724190,5/24/2015 19:01:32,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,153,70,,,170,79,CHRONIC HEPATITIS,RIBAVIRIN,CHRONIC HEPATITIS C:,153-161-171,70,RIBAVIRIN,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.",153 161,70,153,70,-1,170,79,TWrex-cause,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial",chronic hepatitis,ribavirin
725373081,5/24/2015 19:02:58,1642724778,5/24/2015 19:02:37,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,153,70,,,170,79,CHRONIC HEPATITIS,RIBAVIRIN,CHRONIC HEPATITIS C:,153-161-171,70,RIBAVIRIN,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.",153 161,70,153,70,-1,170,79,TWrex-cause,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial",chronic hepatitis,ribavirin
725373081,5/24/2015 19:03:09,1642724857,5/24/2015 19:02:46,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,153,70,,,170,79,CHRONIC HEPATITIS,RIBAVIRIN,CHRONIC HEPATITIS C:,153-161-171,70,RIBAVIRIN,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.",153 161,70,153,70,-1,170,79,TWrex-cause,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial",chronic hepatitis,ribavirin
725373081,5/24/2015 19:11:53,1642728916,5/24/2015 19:11:16,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,153,70,,,170,79,CHRONIC HEPATITIS,RIBAVIRIN,CHRONIC HEPATITIS C:,153-161-171,43-57-62-65-70,Peginterferon alfa 2b plus RIBAVIRIN,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.",153 161,70,153,70,-1,170,79,TWrex-cause,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial",chronic hepatitis,ribavirin
725373081,5/24/2015 19:22:57,1642738859,5/24/2015 19:22:34,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,153,70,,,170,79,CHRONIC HEPATITIS,RIBAVIRIN,CHRONIC HEPATITIS C:,153-161-171,43-57-62-65-70,Peginterferon alfa 2b plus RIBAVIRIN,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.",153 161,70,153,70,-1,170,79,TWrex-cause,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial",chronic hepatitis,ribavirin
725373081,5/24/2015 19:27:16,1642741542,5/24/2015 19:26:57,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,153,70,,,170,79,CHRONIC HEPATITIS,RIBAVIRIN,CHRONIC HEPATITIS C:,153-161-171,70,RIBAVIRIN,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.",153 161,70,153,70,-1,170,79,TWrex-cause,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial",chronic hepatitis,ribavirin
725373081,5/24/2015 19:32:08,1642744036,5/24/2015 19:30:54,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,153,70,,,170,79,CHRONIC HEPATITIS,RIBAVIRIN,CHRONIC HEPATITIS C:,153-161-171,70,RIBAVIRIN,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.",153 161,70,153,70,-1,170,79,TWrex-cause,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial",chronic hepatitis,ribavirin
725373081,5/24/2015 19:33:21,1642744714,5/24/2015 19:32:36,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,153,70,,,170,79,CHRONIC HEPATITIS,RIBAVIRIN,initial treatment of CHRONIC HEPATITIS C:,132-140-150-153-161-171,57-62-65-70-80-89-94,alfa 2b plus RIBAVIRIN compared with interferon,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.",153 161,70,153,70,-1,170,79,TWrex-cause,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial",chronic hepatitis,ribavirin
725373081,5/24/2015 19:34:47,1642745342,5/24/2015 19:34:11,false,clixsense,1,6417722,USA,MI,Taylor,99.170.106.105,153,70,,,170,79,CHRONIC HEPATITIS,RIBAVIRIN,CHRONIC HEPATITIS C:,153-161-171,70,RIBAVIRIN,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.",153 161,70,153,70,-1,170,79,TWrex-cause,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial",chronic hepatitis,ribavirin
725373082,5/24/2015 21:00:55,1642771122,5/24/2015 21:00:40,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,19,34,,,21,36,MD,VA,"MD,",19,34,VA,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1.",19,34,19,34,-1,21,36,TWrex-cause,803525,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1",MD,VA
725373082,5/24/2015 21:01:11,1642771246,5/24/2015 21:00:53,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,19,34,,,21,36,MD,VA,"Allan V. Prochazka MD,",6-9-19-0,34-37-45,VA Medical Center,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1.",19,34,19,34,-1,21,36,TWrex-cause,803525,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1",MD,VA
725373082,5/24/2015 21:14:07,1642775583,5/24/2015 21:13:54,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,19,34,,,21,36,MD,VA,"MD,",19,34,VA,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1.",19,34,19,34,-1,21,36,TWrex-cause,803525,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1",MD,VA
725373082,5/24/2015 21:14:32,1642775716,5/24/2015 21:14:17,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,19,34,,,21,36,MD,VA,"MD, MSc Denver VA",19-23-27-34,19-23-27-34-37-45-52-60,"MD, MSc Denver VA Medical Center Denver, Colorado,","Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1.",19,34,19,34,-1,21,36,TWrex-cause,803525,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1",MD,VA
725373082,5/24/2015 21:26:08,1642779144,5/24/2015 21:24:51,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,19,34,,,21,36,MD,VA,"MD,",19,34-37-45,VA Medical Center,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1.",19,34,19,34,-1,21,36,TWrex-cause,803525,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1",MD,VA
725373082,5/24/2015 21:27:26,1642779482,5/24/2015 21:26:58,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,19,34,,,21,36,MD,VA,"Allan V. Prochazka MD, MSc",0-6-9-19-23,27-34-37-45,Denver VA Medical Center,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1.",19,34,19,34,-1,21,36,TWrex-cause,803525,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1",MD,VA
725373082,5/24/2015 21:27:50,1642779605,5/24/2015 21:27:35,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,19,34,,,21,36,MD,VA,"MD,",19,34,VA,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1.",19,34,19,34,-1,21,36,TWrex-cause,803525,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1",MD,VA
725373082,5/24/2015 21:59:17,1642789261,5/24/2015 21:58:49,false,neodev,1,31670127,USA,FL,Key West,162.233.108.112,19,34,,,21,36,MD,VA,"Allan V. Prochazka MD,",0-6-9-19,34-37-45-52,"VA Medical Center Denver,","Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1.",19,34,19,34,-1,21,36,TWrex-cause,803525,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1",MD,VA
725373082,5/24/2015 22:03:24,1642790519,5/24/2015 22:02:41,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,19,34,,,21,36,MD,VA,"MD,",19,27-34-37-45-52-23,"MSc Denver VA Medical Center Denver,","Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1.",19,34,19,34,-1,21,36,TWrex-cause,803525,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1",MD,VA
725373082,5/24/2015 22:06:14,1642791197,5/24/2015 22:04:45,false,neodev,1,24628757,CAN,,,107.179.231.99,19,34,,,21,36,MD,VA,"MD,",19,34,VA,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1.",19,34,19,34,-1,21,36,TWrex-cause,803525,"Allan V. Prochazka MD, MSc Denver VA Medical Center Denver, Colorado, USA    REFERENCES  1",MD,VA
725373083,5/24/2015 21:03:40,1642772137,5/24/2015 21:03:14,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,202,17,,,209,24,KIDNEY,DISEASE,KIDNEYS.,202,0-6-17,edit] Polycystic DISEASE,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys.,202,17,202,17,-1,209,24,TWrex-cause,802042,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys,kidney,disease
725373083,5/24/2015 21:04:21,1642772370,5/24/2015 21:04:02,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,202,17,,,209,24,KIDNEY,DISEASE,KIDNEYS.,202,17,DISEASE,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys.,202,17,202,17,-1,209,24,TWrex-cause,802042,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys,kidney,disease
725373083,5/24/2015 21:16:03,1642776201,5/24/2015 21:15:54,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,202,17,,,209,24,KIDNEY,DISEASE,KIDNEYS.,202,17,DISEASE,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys.,202,17,202,17,-1,209,24,TWrex-cause,802042,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys,kidney,disease
725373083,5/24/2015 21:17:05,1642776456,5/24/2015 21:16:53,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,202,17,,,209,24,KIDNEY,DISEASE,fluid the KIDNEYS.,185-198-202,6-17-25-28-32,Polycystic DISEASE of the Kidneys,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys.,202,17,202,17,-1,209,24,TWrex-cause,802042,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys,kidney,disease
725373083,5/24/2015 21:30:09,1642780313,5/24/2015 21:29:54,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,202,17,,,209,24,KIDNEY,DISEASE,KIDNEYS.,202,6-17,Polycystic DISEASE,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys.,202,17,202,17,-1,209,24,TWrex-cause,802042,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys,kidney,disease
725373083,5/24/2015 21:33:11,1642781535,5/24/2015 21:32:26,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,202,17,,,209,24,KIDNEY,DISEASE,fluid within the KIDNEYS.,185-191-198-202,6-17-25-28-32,Polycystic DISEASE of the Kidneys,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys.,202,17,202,17,-1,209,24,TWrex-cause,802042,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys,kidney,disease
725373083,5/24/2015 22:06:41,1642791433,5/24/2015 22:06:25,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,202,17,,,209,24,KIDNEY,DISEASE,KIDNEYS.,202,6-17,Polycystic DISEASE,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys.,202,17,202,17,-1,209,24,TWrex-cause,802042,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys,kidney,disease
725373083,5/24/2015 22:31:17,1642800829,5/24/2015 22:31:09,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,202,17,,,209,24,KIDNEY,DISEASE,KIDNEYS.,202,6-17-25-28-32,Polycystic DISEASE of the Kidneys,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys.,202,17,202,17,-1,209,24,TWrex-cause,802042,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys,kidney,disease
725373083,5/24/2015 22:44:19,1642804929,5/24/2015 22:44:16,false,clixsense,1,6344072,CAN,BC,Burnaby,172.218.166.58,202,17,,,209,24,KIDNEY,DISEASE,fluid within the KIDNEYS.,185-191-198-202,0-6-17-25-28-32,edit] Polycystic DISEASE of the Kidneys,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys.,202,17,202,17,-1,209,24,TWrex-cause,802042,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys,kidney,disease
725373083,5/24/2015 22:45:11,1642805193,5/24/2015 22:44:50,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,202,17,,,209,24,KIDNEY,DISEASE,KIDNEYS.,202,17,DISEASE,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys.,202,17,202,17,-1,209,24,TWrex-cause,802042,edit] Polycystic Disease of the Kidneys Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys,kidney,disease
725373084,5/24/2015 20:34:33,1642762724,5/24/2015 20:34:16,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,56,0,,,69,15,SHORT STATURE,PYKNODYSOSTOSIS,SHORT STATURE,56-62,0,PYKNODYSOSTOSIS:,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",56 62,0,56,0,1,69,15,TWrex-cause,813251,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft",short stature,pyknodysostosis
725373084,5/24/2015 21:00:20,1642770901,5/24/2015 21:00:08,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,56,0,,,69,15,SHORT STATURE,PYKNODYSOSTOSIS,SHORT STATURE,56-62,0,PYKNODYSOSTOSIS:,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",56 62,0,56,0,1,69,15,TWrex-cause,813251,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft",short stature,pyknodysostosis
725373084,5/24/2015 21:00:33,1642771012,5/24/2015 21:00:23,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,56,0,,,69,15,SHORT STATURE,PYKNODYSOSTOSIS,SHORT STATURE,56-62,0,PYKNODYSOSTOSIS:,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",56 62,0,56,0,1,69,15,TWrex-cause,813251,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft",short stature,pyknodysostosis
725373084,5/24/2015 21:13:41,1642775466,5/24/2015 21:13:25,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,56,0,,,69,15,SHORT STATURE,PYKNODYSOSTOSIS,"autosomal recessive disorder, SHORT STATURE",26-36-56-62-46,0-26-36-46,"PYKNODYSOSTOSIS: autosomal recessive disorder,","Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",56 62,0,56,0,1,69,15,TWrex-cause,813251,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft",short stature,pyknodysostosis
725373084,5/24/2015 21:14:01,1642775544,5/24/2015 21:13:48,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,56,0,,,69,15,SHORT STATURE,PYKNODYSOSTOSIS,"autosomal recessive disorder, SHORT STATURE",26-36-46-56-62,0,PYKNODYSOSTOSIS:,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",56 62,0,56,0,1,69,15,TWrex-cause,813251,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft",short stature,pyknodysostosis
725373084,5/24/2015 21:23:56,1642778425,5/24/2015 21:23:16,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,56,0,,,69,15,SHORT STATURE,PYKNODYSOSTOSIS,SHORT STATURE,56-62,0,PYKNODYSOSTOSIS:,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",56 62,0,56,0,1,69,15,TWrex-cause,813251,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft",short stature,pyknodysostosis
725373084,5/24/2015 21:26:32,1642779246,5/24/2015 21:26:12,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,56,0,,,69,15,SHORT STATURE,PYKNODYSOSTOSIS,SHORT STATURE,56-62,0,PYKNODYSOSTOSIS:,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",56 62,0,56,0,1,69,15,TWrex-cause,813251,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft",short stature,pyknodysostosis
725373084,5/24/2015 21:27:22,1642779459,5/24/2015 21:27:12,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,56,0,,,69,15,SHORT STATURE,PYKNODYSOSTOSIS,SHORT STATURE,56-62,0,PYKNODYSOSTOSIS:,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",56 62,0,56,0,1,69,15,TWrex-cause,813251,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft",short stature,pyknodysostosis
725373084,5/24/2015 21:46:44,1642785423,5/24/2015 21:45:32,false,neodev,1,17426565,CAN,BC,Burnaby,70.79.18.187,56,0,,,69,15,SHORT STATURE,PYKNODYSOSTOSIS,SHORT STATURE,56-62,0,PYKNODYSOSTOSIS:,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",56 62,0,56,0,1,69,15,TWrex-cause,813251,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft",short stature,pyknodysostosis
725373084,5/24/2015 21:57:47,1642788847,5/24/2015 21:57:31,false,neodev,1,31670127,USA,FL,Key West,162.233.108.112,56,0,,,69,15,SHORT STATURE,PYKNODYSOSTOSIS,SHORT STATURE,56-62,0,PYKNODYSOSTOSIS:,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft.",56 62,0,56,0,1,69,15,TWrex-cause,813251,"Pyknodysostosis:  In this autosomal recessive disorder, short stature becomes evident in early childhood; adult height is ≤ 150 cm (5 ft",short stature,pyknodysostosis
725373085,5/24/2015 19:02:14,1642724432,5/24/2015 19:01:55,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0,NICOTINE,Nicotine replacement therapy during pregnancy.,36,0,36,0,1,45,8,TWrex-cause,811999,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
725373085,5/24/2015 19:03:29,1642725023,5/24/2015 19:03:04,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,1,45,8,TWrex-cause,811999,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
725373085,5/24/2015 19:03:43,1642725145,5/24/2015 19:03:34,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0,NICOTINE,Nicotine replacement therapy during pregnancy.,36,0,36,0,1,45,8,TWrex-cause,811999,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
725373085,5/24/2015 19:04:20,1642725510,5/24/2015 19:04:02,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0,NICOTINE,Nicotine replacement therapy during pregnancy.,36,0,36,0,1,45,8,TWrex-cause,811999,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
725373085,5/24/2015 19:14:43,1642730061,5/24/2015 19:14:16,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,1,45,8,TWrex-cause,811999,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
725373085,5/24/2015 19:24:13,1642740041,5/24/2015 19:23:51,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,1,45,8,TWrex-cause,811999,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
725373085,5/24/2015 19:28:01,1642742012,5/24/2015 19:27:52,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0,NICOTINE,Nicotine replacement therapy during pregnancy.,36,0,36,0,1,45,8,TWrex-cause,811999,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
725373085,5/24/2015 19:35:20,1642745573,5/24/2015 19:34:45,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,1,45,8,TWrex-cause,811999,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
725373085,5/24/2015 19:35:23,1642745599,5/24/2015 19:34:27,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,36,0,,,45,8,PREGNANCY,NICOTINE,replacement therapy during PREGNANCY.,9-21-29-36,0-9,NICOTINE replacement,Nicotine replacement therapy during pregnancy.,36,0,36,0,1,45,8,TWrex-cause,811999,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
725373085,5/24/2015 19:35:27,1642745624,5/24/2015 19:35:19,false,clixsense,1,6417722,USA,MI,Taylor,99.170.106.105,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0,NICOTINE,Nicotine replacement therapy during pregnancy.,36,0,36,0,1,45,8,TWrex-cause,811999,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
725373086,5/24/2015 21:02:38,1642771727,5/24/2015 21:02:23,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,52,95,,,60,110,DIARRHEA,CROHN'S DISEASE,DIARRHEA,52,95-103,CROHN'S DISEASE,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures.",52,95 103,52,95,1,60,110,TWrex-cause,813142,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures",diarrhea,crohn's disease
725373086,5/24/2015 21:03:14,1642771966,5/24/2015 21:03:01,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,52,95,,,60,110,DIARRHEA,CROHN'S DISEASE,DIARRHEA,52,95-103,CROHN'S DISEASE,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures.",52,95 103,52,95,1,60,110,TWrex-cause,813142,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures",diarrhea,crohn's disease
725373086,5/24/2015 21:15:28,1642775927,5/24/2015 21:15:03,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,52,95,,,60,110,DIARRHEA,CROHN'S DISEASE,DIARRHEA,52,95-103,CROHN'S DISEASE,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures.",52,95 103,52,95,1,60,110,TWrex-cause,813142,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures",diarrhea,crohn's disease
725373086,5/24/2015 21:16:01,1642776184,5/24/2015 21:15:44,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,52,95,,,60,110,DIARRHEA,CROHN'S DISEASE,DIARRHEA,52,90-95-103,Anal CROHN'S DISEASE,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures.",52,95 103,52,95,1,60,110,TWrex-cause,813142,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures",diarrhea,crohn's disease
725373086,5/24/2015 21:28:49,1642779916,5/24/2015 21:28:34,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,52,95,,,60,110,DIARRHEA,CROHN'S DISEASE,DIARRHEA,52,95-103,CROHN'S DISEASE,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures.",52,95 103,52,95,1,60,110,TWrex-cause,813142,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures",diarrhea,crohn's disease
725373086,5/24/2015 21:29:00,1642779967,5/24/2015 21:28:34,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,52,95,,,60,110,DIARRHEA,CROHN'S DISEASE,DIARRHEA,52,90-95-103,Anal CROHN'S DISEASE,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures.",52,95 103,52,95,1,60,110,TWrex-cause,813142,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures",diarrhea,crohn's disease
725373086,5/24/2015 21:29:54,1642780246,5/24/2015 21:28:42,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,52,95,,,60,110,DIARRHEA,CROHN'S DISEASE,DIARRHEA,52,90-95-103,Anal CROHN'S DISEASE,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures.",52,95 103,52,95,1,60,110,TWrex-cause,813142,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures",diarrhea,crohn's disease
725373086,5/24/2015 22:05:05,1642790910,5/24/2015 22:04:47,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,52,95,,,60,110,DIARRHEA,CROHN'S DISEASE,DIARRHEA,52,90-95-103,Anal CROHN'S DISEASE,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures.",52,95 103,52,95,1,60,110,TWrex-cause,813142,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures",diarrhea,crohn's disease
725373086,5/24/2015 22:22:26,1642798148,5/24/2015 22:22:18,false,clixsense,1,30681680,NLD,11,Rotterdam,87.211.12.50,52,95,,,60,110,DIARRHEA,CROHN'S DISEASE,"be present, including DIARRHEA and bleeding or",30-33-42-52-61-65-74,77-84-90-95-103-111-114-118,weight loss Anal CROHN'S DISEASE is the most,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures.",52,95 103,52,95,1,60,110,TWrex-cause,813142,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures",diarrhea,crohn's disease
725373086,5/24/2015 22:24:30,1642798801,5/24/2015 22:24:17,false,tremorgames,1,17272211,USA,PA,Havertown,173.49.116.92,52,95,,,60,110,DIARRHEA,CROHN'S DISEASE,DIARRHEA,52,90-95-103,Anal CROHN'S DISEASE,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures.",52,95 103,52,95,1,60,110,TWrex-cause,813142,"Other symptoms of colitis may be present, including diarrhea and bleeding or weight loss  Anal Crohn's disease is the most significant secondary diagnosis to consider in patients with atypical fissures",diarrhea,crohn's disease
725373087,5/24/2015 21:04:44,1642772530,5/24/2015 21:04:28,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,2,108,,,19,120,CUTANEOUS ANTHRAX,B. ANTHRACIS,CUTANEOUS ANTHRAX,2-12,108-111-122-128,B. ANTHRACIS edema toxin,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24.",2 12,108 111,2,108,1,19,120,TWrex-cause,811940,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24",cutaneous anthrax,b. anthracis
725373087,5/24/2015 21:05:06,1642772644,5/24/2015 21:04:48,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,2,108,,,19,120,CUTANEOUS ANTHRAX,B. ANTHRACIS,CUTANEOUS ANTHRAX,2-12,108-111,B. ANTHRACIS,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24.",2 12,108 111,2,108,1,19,120,TWrex-cause,811940,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24",cutaneous anthrax,b. anthracis
725373087,5/24/2015 21:18:02,1642776674,5/24/2015 21:17:36,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,2,108,,,19,120,CUTANEOUS ANTHRAX,B. ANTHRACIS,• CUTANEOUS ANTHRAX on the face or neck,0-2-12-20-23-27-32-35,86-95-104-108-111-122-128-136,response elicited by B. ANTHRACIS edema toxin 24.,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24.",2 12,108 111,2,108,1,19,120,TWrex-cause,811940,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24",cutaneous anthrax,b. anthracis
725373087,5/24/2015 21:31:21,1642780665,5/24/2015 21:30:58,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,2,108,,,19,120,CUTANEOUS ANTHRAX,B. ANTHRACIS,CUTANEOUS ANTHRAX,2-12,108-111-122-128,B. ANTHRACIS edema toxin,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24.",2 12,108 111,2,108,1,19,120,TWrex-cause,811940,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24",cutaneous anthrax,b. anthracis
725373087,5/24/2015 21:39:27,1642783313,5/24/2015 21:38:07,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,2,108,,,19,120,CUTANEOUS ANTHRAX,B. ANTHRACIS,CUTANEOUS ANTHRAX,2-12,108-111-122-128,B. ANTHRACIS edema toxin,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24.",2 12,108 111,2,108,1,19,120,TWrex-cause,811940,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24",cutaneous anthrax,b. anthracis
725373087,5/24/2015 22:07:42,1642791745,5/24/2015 22:07:24,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,2,108,,,19,120,CUTANEOUS ANTHRAX,B. ANTHRACIS,CUTANEOUS ANTHRAX,2-12,108-111-122-128,B. ANTHRACIS edema toxin,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24.",2 12,108 111,2,108,1,19,120,TWrex-cause,811940,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24",cutaneous anthrax,b. anthracis
725373087,5/24/2015 22:45:47,1642805363,5/24/2015 22:45:43,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,2,108,,,19,120,CUTANEOUS ANTHRAX,B. ANTHRACIS,• CUTANEOUS ANTHRAX on the face,0-2-12-20-23-27,86-95-104-108-111-122-128-136,response elicited by B. ANTHRACIS edema toxin 24.,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24.",2 12,108 111,2,108,1,19,120,TWrex-cause,811940,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24",cutaneous anthrax,b. anthracis
725373087,5/24/2015 22:49:18,1642806365,5/24/2015 22:49:03,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,2,108,,,19,120,CUTANEOUS ANTHRAX,B. ANTHRACIS,CUTANEOUS ANTHRAX,2-12,108-111,B. ANTHRACIS,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24.",2 12,108 111,2,108,1,19,120,TWrex-cause,811940,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24",cutaneous anthrax,b. anthracis
725373087,5/24/2015 22:54:25,1642807755,5/24/2015 22:52:32,false,clixsense,1,26770238,CAN,ON,Ilderton,209.183.157.27,2,108,,,19,120,CUTANEOUS ANTHRAX,B. ANTHRACIS,• CUTANEOUS ANTHRAX anthracis edema toxin,0-2-12-111-122-128,86-95-104-108-111-122-128-136,response elicited by B. ANTHRACIS edema toxin 24.,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24.",2 12,108 111,2,108,1,19,120,TWrex-cause,811940,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24",cutaneous anthrax,b. anthracis
725373087,5/24/2015 22:55:32,1642808074,5/24/2015 22:54:47,false,points4rewards,1,28703583,USA,,,97.73.85.52,2,108,,,19,120,CUTANEOUS ANTHRAX,B. ANTHRACIS,CUTANEOUS ANTHRAX,2-12,2-12-108-111-122-128,Cutaneous anthrax B. ANTHRACIS edema toxin,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24.",2 12,108 111,2,108,1,19,120,TWrex-cause,811940,"• Cutaneous anthrax on the face or neck may compromise breathing, given the edematous response elicited by  B. anthracis  edema toxin ( 24",cutaneous anthrax,b. anthracis
725373088,5/24/2015 19:54:21,1642752216,5/24/2015 19:54:07,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,36,54,,,41,64,COLON,MICROCOLON,COLON,36,54,MICROCOLON.,"The relatively empty, small-caliber colon is called a microcolon.",36,54,36,54,-1,41,64,TWrex-cause,802353,"The relatively empty, small-caliber colon is called a microcolon",colon,microcolon
725373088,5/24/2015 19:55:36,1642752640,5/24/2015 19:55:21,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,36,54,,,41,64,COLON,MICROCOLON,COLON,36,54,MICROCOLON.,"The relatively empty, small-caliber colon is called a microcolon.",36,54,36,54,-1,41,64,TWrex-cause,802353,"The relatively empty, small-caliber colon is called a microcolon",colon,microcolon
725373088,5/24/2015 19:55:42,1642752660,5/24/2015 19:55:27,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,36,54,,,41,64,COLON,MICROCOLON,COLON,36,54,MICROCOLON.,"The relatively empty, small-caliber colon is called a microcolon.",36,54,36,54,-1,41,64,TWrex-cause,802353,"The relatively empty, small-caliber colon is called a microcolon",colon,microcolon
725373088,5/24/2015 20:02:39,1642754573,5/24/2015 20:02:27,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,36,54,,,41,64,COLON,MICROCOLON,COLON,36,54,MICROCOLON.,"The relatively empty, small-caliber colon is called a microcolon.",36,54,36,54,-1,41,64,TWrex-cause,802353,"The relatively empty, small-caliber colon is called a microcolon",colon,microcolon
725373088,5/24/2015 20:08:44,1642756169,5/24/2015 20:08:22,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,36,54,,,41,64,COLON,MICROCOLON,"The relatively empty, small - caliber COLON is called a microcolon.",0-4-15-22-28-36-42-45-52-54-27,0-4-15-22-27-28-42-45-52-54-36,"The relatively empty, small - caliber colon is called a MICROCOLON.","The relatively empty, small-caliber colon is called a microcolon.",36,54,36,54,-1,41,64,TWrex-cause,802353,"The relatively empty, small-caliber colon is called a microcolon",colon,microcolon
725373088,5/24/2015 20:25:07,1642760273,5/24/2015 20:24:49,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,36,54,,,41,64,COLON,MICROCOLON,COLON,36,54,MICROCOLON.,"The relatively empty, small-caliber colon is called a microcolon.",36,54,36,54,-1,41,64,TWrex-cause,802353,"The relatively empty, small-caliber colon is called a microcolon",colon,microcolon
725373088,5/24/2015 20:28:33,1642761227,5/24/2015 20:28:21,false,instagc,1,19740138,CAN,,,50.69.96.237,36,54,,,41,64,COLON,MICROCOLON,COLON,36,54,MICROCOLON.,"The relatively empty, small-caliber colon is called a microcolon.",36,54,36,54,-1,41,64,TWrex-cause,802353,"The relatively empty, small-caliber colon is called a microcolon",colon,microcolon
725373088,5/24/2015 20:29:02,1642761442,5/24/2015 20:28:49,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,36,54,,,41,64,COLON,MICROCOLON,COLON,36,54,MICROCOLON.,"The relatively empty, small-caliber colon is called a microcolon.",36,54,36,54,-1,41,64,TWrex-cause,802353,"The relatively empty, small-caliber colon is called a microcolon",colon,microcolon
725373088,5/24/2015 20:32:41,1642762265,5/24/2015 20:32:25,false,neodev,1,29074051,GBR,G5,Folkestone,80.6.67.18,36,54,,,41,64,COLON,MICROCOLON,COLON,36,54,MICROCOLON.,"The relatively empty, small-caliber colon is called a microcolon.",36,54,36,54,-1,41,64,TWrex-cause,802353,"The relatively empty, small-caliber colon is called a microcolon",colon,microcolon
725373088,5/24/2015 20:50:26,1642767248,5/24/2015 20:50:12,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,36,54,,,41,64,COLON,MICROCOLON,small caliber COLON,22-28-36,54,MICROCOLON.,"The relatively empty, small-caliber colon is called a microcolon.",36,54,36,54,-1,41,64,TWrex-cause,802353,"The relatively empty, small-caliber colon is called a microcolon",colon,microcolon
725373089,5/24/2015 18:57:27,1642722201,5/24/2015 18:57:09,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,6,41,,,15,51,PREGNANCY,FOSINOPRIL,PREGNANCY,6,41,FOSINOPRIL,"•  If pregnancy is detected, discontinue fosinopril as soon as possible.",6,41,6,41,-1,15,51,TWrex-cause,803094,"•  If pregnancy is detected, discontinue fosinopril as soon as possible",pregnancy,fosinopril
725373089,5/24/2015 18:57:35,1642722267,5/24/2015 18:57:08,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,6,41,,,15,51,PREGNANCY,FOSINOPRIL,PREGNANCY,6,41,FOSINOPRIL,"•  If pregnancy is detected, discontinue fosinopril as soon as possible.",6,41,6,41,-1,15,51,TWrex-cause,803094,"•  If pregnancy is detected, discontinue fosinopril as soon as possible",pregnancy,fosinopril
725373089,5/24/2015 18:59:34,1642723169,5/24/2015 18:59:08,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,6,41,,,15,51,PREGNANCY,FOSINOPRIL,PREGNANCY,6,41,FOSINOPRIL,"•  If pregnancy is detected, discontinue fosinopril as soon as possible.",6,41,6,41,-1,15,51,TWrex-cause,803094,"•  If pregnancy is detected, discontinue fosinopril as soon as possible",pregnancy,fosinopril
725373089,5/24/2015 18:59:53,1642723301,5/24/2015 18:59:43,false,neodev,1,32456300,USA,CA,Laguna Niguel,216.177.129.227,6,41,,,15,51,PREGNANCY,FOSINOPRIL,"• If PREGNANCY is detected, discontinue",0-3-6-16-19-29,16-19-29-41-52-55-60,"is detected, discontinue FOSINOPRIL as soon as","•  If pregnancy is detected, discontinue fosinopril as soon as possible.",6,41,6,41,-1,15,51,TWrex-cause,803094,"•  If pregnancy is detected, discontinue fosinopril as soon as possible",pregnancy,fosinopril
725373089,5/24/2015 18:59:55,1642723340,5/24/2015 18:58:49,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,6,41,,,15,51,PREGNANCY,FOSINOPRIL,• PREGNANCY,0-6,41,FOSINOPRIL,"•  If pregnancy is detected, discontinue fosinopril as soon as possible.",6,41,6,41,-1,15,51,TWrex-cause,803094,"•  If pregnancy is detected, discontinue fosinopril as soon as possible",pregnancy,fosinopril
725373089,5/24/2015 19:04:55,1642725751,5/24/2015 19:03:10,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,6,41,,,15,51,PREGNANCY,FOSINOPRIL,PREGNANCY,6,41,FOSINOPRIL,"•  If pregnancy is detected, discontinue fosinopril as soon as possible.",6,41,6,41,-1,15,51,TWrex-cause,803094,"•  If pregnancy is detected, discontinue fosinopril as soon as possible",pregnancy,fosinopril
725373089,5/24/2015 19:19:29,1642734026,5/24/2015 19:19:06,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,6,41,,,15,51,PREGNANCY,FOSINOPRIL,PREGNANCY,6,41,FOSINOPRIL,"•  If pregnancy is detected, discontinue fosinopril as soon as possible.",6,41,6,41,-1,15,51,TWrex-cause,803094,"•  If pregnancy is detected, discontinue fosinopril as soon as possible",pregnancy,fosinopril
725373089,5/24/2015 19:24:25,1642740163,5/24/2015 19:24:09,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,6,41,,,15,51,PREGNANCY,FOSINOPRIL,PREGNANCY,6,41,FOSINOPRIL,"•  If pregnancy is detected, discontinue fosinopril as soon as possible.",6,41,6,41,-1,15,51,TWrex-cause,803094,"•  If pregnancy is detected, discontinue fosinopril as soon as possible",pregnancy,fosinopril
725373089,5/24/2015 19:24:45,1642740330,5/24/2015 19:24:25,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,6,41,,,15,51,PREGNANCY,FOSINOPRIL,PREGNANCY,6,41,FOSINOPRIL,"•  If pregnancy is detected, discontinue fosinopril as soon as possible.",6,41,6,41,-1,15,51,TWrex-cause,803094,"•  If pregnancy is detected, discontinue fosinopril as soon as possible",pregnancy,fosinopril
725373089,5/24/2015 19:25:07,1642740464,5/24/2015 19:24:03,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,6,41,,,15,51,PREGNANCY,FOSINOPRIL,PREGNANCY,6,41,FOSINOPRIL,"•  If pregnancy is detected, discontinue fosinopril as soon as possible.",6,41,6,41,-1,15,51,TWrex-cause,803094,"•  If pregnancy is detected, discontinue fosinopril as soon as possible",pregnancy,fosinopril
725373090,5/24/2015 19:51:32,1642751434,5/24/2015 19:51:17,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,161,94,,,176,96,THROMBOCYTHEMIA,PV,"THROMBOCYTHEMIA,",161,94,"PV,","• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.",161,94,161,94,1,176,96,TWrex-cause,812771,"• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2",thrombocythemia,pv
725373090,5/24/2015 19:51:33,1642751435,5/24/2015 19:50:24,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,161,94,,,176,96,THROMBOCYTHEMIA,PV,"A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of THROMBOCYTHEMIA, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high",2-4-11-14-18-26-34-37-40-50-54-63-77-80-89-94-98-101-108-111-125-137-150-158-161-178-182-189-193-198-202-207-210-216-225-234-243-246-253-264-267-272-274-285-293-297-300-304-307,2-4-11-14-18-26-34-37-40-50-54-63-77-80-89-94-98-101-108-111-125-137-150-158-161-178-182-189-193-198-202-207-210-216-225-234-243-246-253-264-267-272-274-285-293-297-300-304-307,"A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high","• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.",161,94,161,94,1,176,96,TWrex-cause,812771,"• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2",thrombocythemia,pv
725373090,5/24/2015 19:52:09,1642751529,5/24/2015 19:51:27,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,161,94,,,176,96,THROMBOCYTHEMIA,PV,"disturbances typical of THROMBOCYTHEMIA,",137-150-158-161,80-89-94,"patients with PV,","• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.",161,94,161,94,1,176,96,TWrex-cause,812771,"• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2",thrombocythemia,pv
725373090,5/24/2015 19:52:20,1642751549,5/24/2015 19:52:05,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,161,94,,,176,96,THROMBOCYTHEMIA,PV,"THROMBOCYTHEMIA,",161,94,"PV,","• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.",161,94,161,94,1,176,96,TWrex-cause,812771,"• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2",thrombocythemia,pv
725373090,5/24/2015 19:52:32,1642751577,5/24/2015 19:52:15,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,161,94,,,176,96,THROMBOCYTHEMIA,PV,"THROMBOCYTHEMIA,",161,94,"PV,","• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.",161,94,161,94,1,176,96,TWrex-cause,812771,"• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2",thrombocythemia,pv
725373090,5/24/2015 19:59:16,1642753657,5/24/2015 19:59:01,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,161,94,,,176,96,THROMBOCYTHEMIA,PV,"THROMBOCYTHEMIA,",161,94,"PV,","• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.",161,94,161,94,1,176,96,TWrex-cause,812771,"• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2",thrombocythemia,pv
725373090,5/24/2015 20:12:05,1642757125,5/24/2015 20:11:39,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,161,94,,,176,96,THROMBOCYTHEMIA,PV,"THROMBOCYTHEMIA,",161,94,"PV,","• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.",161,94,161,94,1,176,96,TWrex-cause,812771,"• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2",thrombocythemia,pv
725373090,5/24/2015 20:13:29,1642757542,5/24/2015 20:13:03,false,instagc,1,19740138,CAN,,,50.69.96.237,161,94,,,176,96,THROMBOCYTHEMIA,PV,"THROMBOCYTHEMIA,",161,94,"PV,","• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.",161,94,161,94,1,176,96,TWrex-cause,812771,"• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2",thrombocythemia,pv
725373090,5/24/2015 20:16:18,1642758325,5/24/2015 20:15:49,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,161,94,,,176,96,THROMBOCYTHEMIA,PV,"THROMBOCYTHEMIA,",161,94,"PV,","• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.",161,94,161,94,1,176,96,TWrex-cause,812771,"• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2",thrombocythemia,pv
725373090,5/24/2015 20:20:32,1642759259,5/24/2015 20:20:13,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,161,94,,,176,96,THROMBOCYTHEMIA,PV,"THROMBOCYTHEMIA,",161,94,"PV,","• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2.",161,94,161,94,1,176,96,TWrex-cause,812771,"• A review on the natural history of PV addresses the vascular complications in patients with PV, in regard to microvascular circulatory disturbances typical of thrombocythemia, and points out that the risk of major vascular ischemic episodes in poorly controlled PV with a hematocrit between 45% to 50% is high ( 2",thrombocythemia,pv
725373091,5/24/2015 19:52:54,1642751701,5/24/2015 19:52:42,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,17,78,,,28,89,PSITTACOSIS,C. PSITTACI,PSITTACOSIS,17,78-81,C. PSITTACI,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions.",17,78 81,17,78,1,28,89,TWrex-cause,811122,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions",psittacosis,C. psittaci
725373091,5/24/2015 19:54:05,1642752165,5/24/2015 19:53:42,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,17,78,,,28,89,PSITTACOSIS,C. PSITTACI,PSITTACOSIS,17,78-81,C. PSITTACI,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions.",17,78 81,17,78,1,28,89,TWrex-cause,811122,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions",psittacosis,C. psittaci
725373091,5/24/2015 19:54:09,1642752193,5/24/2015 19:53:54,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,17,78,,,28,89,PSITTACOSIS,C. PSITTACI,PSITTACOSIS,17,78-81,C. PSITTACI,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions.",17,78 81,17,78,1,28,89,TWrex-cause,811122,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions",psittacosis,C. psittaci
725373091,5/24/2015 20:01:04,1642754148,5/24/2015 20:00:46,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,17,78,,,28,89,PSITTACOSIS,C. PSITTACI,PSITTACOSIS,17,78-81,C. PSITTACI,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions.",17,78 81,17,78,1,28,89,TWrex-cause,811122,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions",psittacosis,C. psittaci
725373091,5/24/2015 20:05:32,1642755229,5/24/2015 20:04:55,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,17,78,,,28,89,PSITTACOSIS,C. PSITTACI,"The diagnosis of PSITTACOSIS is best confirmed by serologic studies, because C. psittaci is difficult to isolate from blood or infected secretions.",0-4-14-17-29-32-37-47-50-60-69-78-81-91-94-104-107-115-120-126-129-138,0-4-14-17-29-32-37-47-50-60-69-78-81-91-94-104-107-115-120-126-129-138,"The diagnosis of psittacosis is best confirmed by serologic studies, because C. PSITTACI is difficult to isolate from blood or infected secretions.","The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions.",17,78 81,17,78,1,28,89,TWrex-cause,811122,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions",psittacosis,C. psittaci
725373091,5/24/2015 20:13:42,1642757568,5/24/2015 20:13:29,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,17,78,,,28,89,PSITTACOSIS,C. PSITTACI,PSITTACOSIS,17,78-81,C. PSITTACI,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions.",17,78 81,17,78,1,28,89,TWrex-cause,811122,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions",psittacosis,C. psittaci
725373091,5/24/2015 20:22:13,1642759631,5/24/2015 20:21:57,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,17,78,,,28,89,PSITTACOSIS,C. PSITTACI,PSITTACOSIS,17,78-81,C. PSITTACI,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions.",17,78 81,17,78,1,28,89,TWrex-cause,811122,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions",psittacosis,C. psittaci
725373091,5/24/2015 20:25:47,1642760349,5/24/2015 20:25:34,false,instagc,1,19740138,CAN,,,50.69.96.237,17,78,,,28,89,PSITTACOSIS,C. PSITTACI,PSITTACOSIS,17,78-81,C. PSITTACI,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions.",17,78 81,17,78,1,28,89,TWrex-cause,811122,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions",psittacosis,C. psittaci
725373091,5/24/2015 20:27:29,1642760809,5/24/2015 20:27:09,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,17,78,,,28,89,PSITTACOSIS,C. PSITTACI,PSITTACOSIS,17,78-81,C. PSITTACI,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions.",17,78 81,17,78,1,28,89,TWrex-cause,811122,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions",psittacosis,C. psittaci
725373091,5/24/2015 20:28:22,1642761141,5/24/2015 20:28:08,false,cointasker,1,21783324,NLD,,,31.151.239.133,17,78,,,28,89,PSITTACOSIS,C. PSITTACI,PSITTACOSIS,17,78-81,C. PSITTACI,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions.",17,78 81,17,78,1,28,89,TWrex-cause,811122,"The diagnosis of psittacosis is best confirmed by serologic studies, because  C. psittaci  is difficult to isolate from blood or infected secretions",psittacosis,C. psittaci
725373092,5/24/2015 19:48:12,1642750485,5/24/2015 19:47:33,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,23,126,,,35,145,HYPERTENSION,HYDROCHLOROTHIAZIDE,Geriatric Patients HYPERTENSION &gt; Enalapril / Hydrochlorothiazide Combination Therapy Initiate therapy with enalapril / hydrochlorothiazide fixed combination at lower end of usual range.,3-13-23-37-43-53-73-85-94-103-111-116-125-126-146-152-164-167-173-177-180-186-52,3-13-23-37-43-52-53-73-85-94-103-111-116-125-126-146-152-164-167-173-177-180-186,Geriatric Patients Hypertension &gt; Enalapril / Hydrochlorothiazide Combination Therapy Initiate therapy with enalapril / HYDROCHLOROTHIAZIDE fixed combination at lower end of usual range.,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range.,23,126,23,126,-1,35,145,TWrex-cause,804154,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range,hypertension,hydrochlorothiazide
725373092,5/24/2015 19:48:45,1642750642,5/24/2015 19:47:53,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,23,126,,,35,145,HYPERTENSION,HYDROCHLOROTHIAZIDE,Geriatric Patients HYPERTENSION,3-13-23,103-111-116-126,therapy with enalapril HYDROCHLOROTHIAZIDE,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range.,23,126,23,126,-1,35,145,TWrex-cause,804154,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range,hypertension,hydrochlorothiazide
725373092,5/24/2015 19:50:18,1642751111,5/24/2015 19:49:58,false,neodev,1,31743852,GBR,G5,Faversham,85.210.123.52,23,126,,,35,145,HYPERTENSION,HYDROCHLOROTHIAZIDE,1 HYPERTENSION Enalapril Hydrochlorothiazide Combination Therapy,0-23-43-53-73-85,23-43-53-73-103-111-116-126-146-152-164-85,Hypertension Enalapril Hydrochlorothiazide Combination Therapy therapy with enalapril HYDROCHLOROTHIAZIDE fixed combination at,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range.,23,126,23,126,-1,35,145,TWrex-cause,804154,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range,hypertension,hydrochlorothiazide
725373092,5/24/2015 19:50:33,1642751206,5/24/2015 19:50:19,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,23,126,,,35,145,HYPERTENSION,HYDROCHLOROTHIAZIDE,HYPERTENSION,23,126,HYDROCHLOROTHIAZIDE,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range.,23,126,23,126,-1,35,145,TWrex-cause,804154,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range,hypertension,hydrochlorothiazide
725373092,5/24/2015 19:50:53,1642751298,5/24/2015 19:50:33,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,23,126,,,35,145,HYPERTENSION,HYDROCHLOROTHIAZIDE,HYPERTENSION,23,126,HYDROCHLOROTHIAZIDE,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range.,23,126,23,126,-1,35,145,TWrex-cause,804154,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range,hypertension,hydrochlorothiazide
725373092,5/24/2015 19:51:24,1642751401,5/24/2015 19:51:07,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,23,126,,,35,145,HYPERTENSION,HYDROCHLOROTHIAZIDE,HYPERTENSION,23,126,HYDROCHLOROTHIAZIDE,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range.,23,126,23,126,-1,35,145,TWrex-cause,804154,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range,hypertension,hydrochlorothiazide
725373092,5/24/2015 19:56:44,1642753061,5/24/2015 19:56:18,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,23,126,,,35,145,HYPERTENSION,HYDROCHLOROTHIAZIDE,HYPERTENSION,23,126,HYDROCHLOROTHIAZIDE,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range.,23,126,23,126,-1,35,145,TWrex-cause,804154,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range,hypertension,hydrochlorothiazide
725373092,5/24/2015 20:10:36,1642756733,5/24/2015 20:10:22,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,23,126,,,35,145,HYPERTENSION,HYDROCHLOROTHIAZIDE,HYPERTENSION,23,126,HYDROCHLOROTHIAZIDE,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range.,23,126,23,126,-1,35,145,TWrex-cause,804154,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range,hypertension,hydrochlorothiazide
725373092,5/24/2015 20:11:50,1642757044,5/24/2015 20:11:28,false,instagc,1,19740138,CAN,,,50.69.96.237,23,126,,,35,145,HYPERTENSION,HYDROCHLOROTHIAZIDE,HYPERTENSION,23,126,HYDROCHLOROTHIAZIDE,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range.,23,126,23,126,-1,35,145,TWrex-cause,804154,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range,hypertension,hydrochlorothiazide
725373092,5/24/2015 20:13:51,1642757605,5/24/2015 20:12:40,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,23,126,,,35,145,HYPERTENSION,HYDROCHLOROTHIAZIDE,Geriatric Patients HYPERTENSION,3-13-23,116-126,enalapril HYDROCHLOROTHIAZIDE,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range.,23,126,23,126,-1,35,145,TWrex-cause,804154,1  Geriatric Patients  Hypertension  >     Enalapril/Hydrochlorothiazide Combination Therapy  Initiate therapy with enalapril/hydrochlorothiazide fixed combination at lower end of usual range,hypertension,hydrochlorothiazide
725373093,5/24/2015 18:54:48,1642720899,5/24/2015 18:54:18,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,91,42,,,102,56,INFERTILITY,CELIAC DISEASE,unexplained INFERTILITY.,91-79,42-49,CELIAC DISEASE,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility.,91,42 49,91,42,1,102,56,TWrex-cause,814537,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility,infertility,celiac disease
725373093,5/24/2015 18:55:32,1642721238,5/24/2015 18:55:12,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,91,42,,,102,56,INFERTILITY,CELIAC DISEASE,INFERTILITY.,91,42-49,CELIAC DISEASE,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility.,91,42 49,91,42,1,102,56,TWrex-cause,814537,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility,infertility,celiac disease
725373093,5/24/2015 18:55:32,1642721240,5/24/2015 18:55:16,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,91,42,,,102,56,INFERTILITY,CELIAC DISEASE,INFERTILITY.,91,29-42-49,• CELIAC DISEASE,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility.,91,42 49,91,42,1,102,56,TWrex-cause,814537,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility,infertility,celiac disease
725373093,5/24/2015 18:56:32,1642721708,5/24/2015 18:56:11,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,91,42,,,102,56,INFERTILITY,CELIAC DISEASE,INFERTILITY.,91,42-49,CELIAC DISEASE,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility.,91,42 49,91,42,1,102,56,TWrex-cause,814537,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility,infertility,celiac disease
725373093,5/24/2015 18:57:07,1642722038,5/24/2015 18:56:49,false,neodev,1,32456300,USA,CA,Laguna Niguel,216.177.129.227,91,42,,,102,56,INFERTILITY,CELIAC DISEASE,men and women with unexplained INFERTILITY.,60-68-74-79-91-64,29-31-38-42-49-57-60-64-68,• Screen for CELIAC DISEASE in men and women,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility.,91,42 49,91,42,1,102,56,TWrex-cause,814537,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility,infertility,celiac disease
725373093,5/24/2015 18:59:11,1642722997,5/24/2015 18:58:33,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,91,42,,,102,56,INFERTILITY,CELIAC DISEASE,unexplained INFERTILITY.,79-91,42-49,CELIAC DISEASE,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility.,91,42 49,91,42,1,102,56,TWrex-cause,814537,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility,infertility,celiac disease
725373093,5/24/2015 19:01:13,1642723958,5/24/2015 19:00:58,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,91,42,,,102,56,INFERTILITY,CELIAC DISEASE,celiac disease women with unexplained INFERTILITY.,42-68-74-79-91-49,29-31-38-42-49-57-60-64-79-91,• Screen for CELIAC DISEASE in men and unexplained infertility.,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility.,91,42 49,91,42,1,102,56,TWrex-cause,814537,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility,infertility,celiac disease
725373093,5/24/2015 19:08:42,1642727521,5/24/2015 19:08:33,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,91,42,,,102,56,INFERTILITY,CELIAC DISEASE,INFERTILITY.,91,42-49,CELIAC DISEASE,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility.,91,42 49,91,42,1,102,56,TWrex-cause,814537,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility,infertility,celiac disease
725373093,5/24/2015 19:18:15,1642732548,5/24/2015 19:17:06,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,91,42,,,102,56,INFERTILITY,CELIAC DISEASE,unexplained INFERTILITY.,79-91,42-49,CELIAC DISEASE,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility.,91,42 49,91,42,1,102,56,TWrex-cause,814537,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility,infertility,celiac disease
725373093,5/24/2015 19:18:25,1642732778,5/24/2015 19:17:13,false,pocketmoneygpt,1,32162555,CAN,BC,Vancouver,108.180.194.80,91,42,,,102,56,INFERTILITY,CELIAC DISEASE,INFERTILITY.,91,42-49,CELIAC DISEASE,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility.,91,42 49,91,42,1,102,56,TWrex-cause,814537,B]  Specific recommendation: • Screen for celiac disease in men and women with unexplained infertility,infertility,celiac disease
725373094,5/24/2015 20:28:18,1642761116,5/24/2015 20:28:03,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,142,0,,,155,3,GENITAL WART,HPV,GENITAL WARTS,142-150,0,HPV,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer.",142 150,0,142,0,1,155,3,TWrex-cause,814775,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer",genital wart,HPV
725373094,5/24/2015 20:32:51,1642762325,5/24/2015 20:32:35,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,142,0,,,155,3,GENITAL WART,HPV,GENITAL WARTS,142-150,0,HPV,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer.",142 150,0,142,0,1,155,3,TWrex-cause,814775,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer",genital wart,HPV
725373094,5/24/2015 20:59:00,1642770387,5/24/2015 20:58:47,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,142,0,,,155,3,GENITAL WART,HPV,GENITAL WARTS,142-150,0,HPV,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer.",142 150,0,142,0,1,155,3,TWrex-cause,814775,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer",genital wart,HPV
725373094,5/24/2015 20:59:04,1642770413,5/24/2015 20:58:49,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,142,0,,,155,3,GENITAL WART,HPV,GENITAL WARTS,142-150,0,HPV,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer.",142 150,0,142,0,1,155,3,TWrex-cause,814775,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer",genital wart,HPV
725373094,5/24/2015 21:00:49,1642771090,5/24/2015 21:00:22,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,142,0,,,155,3,GENITAL WART,HPV,GENITAL WARTS cervical cancer.,142-150-160-169,0,HPV,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer.",142 150,0,142,0,1,155,3,TWrex-cause,814775,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer",genital wart,HPV
725373094,5/24/2015 21:09:34,1642774180,5/24/2015 21:09:24,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,142,0,,,155,3,GENITAL WART,HPV,GENITAL WARTS,142-150,0,HPV,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer.",142 150,0,142,0,1,155,3,TWrex-cause,814775,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer",genital wart,HPV
725373094,5/24/2015 21:12:06,1642774954,5/24/2015 21:11:53,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,142,0,,,155,3,GENITAL WART,HPV,GENITAL WARTS and cervical cancer.,142-150-156-160-169,0-4-11-13,HPV v. A vaccine,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer.",142 150,0,142,0,1,155,3,TWrex-cause,814775,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer",genital wart,HPV
725373094,5/24/2015 21:14:42,1642775759,5/24/2015 21:13:11,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,142,0,,,155,3,GENITAL WART,HPV,GENITAL WARTS,142-150,0,HPV,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer.",142 150,0,142,0,1,155,3,TWrex-cause,814775,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer",genital wart,HPV
725373094,5/24/2015 21:14:46,1642775763,5/24/2015 21:14:40,false,neodev,1,31977841,USA,IL,Chicago,69.175.85.2,142,0,,,155,3,GENITAL WART,HPV,been associated with GENITAL WARTS and cervical cancer.,121-126-137-142-150-156-160-169,0-4-11-13,HPV v. A vaccine,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer.",142 150,0,142,0,1,155,3,TWrex-cause,814775,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer",genital wart,HPV
725373094,5/24/2015 21:22:11,1642777860,5/24/2015 21:21:45,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,142,0,,,155,3,GENITAL WART,HPV,GENITAL WARTS,142-150,0-4-11-13,HPV v. A vaccine,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer.",142 150,0,142,0,1,155,3,TWrex-cause,814775,"HPV v.     A vaccine that protects against several types of human papillomavirus infection, specifically those that have been associated with genital warts and cervical cancer",genital wart,HPV
725373095,5/24/2015 19:56:51,1642753084,5/24/2015 19:56:38,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,136,102,,,159,114,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS.,136-149,102-115,AMPHOTERICIN B,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis.,136 149,102,136,102,-1,159,114,TWrex-cause,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis,cryptococcal meningitis,amphotericin
725373095,5/24/2015 20:26:19,1642760470,5/24/2015 20:26:05,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,136,102,,,159,114,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS.,136-149,102-115,AMPHOTERICIN B,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis.,136 149,102,136,102,-1,159,114,TWrex-cause,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis,cryptococcal meningitis,amphotericin
725373095,5/24/2015 20:30:16,1642761810,5/24/2015 20:29:58,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,136,102,,,159,114,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS.,136-149,102,AMPHOTERICIN,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis.,136 149,102,136,102,-1,159,114,TWrex-cause,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis,cryptococcal meningitis,amphotericin
725373095,5/24/2015 20:30:39,1642761853,5/24/2015 20:30:25,false,instagc,1,19740138,CAN,,,50.69.96.237,136,102,,,159,114,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS.,136-149,102-115,AMPHOTERICIN B,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis.,136 149,102,136,102,-1,159,114,TWrex-cause,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis,cryptococcal meningitis,amphotericin
725373095,5/24/2015 20:53:54,1642768708,5/24/2015 20:53:22,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,136,102,,,159,114,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,physicians: clinical trial fluconazole amphotericin B CRYPTOCOCCAL MENINGITIS.,10-68-77-86-102-115-136-149,10-68-77-86-102-115-136-149,physicians: clinical trial fluconazole AMPHOTERICIN B cryptococcal meningitis.,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis.,136 149,102,136,102,-1,159,114,TWrex-cause,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis,cryptococcal meningitis,amphotericin
725373095,5/24/2015 20:54:38,1642768973,5/24/2015 20:54:24,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,136,102,,,159,114,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS.,136-149,102,AMPHOTERICIN,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis.,136 149,102,136,102,-1,159,114,TWrex-cause,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis,cryptococcal meningitis,amphotericin
725373095,5/24/2015 20:55:43,1642769395,5/24/2015 20:54:31,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,136,102,,,159,114,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS.,136-149,102,AMPHOTERICIN,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis.,136 149,102,136,102,-1,159,114,TWrex-cause,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis,cryptococcal meningitis,amphotericin
725373095,5/24/2015 20:56:04,1642769507,5/24/2015 20:55:43,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,136,102,,,159,114,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS.,136-149,102-115,AMPHOTERICIN B,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis.,136 149,102,136,102,-1,159,114,TWrex-cause,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis,cryptococcal meningitis,amphotericin
725373095,5/24/2015 20:56:34,1642769630,5/24/2015 20:56:17,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,136,102,,,159,114,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS.,136-149,102,AMPHOTERICIN,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis.,136 149,102,136,102,-1,159,114,TWrex-cause,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis,cryptococcal meningitis,amphotericin
725373095,5/24/2015 20:58:36,1642770260,5/24/2015 20:57:42,false,neodev,1,17426565,CAN,BC,Burnaby,70.79.18.187,136,102,,,159,114,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS.,136-149,102-115,AMPHOTERICIN B,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis.,136 149,102,136,102,-1,159,114,TWrex-cause,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis,cryptococcal meningitis,amphotericin
725373096,5/24/2015 19:02:59,1642724779,5/24/2015 19:02:40,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,54,84,,,62,97,SYNDROME,STAPHYLOCOCCUS,SYNDROME],54,84,STAPHYLOCOCCI,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,54,84,54,84,1,62,97,TWrex-cause,812023,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora,syndrome,staphylococcus
725373096,5/24/2015 19:04:12,1642725448,5/24/2015 19:03:51,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,54,84,,,62,97,SYNDROME,STAPHYLOCOCCUS,Staphylococcal Toxic Shock SYNDROME],27-42-48-54,65-75-84,COAGULASE NEGATIVE STAPHYLOCOCCI,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,54,84,54,84,1,62,97,TWrex-cause,812023,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora,syndrome,staphylococcus
725373096,5/24/2015 19:05:15,1642726001,5/24/2015 19:04:47,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,54,84,,,62,97,SYNDROME,STAPHYLOCOCCUS,Staphylococcal Toxic Shock SYNDROME],27-42-48-54,65-75-84,COAGULASE NEGATIVE STAPHYLOCOCCI,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,54,84,54,84,1,62,97,TWrex-cause,812023,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora,syndrome,staphylococcus
725373096,5/24/2015 19:17:10,1642731467,5/24/2015 19:15:25,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,54,84,,,62,97,SYNDROME,STAPHYLOCOCCUS,Staphylococcal Toxic Shock SYNDROME],27-42-48-54,65-75-84-99-102,COAGULASE NEGATIVE STAPHYLOCOCCI S. epidermidis,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,54,84,54,84,1,62,97,TWrex-cause,812023,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora,syndrome,staphylococcus
725373096,5/24/2015 19:24:44,1642740317,5/24/2015 19:24:29,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,54,84,,,62,97,SYNDROME,STAPHYLOCOCCUS,Staphylococcal Toxic Shock SYNDROME],27-42-48-54,65-75-84,COAGULASE NEGATIVE STAPHYLOCOCCI,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,54,84,54,84,1,62,97,TWrex-cause,812023,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora,syndrome,staphylococcus
725373096,5/24/2015 19:36:36,1642746153,5/24/2015 19:36:14,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,54,84,,,62,97,SYNDROME,STAPHYLOCOCCUS,Toxic Shock SYNDROME] COAGULASE NEGATIVE STAPHYLOCOCCI,42-48-54-65-75-84,65-75-84-99-102,COAGULASE NEGATIVE STAPHYLOCOCCI S. epidermidis,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,54,84,54,84,1,62,97,TWrex-cause,812023,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora,syndrome,staphylococcus
725373096,5/24/2015 19:37:57,1642746828,5/24/2015 19:37:21,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,54,84,,,62,97,SYNDROME,STAPHYLOCOCCUS,Staphylococcal Toxic Shock SYNDROME],27-42-48-54,65-75-84,COAGULASE NEGATIVE STAPHYLOCOCCI,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,54,84,54,84,1,62,97,TWrex-cause,812023,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora,syndrome,staphylococcus
725373096,5/24/2015 19:38:15,1642746952,5/24/2015 19:37:58,false,clixsense,1,31482589,NLD,,,31.201.11.16,54,84,,,62,97,SYNDROME,STAPHYLOCOCCUS,Staphylococcal Toxic Shock SYNDROME],27-42-48-54,65-75-84-102-99,COAGULASE NEGATIVE STAPHYLOCOCCI S. epidermidis,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,54,84,54,84,1,62,97,TWrex-cause,812023,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora,syndrome,staphylococcus
725373096,5/24/2015 19:38:40,1642747058,5/24/2015 19:38:18,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,54,84,,,62,97,SYNDROME,STAPHYLOCOCCUS,Staphylococcal Toxic - Shock SYNDROME],27-42-47-48-54,65-74-75-84,COAGULASE - NEGATIVE STAPHYLOCOCCI,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,54,84,54,84,1,62,97,TWrex-cause,812023,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora,syndrome,staphylococcus
725373096,5/24/2015 19:39:07,1642747184,5/24/2015 19:38:19,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,54,84,,,62,97,SYNDROME,STAPHYLOCOCCUS,Staphylococcal Toxic Shock SYNDROME] COAGULASE NEGATIVE STAPHYLOCOCCI S. epidermidis,27-42-48-54-65-75-84-99-102,27-42-48-54-65-75-84-99-102,Staphylococcal Toxic Shock Syndrome] COAGULASE NEGATIVE STAPHYLOCOCCI S. epidermidis,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora.,54,84,54,84,1,62,97,TWrex-cause,812023,Clinical Manifestations of Staphylococcal Toxic-Shock Syndrome]  COAGULASE-NEGATIVE STAPHYLOCOCCI  S. epidermidis  and other coagulase-negative staphylococcal species are organisms of low pathogenic potential that are universally present as part of the normal skin flora,syndrome,staphylococcus
725373097,5/24/2015 19:52:28,1642751572,5/24/2015 19:52:16,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,211,10,,,219,18,HEADACHE,MIGRAINE,"HEADACHE,",211,10,MIGRAINE,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting.",211,10,211,10,1,219,18,TWrex-cause,813482,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting",headache,migraine
725373097,5/24/2015 19:53:27,1642751930,5/24/2015 19:53:13,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,211,10,,,219,18,HEADACHE,MIGRAINE,"HEADACHE,",211,10,MIGRAINE,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting.",211,10,211,10,1,219,18,TWrex-cause,813482,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting",headache,migraine
725373097,5/24/2015 19:53:40,1642751997,5/24/2015 19:53:25,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,211,10,,,219,18,HEADACHE,MIGRAINE,"HEADACHE,",211,10,MIGRAINE,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting.",211,10,211,10,1,219,18,TWrex-cause,813482,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting",headache,migraine
725373097,5/24/2015 19:53:46,1642752043,5/24/2015 19:52:55,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,211,10,,,219,18,HEADACHE,MIGRAINE,"This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing HEADACHE, frequently with vomiting.",5-10-19-26-29-41-45-51-59-69-78-81-88-93-96-102-111-119-131-135-147-155-158-161-164-173-177-180-196-199-201-211-221-232-237-187,5-10-19-26-29-41-45-51-59-69-78-81-88-93-96-102-111-119-131-135-147-155-158-161-164-173-177-180-187-196-199-201-211-221-232-237,"This MIGRAINE occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting.","66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting.",211,10,211,10,1,219,18,TWrex-cause,813482,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting",headache,migraine
725373097,5/24/2015 20:00:29,1642753993,5/24/2015 20:00:08,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,211,10,,,219,18,HEADACHE,MIGRAINE,"HEADACHE,",211,10,MIGRAINE,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting.",211,10,211,10,1,219,18,TWrex-cause,813482,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting",headache,migraine
725373097,5/24/2015 20:13:13,1642757488,5/24/2015 20:12:56,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,211,10,,,219,18,HEADACHE,MIGRAINE,"HEADACHE,",211,10,MIGRAINE,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting.",211,10,211,10,1,219,18,TWrex-cause,813482,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting",headache,migraine
725373097,5/24/2015 20:14:48,1642757970,5/24/2015 20:14:35,false,instagc,1,19740138,CAN,,,50.69.96.237,211,10,,,219,18,HEADACHE,MIGRAINE,"HEADACHE,",211,10,MIGRAINE,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting.",211,10,211,10,1,219,18,TWrex-cause,813482,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting",headache,migraine
725373097,5/24/2015 20:21:39,1642759443,5/24/2015 20:21:23,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,211,10,,,219,18,HEADACHE,MIGRAINE,"HEADACHE,",211,10,MIGRAINE,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting.",211,10,211,10,1,219,18,TWrex-cause,813482,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting",headache,migraine
725373097,5/24/2015 20:26:54,1642760631,5/24/2015 20:26:39,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,211,10,,,219,18,HEADACHE,MIGRAINE,"HEADACHE,",211,10,MIGRAINE,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting.",211,10,211,10,1,219,18,TWrex-cause,813482,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting",headache,migraine
725373097,5/24/2015 20:27:54,1642760943,5/24/2015 20:27:41,false,cointasker,1,21783324,NLD,,,31.151.239.133,211,10,,,219,18,HEADACHE,MIGRAINE,"throbbing HEADACHE,",201-211,10,MIGRAINE,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting.",211,10,211,10,1,219,18,TWrex-cause,813482,"66   This migraine occurs in adolescents and young adults; typically presents as visual loss or aura, vertigo, ataxia, dysarthria, and dysesthesia lasting up to 45 minutes; and is always followed by a throbbing headache, frequently with vomiting",headache,migraine
725373098,5/24/2015 21:20:04,1642777376,5/24/2015 21:19:51,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,225,255,,,232,264,MALARIA,PLASMODIUM,MALARIA caused by susceptible plasmodia.,225-233-240-243-255,233-240-243-255-225,malaria caused by susceptible PLASMODIA.,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia.",225,255,225,255,1,232,264,TWrex-cause,810506,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia",malaria,plasmodium
725373098,5/24/2015 21:34:32,1642781993,5/24/2015 21:34:07,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,225,255,,,232,264,MALARIA,PLASMODIUM,MALARIA,225,243-255,susceptible PLASMODIA.,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia.",225,255,225,255,1,232,264,TWrex-cause,810506,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia",malaria,plasmodium
725373098,5/24/2015 21:46:11,1642785191,5/24/2015 21:45:23,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,225,255,,,232,264,MALARIA,PLASMODIUM,MALARIA,225,240-243-255,by susceptible PLASMODIA.,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia.",225,255,225,255,1,232,264,TWrex-cause,810506,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia",malaria,plasmodium
725373098,5/24/2015 22:10:14,1642792783,5/24/2015 22:09:46,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,225,255,,,232,264,MALARIA,PLASMODIUM,MALARIA,225,243-255,susceptible PLASMODIA.,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia.",225,255,225,255,1,232,264,TWrex-cause,810506,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia",malaria,plasmodium
725373098,5/24/2015 22:51:18,1642806923,5/24/2015 22:51:05,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,225,255,,,232,264,MALARIA,PLASMODIUM,MALARIA,225,255,PLASMODIA.,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia.",225,255,225,255,1,232,264,TWrex-cause,810506,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia",malaria,plasmodium
725373098,5/24/2015 22:57:31,1642808629,5/24/2015 22:57:23,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,225,255,,,232,264,MALARIA,PLASMODIUM,MALARIA,225,255,PLASMODIA.,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia.",225,255,225,255,1,232,264,TWrex-cause,810506,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia",malaria,plasmodium
725373098,5/24/2015 22:57:50,1642808658,5/24/2015 22:57:14,false,clixsense,1,26770238,CAN,ON,Ilderton,209.183.157.27,225,255,,,232,264,MALARIA,PLASMODIUM,use of other antimalarial agents MALARIA,48-51-57-70-225-44,57-255-70,antimalarial agents PLASMODIA.,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia.",225,255,225,255,1,232,264,TWrex-cause,810506,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia",malaria,plasmodium
725373098,5/24/2015 22:58:58,1642808939,5/24/2015 22:58:27,false,points4rewards,1,28703583,USA,,,97.73.85.52,225,255,,,232,264,MALARIA,PLASMODIUM,MALARIA susceptible plasmodia.,225-243-255,243-255-225,malaria susceptible PLASMODIA.,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia.",225,255,225,255,1,232,264,TWrex-cause,810506,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia",malaria,plasmodium
725373098,5/24/2015 22:59:15,1642809081,5/24/2015 22:58:33,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,225,255,,,232,264,MALARIA,PLASMODIUM,MALARIA,225,243-255,susceptible PLASMODIA.,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia.",225,255,225,255,1,232,264,TWrex-cause,810506,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia",malaria,plasmodium
725373098,5/24/2015 23:02:22,1642809724,5/24/2015 23:02:07,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,225,255,,,232,264,MALARIA,PLASMODIUM,MALARIA,225,243-255,susceptible PLASMODIA.,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia.",225,255,225,255,1,232,264,TWrex-cause,810506,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of malaria caused by susceptible plasmodia",malaria,plasmodium
725373099,5/24/2015 19:05:55,1642726247,5/24/2015 19:05:22,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,93,27,,,102,34,BLINDNESS,DISEASE,"BLINDNESS,",93,27,DISEASE,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death.",93,27,93,27,1,102,34,TWrex-cause,814972,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death",blindness,disease
725373099,5/24/2015 19:07:29,1642726963,5/24/2015 19:07:03,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,93,27,,,102,34,BLINDNESS,DISEASE,"BLINDNESS,",93,18-27,Krabbe's DISEASE,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death.",93,27,93,27,1,102,34,TWrex-cause,814972,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death",blindness,disease
725373099,5/24/2015 19:08:57,1642727621,5/24/2015 19:08:32,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,93,27,,,102,34,BLINDNESS,DISEASE,"BLINDNESS,",93,18-27,Krabbe's DISEASE,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death.",93,27,93,27,1,102,34,TWrex-cause,814972,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death",blindness,disease
725373099,5/24/2015 19:22:02,1642737803,5/24/2015 19:21:23,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,93,27,,,102,34,BLINDNESS,DISEASE,"BLINDNESS,",93,18-27,Krabbe's DISEASE,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death.",93,27,93,27,1,102,34,TWrex-cause,814972,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death",blindness,disease
725373099,5/24/2015 19:27:03,1642741440,5/24/2015 19:26:35,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,93,27,,,102,34,BLINDNESS,DISEASE,"BLINDNESS,",93,0-9-18-27,KRABBE'S DISEASE Krabbe's DISEASE,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death.",93,27,93,27,1,102,34,TWrex-cause,814972,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death",blindness,disease
725373099,5/24/2015 19:40:05,1642747574,5/24/2015 19:39:50,false,clixsense,1,31482589,NLD,,,31.201.11.16,93,27,,,102,34,BLINDNESS,DISEASE,"BLINDNESS,",93,18-27,Krabbe's DISEASE,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death.",93,27,93,27,1,102,34,TWrex-cause,814972,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death",blindness,disease
725373099,5/24/2015 19:44:40,1642749253,5/24/2015 19:44:05,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,93,27,,,102,34,BLINDNESS,DISEASE,"BLINDNESS,",93,0-9-18-27,KRABBE'S DISEASE Krabbe's DISEASE,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death.",93,27,93,27,1,102,34,TWrex-cause,814972,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death",blindness,disease
725373099,5/24/2015 19:44:54,1642749320,5/24/2015 19:43:47,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,93,27,,,102,34,BLINDNESS,DISEASE,"causes retardation, paralysis, BLINDNESS, deafness, and pseudobulbar palsy,",62-69-82-93-104-114-118-131,0-9-18-27,KRABBE'S DISEASE Krabbe's DISEASE,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death.",93,27,93,27,1,102,34,TWrex-cause,814972,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death",blindness,disease
725373099,5/24/2015 19:45:16,1642749504,5/24/2015 19:43:49,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,93,27,,,102,34,BLINDNESS,DISEASE,"KRABBE'S DISEASE Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, BLINDNESS, deafness, and pseudobulbar palsy, progressing to death.",0-9-18-27-35-38-40-57-62-69-82-93-104-114-118-131-138-150-153,0-9-18-27-35-38-40-57-62-69-82-93-104-114-118-131-138-150-153,"KRABBE'S DISEASE Krabbe's DISEASE is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death.","KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death.",93,27,93,27,1,102,34,TWrex-cause,814972,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death",blindness,disease
725373099,5/24/2015 19:48:59,1642750745,5/24/2015 19:48:39,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,93,27,,,102,34,BLINDNESS,DISEASE,"BLINDNESS,",93,27,DISEASE,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death.",93,27,93,27,1,102,34,TWrex-cause,814972,"KRABBE'S DISEASE  Krabbe's disease is a sphingolipidosis that causes retardation, paralysis, blindness, deafness, and pseudobulbar palsy, progressing to death",blindness,disease
725373100,5/24/2015 19:49:32,1642750862,5/24/2015 19:48:47,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,131,195,,,140,209,HEMATURIA,BLADDER CANCER,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile HEMATURIA, suprapubic or perineal discomfort, or a high risk of bladder cancer.",0-6-12-17-23-33-45-53-61-65-68-78-81-90-100-105-109-118-123-131-142-153-156-165-177-180-182-187-192-195-203,0-6-12-17-23-33-45-53-61-65-68-78-81-90-100-105-109-118-123-131-142-153-156-165-177-182-187-192-195-203-180,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of BLADDER CANCER.","Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer.",131,195 203,131,195,1,140,209,TWrex-cause,813355,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer",hematuria,bladder cancer
725373100,5/24/2015 19:50:51,1642751290,5/24/2015 19:50:00,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,131,195,,,140,209,HEMATURIA,BLADDER CANCER,"patients with sterile HEMATURIA,",109-118-123-131,182-187-192-195-203,high risk of BLADDER CANCER.,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer.",131,195 203,131,195,1,140,209,TWrex-cause,813355,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer",hematuria,bladder cancer
725373100,5/24/2015 19:51:00,1642751324,5/24/2015 19:50:48,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,131,195,,,140,209,HEMATURIA,BLADDER CANCER,"HEMATURIA,",131,195-203,BLADDER CANCER.,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer.",131,195 203,131,195,1,140,209,TWrex-cause,813355,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer",hematuria,bladder cancer
725373100,5/24/2015 19:51:36,1642751439,5/24/2015 19:51:16,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,131,195,,,140,209,HEMATURIA,BLADDER CANCER,"sterile HEMATURIA,",131-123,195-203,BLADDER CANCER.,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer.",131,195 203,131,195,1,140,209,TWrex-cause,813355,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer",hematuria,bladder cancer
725373100,5/24/2015 19:51:55,1642751505,5/24/2015 19:51:39,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,131,195,,,140,209,HEMATURIA,BLADDER CANCER,"HEMATURIA,",131,195-203,BLADDER CANCER.,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer.",131,195 203,131,195,1,140,209,TWrex-cause,813355,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer",hematuria,bladder cancer
725373100,5/24/2015 19:58:34,1642753497,5/24/2015 19:58:23,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,131,195,,,140,209,HEMATURIA,BLADDER CANCER,"sterile HEMATURIA,",123-131,195-203,BLADDER CANCER.,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer.",131,195 203,131,195,1,140,209,TWrex-cause,813355,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer",hematuria,bladder cancer
725373100,5/24/2015 20:11:04,1642756853,5/24/2015 20:10:53,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,131,195,,,140,209,HEMATURIA,BLADDER CANCER,"HEMATURIA,",131,195-203,BLADDER CANCER.,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer.",131,195 203,131,195,1,140,209,TWrex-cause,813355,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer",hematuria,bladder cancer
725373100,5/24/2015 20:12:36,1642757343,5/24/2015 20:12:17,false,instagc,1,19740138,CAN,,,50.69.96.237,131,195,,,140,209,HEMATURIA,BLADDER CANCER,"sterile HEMATURIA,",123-131,195-203,BLADDER CANCER.,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer.",131,195 203,131,195,1,140,209,TWrex-cause,813355,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer",hematuria,bladder cancer
725373100,5/24/2015 20:15:06,1642758026,5/24/2015 20:14:31,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,131,195,,,140,209,HEMATURIA,BLADDER CANCER,"sterile HEMATURIA, suprapubic",123-131-142,195-203,BLADDER CANCER.,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer.",131,195 203,131,195,1,140,209,TWrex-cause,813355,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer",hematuria,bladder cancer
725373100,5/24/2015 20:19:29,1642758956,5/24/2015 20:18:51,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,131,195,,,140,209,HEMATURIA,BLADDER CANCER,"sterile HEMATURIA,",123-131,195-203,BLADDER CANCER.,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer.",131,195 203,131,195,1,140,209,TWrex-cause,813355,"Other tests (eg, urine cytology, cystoscopy, bladder biopsy) may be indicated in specific instances (eg, for patients with sterile hematuria, suprapubic or perineal discomfort, or a high risk of bladder cancer",hematuria,bladder cancer
725373101,5/24/2015 18:58:08,1642722546,5/24/2015 18:57:50,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,84,32,,,92,39,EMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,pulmonary EMBOLISM.,74-84,32,HEPARIN,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism.,84,32,84,32,-1,92,39,TWrex-cause,803544,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism,embolism,low molecular weight heparin
725373101,5/24/2015 18:58:18,1642722663,5/24/2015 18:57:57,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,84,32,,,92,39,EMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,EMBOLISM.,84,32,HEPARIN,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism.,84,32,84,32,-1,92,39,TWrex-cause,803544,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism,embolism,low molecular weight heparin
725373101,5/24/2015 19:00:34,1642723657,5/24/2015 19:00:01,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,84,32,,,92,39,EMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,pulmonary EMBOLISM.,74-84,32,HEPARIN,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism.,84,32,84,32,-1,92,39,TWrex-cause,803544,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism,embolism,low molecular weight heparin
725373101,5/24/2015 19:00:35,1642723673,5/24/2015 19:00:18,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,84,32,,,92,39,EMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,pulmonary EMBOLISM.,74-84,32,HEPARIN,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism.,84,32,84,32,-1,92,39,TWrex-cause,803544,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism,embolism,low molecular weight heparin
725373101,5/24/2015 19:00:53,1642723834,5/24/2015 19:00:31,false,neodev,1,32456300,USA,CA,Laguna Niguel,216.177.129.227,84,32,,,92,39,EMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,patients with pulmonary EMBOLISM.,60-69-74-84,14-21-29-32-57-60-69,weight heparin vs HEPARIN of patients with,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism.,84,32,84,32,-1,92,39,TWrex-cause,803544,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism,embolism,low molecular weight heparin
725373101,5/24/2015 19:06:31,1642726534,5/24/2015 19:06:02,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,84,32,,,92,39,EMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,pulmonary EMBOLISM.,74-84,32,HEPARIN,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism.,84,32,84,32,-1,92,39,TWrex-cause,803544,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism,embolism,low molecular weight heparin
725373101,5/24/2015 19:20:08,1642734924,5/24/2015 19:19:47,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,84,32,,,92,39,EMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,pulmonary EMBOLISM.,74-84,32,HEPARIN,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism.,84,32,84,32,-1,92,39,TWrex-cause,803544,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism,embolism,low molecular weight heparin
725373101,5/24/2015 19:24:52,1642740387,5/24/2015 19:24:40,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,84,32,,,92,39,EMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,pulmonary EMBOLISM.,74-84,32,HEPARIN,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism.,84,32,84,32,-1,92,39,TWrex-cause,803544,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism,embolism,low molecular weight heparin
725373101,5/24/2015 19:25:18,1642740529,5/24/2015 19:25:03,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,84,32,,,92,39,EMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,pulmonary EMBOLISM.,74-84,0-14-21-29-32-4,Low molecular weight heparin vs HEPARIN,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism.,84,32,84,32,-1,92,39,TWrex-cause,803544,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism,embolism,low molecular weight heparin
725373101,5/24/2015 19:27:07,1642741473,5/24/2015 19:25:38,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,84,32,,,92,39,EMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,patients with pulmonary EMBOLISM.,60-69-74-84,21-29-32,heparin vs HEPARIN,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism.,84,32,84,32,-1,92,39,TWrex-cause,803544,Low molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism,embolism,low molecular weight heparin
725373102,5/24/2015 19:57:08,1642753152,5/24/2015 19:56:52,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,25,0,,,31,11,ULCER,THALIDOMIDE,aphthous ULCERS,25-16,0,THALIDOMIDE,Thalidomide for aphthous ulcers in HIV infection.,25,0,25,0,-1,31,11,TWrex-cause,804857,Thalidomide for aphthous ulcers in HIV infection,ulcer,thalidomide
725373102,5/24/2015 20:26:32,1642760542,5/24/2015 20:26:20,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,25,0,,,31,11,ULCER,THALIDOMIDE,aphthous ULCERS,16-25,0,THALIDOMIDE,Thalidomide for aphthous ulcers in HIV infection.,25,0,25,0,-1,31,11,TWrex-cause,804857,Thalidomide for aphthous ulcers in HIV infection,ulcer,thalidomide
725373102,5/24/2015 20:30:30,1642761845,5/24/2015 20:30:17,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,25,0,,,31,11,ULCER,THALIDOMIDE,aphthous ULCERS,16-25,0,THALIDOMIDE,Thalidomide for aphthous ulcers in HIV infection.,25,0,25,0,-1,31,11,TWrex-cause,804857,Thalidomide for aphthous ulcers in HIV infection,ulcer,thalidomide
725373102,5/24/2015 20:31:00,1642761899,5/24/2015 20:30:40,false,instagc,1,19740138,CAN,,,50.69.96.237,25,0,,,31,11,ULCER,THALIDOMIDE,aphthous ULCERS,16-25,0,THALIDOMIDE,Thalidomide for aphthous ulcers in HIV infection.,25,0,25,0,-1,31,11,TWrex-cause,804857,Thalidomide for aphthous ulcers in HIV infection,ulcer,thalidomide
725373102,5/24/2015 20:54:14,1642768834,5/24/2015 20:53:56,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,25,0,,,31,11,ULCER,THALIDOMIDE,Thalidomide aphthous ULCERS HIV infection.,0-16-25-35-39,0-16-25-35-39,THALIDOMIDE aphthous ulcers HIV infection.,Thalidomide for aphthous ulcers in HIV infection.,25,0,25,0,-1,31,11,TWrex-cause,804857,Thalidomide for aphthous ulcers in HIV infection,ulcer,thalidomide
725373102,5/24/2015 20:55:20,1642769230,5/24/2015 20:54:39,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,25,0,,,31,11,ULCER,THALIDOMIDE,ULCERS,25,0-25,THALIDOMIDE ulcers,Thalidomide for aphthous ulcers in HIV infection.,25,0,25,0,-1,31,11,TWrex-cause,804857,Thalidomide for aphthous ulcers in HIV infection,ulcer,thalidomide
725373102,5/24/2015 20:56:20,1642769588,5/24/2015 20:56:05,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,25,0,,,31,11,ULCER,THALIDOMIDE,aphthous ULCERS,16-25,0,THALIDOMIDE,Thalidomide for aphthous ulcers in HIV infection.,25,0,25,0,-1,31,11,TWrex-cause,804857,Thalidomide for aphthous ulcers in HIV infection,ulcer,thalidomide
725373102,5/24/2015 20:56:47,1642769661,5/24/2015 20:56:36,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,25,0,,,31,11,ULCER,THALIDOMIDE,ULCERS,25,0,THALIDOMIDE,Thalidomide for aphthous ulcers in HIV infection.,25,0,25,0,-1,31,11,TWrex-cause,804857,Thalidomide for aphthous ulcers in HIV infection,ulcer,thalidomide
725373102,5/24/2015 20:59:35,1642770591,5/24/2015 20:58:37,false,neodev,1,17426565,CAN,BC,Burnaby,70.79.18.187,25,0,,,31,11,ULCER,THALIDOMIDE,aphthous ULCERS,16-25,0,THALIDOMIDE,Thalidomide for aphthous ulcers in HIV infection.,25,0,25,0,-1,31,11,TWrex-cause,804857,Thalidomide for aphthous ulcers in HIV infection,ulcer,thalidomide
725373102,5/24/2015 21:04:25,1642772381,5/24/2015 21:04:06,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,25,0,,,31,11,ULCER,THALIDOMIDE,ULCERS,25,0,THALIDOMIDE,Thalidomide for aphthous ulcers in HIV infection.,25,0,25,0,-1,31,11,TWrex-cause,804857,Thalidomide for aphthous ulcers in HIV infection,ulcer,thalidomide
725373103,5/24/2015 19:00:49,1642723799,5/24/2015 19:00:26,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,72,7,,,84,31,HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,HYPOCALCEMIA,72,7,PSEUDOHYPOPARATHYROIDISM,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH.,72,7,72,7,1,84,31,TWrex-cause,813445,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH,hypocalcemia,pseudohypoparathyroidism
725373103,5/24/2015 19:01:30,1642724039,5/24/2015 19:00:53,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,72,7,,,84,31,HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,HYPOCALCEMIA,72,0-5-7,Type I PSEUDOHYPOPARATHYROIDISM,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH.,72,7,72,7,1,84,31,TWrex-cause,813445,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH,hypocalcemia,pseudohypoparathyroidism
725373103,5/24/2015 19:02:37,1642724602,5/24/2015 19:02:19,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,72,7,,,84,31,HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,HYPOCALCEMIA,72,5-7,I PSEUDOHYPOPARATHYROIDISM,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH.,72,7,72,7,1,84,31,TWrex-cause,813445,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH,hypocalcemia,pseudohypoparathyroidism
725373103,5/24/2015 19:02:43,1642724621,5/24/2015 19:02:20,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,72,7,,,84,31,HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,HYPOCALCEMIA,72,0-5-7,Type I PSEUDOHYPOPARATHYROIDISM,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH.,72,7,72,7,1,84,31,TWrex-cause,813445,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH,hypocalcemia,pseudohypoparathyroidism
725373103,5/24/2015 19:11:14,1642728635,5/24/2015 19:10:32,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,72,7,,,84,31,HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,HYPOCALCEMIA,72,0-5-7,Type I PSEUDOHYPOPARATHYROIDISM,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH.,72,7,72,7,1,84,31,TWrex-cause,813445,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH,hypocalcemia,pseudohypoparathyroidism
725373103,5/24/2015 19:22:27,1642737945,5/24/2015 19:21:35,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,72,7,,,84,31,HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,HYPOCALCEMIA,72,0-5-7,Type I PSEUDOHYPOPARATHYROIDISM,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH.,72,7,72,7,1,84,31,TWrex-cause,813445,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH,hypocalcemia,pseudohypoparathyroidism
725373103,5/24/2015 19:26:56,1642741371,5/24/2015 19:26:41,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,72,7,,,84,31,HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,HYPOCALCEMIA,72,0-5-7,Type I PSEUDOHYPOPARATHYROIDISM,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH.,72,7,72,7,1,84,31,TWrex-cause,813445,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH,hypocalcemia,pseudohypoparathyroidism
725373103,5/24/2015 19:30:52,1642743414,5/24/2015 19:29:24,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,72,7,,,84,31,HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,HYPOCALCEMIA,72,0-5-7,Type I PSEUDOHYPOPARATHYROIDISM,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH.,72,7,72,7,1,84,31,TWrex-cause,813445,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH,hypocalcemia,pseudohypoparathyroidism
725373103,5/24/2015 19:32:35,1642744228,5/24/2015 19:30:55,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,72,7,,,84,31,HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,the presence of HYPOCALCEMIA,56-60-69-72,7-32-36-39,PSEUDOHYPOPARATHYROIDISM can be distinguished,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH.,72,7,72,7,1,84,31,TWrex-cause,813445,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH,hypocalcemia,pseudohypoparathyroidism
725373103,5/24/2015 19:34:09,1642745057,5/24/2015 19:33:54,false,clixsense,1,6417722,USA,MI,Taylor,99.170.106.105,72,7,,,84,31,HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,HYPOCALCEMIA,72,0-5-7,Type I PSEUDOHYPOPARATHYROIDISM,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH.,72,7,72,7,1,84,31,TWrex-cause,813445,Type I pseudohypoparathyroidism can be distinguished by the presence of hypocalcemia despite normal to elevated levels of circulating PTH,hypocalcemia,pseudohypoparathyroidism
725373104,5/24/2015 18:53:56,1642720586,5/24/2015 18:53:27,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,166,143,,,175,153,HEPATITIS,INTERFERON,chronic HEPATITIS C,158-166-176,143,INTERFERON,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",166,143,166,143,-1,175,153,TWrex-cause,800452,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not",hepatitis,interferon
725373104,5/24/2015 18:54:51,1642720968,5/24/2015 18:54:31,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,166,143,,,175,153,HEPATITIS,INTERFERON,HEPATITIS,166,143,INTERFERON,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",166,143,166,143,-1,175,153,TWrex-cause,800452,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not",hepatitis,interferon
725373104,5/24/2015 18:54:52,1642720969,5/24/2015 18:54:20,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,166,143,,,175,153,HEPATITIS,INTERFERON,HEPATITIS C,166-176,143,INTERFERON,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",166,143,166,143,-1,175,153,TWrex-cause,800452,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not",hepatitis,interferon
725373104,5/24/2015 18:55:49,1642721370,5/24/2015 18:55:10,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,166,143,,,175,153,HEPATITIS,INTERFERON,chronic HEPATITIS C and,158-166-176-184,143,INTERFERON,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",166,143,166,143,-1,175,153,TWrex-cause,800452,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not",hepatitis,interferon
725373104,5/24/2015 18:56:23,1642721641,5/24/2015 18:56:01,false,neodev,1,32456300,USA,CA,Laguna Niguel,216.177.129.227,166,143,,,175,153,HEPATITIS,INTERFERON,interferon for chronic HEPATITIS C 8 and for chronic hepatitis B 9,143-154-158-166-176-180-184-188-192-200-210-214,128-138-143-154-158-166-176-119,received treatment with INTERFERON for chronic hepatitis C,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",166,143,166,143,-1,175,153,TWrex-cause,800452,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not",hepatitis,interferon
725373104,5/24/2015 18:58:02,1642722497,5/24/2015 18:56:51,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,166,143,,,175,153,HEPATITIS,INTERFERON,chronic HEPATITIS C,158-166-176,143,INTERFERON,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",166,143,166,143,-1,175,153,TWrex-cause,800452,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not",hepatitis,interferon
725373104,5/24/2015 19:00:25,1642723597,5/24/2015 19:00:14,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,166,143,,,175,153,HEPATITIS,INTERFERON,interferon for chronic HEPATITIS C 8 and,143-154-158-166-176-180-184,119-128-138-143-154-158-166,received treatment with INTERFERON for chronic hepatitis,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",166,143,166,143,-1,175,153,TWrex-cause,800452,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not",hepatitis,interferon
725373104,5/24/2015 19:08:21,1642727362,5/24/2015 19:08:08,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,166,143,,,175,153,HEPATITIS,INTERFERON,chronic HEPATITIS C,158-166-176,143-154-158-166,INTERFERON for chronic hepatitis,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",166,143,166,143,-1,175,153,TWrex-cause,800452,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not",hepatitis,interferon
725373104,5/24/2015 19:14:51,1642730123,5/24/2015 19:14:35,false,bitcoinget,1,21614812,USA,NJ,Burlington,50.153.125.0,166,143,,,175,153,HEPATITIS,INTERFERON,chronic HEPATITIS C,158-166-176,143,INTERFERON,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",166,143,166,143,-1,175,153,TWrex-cause,800452,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not",hepatitis,interferon
725373104,5/24/2015 19:15:37,1642730444,5/24/2015 19:15:12,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,166,143,,,175,153,HEPATITIS,INTERFERON,chronic HEPATITIS C,158-166-176,143,INTERFERON,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not.",166,143,166,143,-1,175,153,TWrex-cause,800452,"Evidence: • In large cohort studies, survival and complication-free survival were significantly better in patients who received treatment with interferon for chronic hepatitis C ( 8 ) and for chronic hepatitis B ( 9 ) as compared to patients who did not",hepatitis,interferon
725373105,5/24/2015 19:28:57,1642742427,5/24/2015 19:28:41,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,275,163,,,279,182,CORD,CERVICAL MYELOPATHY,"lower cervical spinal CORD,",253-259-268-275,163-172,CERVICAL MYELOPATHY,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.",275,163 172,275,163,-1,279,182,TWrex-cause,802405,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy",cord,cervical myelopathy
725373105,5/24/2015 19:45:41,1642749684,5/24/2015 19:45:14,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,275,163,,,279,182,CORD,CERVICAL MYELOPATHY,"lower cervical spinal CORD,",253-259-268-275,143-149-153-163-172-183-188,canal and sometimes CERVICAL MYELOPATHY from encroachment,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.",275,163 172,275,163,-1,279,182,TWrex-cause,802405,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy",cord,cervical myelopathy
725373105,5/24/2015 19:46:07,1642749788,5/24/2015 19:45:15,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,275,163,,,279,182,CORD,CERVICAL MYELOPATHY,"spinal CORD,",268-275,163-172,CERVICAL MYELOPATHY,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.",275,163 172,275,163,-1,279,182,TWrex-cause,802405,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy",cord,cervical myelopathy
725373105,5/24/2015 19:46:39,1642749975,5/24/2015 19:45:40,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,275,163,,,279,182,CORD,CERVICAL MYELOPATHY,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal CORD, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.",0-9-21-25-37-46-58-67-79-82-97-100-104-113-119-127-136-139-143-149-153-163-172-183-188-201-204-209-224-232-246-249-253-259-268-275-281-291-296-308-311-317-326-332-338,0-9-21-25-37-46-58-67-79-82-97-100-104-113-119-127-136-139-143-149-153-163-172-183-188-201-204-209-224-232-246-249-253-259-268-275-281-291-296-308-311-317-326-332-338,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.","CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.",275,163 172,275,163,-1,279,182,TWrex-cause,802405,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy",cord,cervical myelopathy
725373105,5/24/2015 19:49:21,1642750833,5/24/2015 19:49:09,false,neodev,1,31743852,GBR,G5,Faversham,85.210.123.52,275,163,,,279,182,CORD,CERVICAL MYELOPATHY,"lower cervical spinal CORD, sometimes with involvement lower cervical",253-259-268-275-281-291-296-311-317,143-149-153-163-172-183-188,canal and sometimes CERVICAL MYELOPATHY from encroachment,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.",275,163 172,275,163,-1,279,182,TWrex-cause,802405,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy",cord,cervical myelopathy
725373105,5/24/2015 19:49:28,1642750849,5/24/2015 19:49:10,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,275,163,,,279,182,CORD,CERVICAL MYELOPATHY,"CORD,",275,163-172,CERVICAL MYELOPATHY,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.",275,163 172,275,163,-1,279,182,TWrex-cause,802405,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy",cord,cervical myelopathy
725373105,5/24/2015 19:49:50,1642750916,5/24/2015 19:49:15,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,275,163,,,279,182,CORD,CERVICAL MYELOPATHY,"lower cervical spinal CORD,",253-259-268-275,163-172,CERVICAL MYELOPATHY,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.",275,163 172,275,163,-1,279,182,TWrex-cause,802405,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy",cord,cervical myelopathy
725373105,5/24/2015 19:50:34,1642751216,5/24/2015 19:50:07,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,275,163,,,279,182,CORD,CERVICAL MYELOPATHY,"lower cervical spinal CORD,",253-259-268-275,163-172,CERVICAL MYELOPATHY,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.",275,163 172,275,163,-1,279,182,TWrex-cause,802405,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy",cord,cervical myelopathy
725373105,5/24/2015 19:55:03,1642752464,5/24/2015 19:54:44,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,275,163,,,279,182,CORD,CERVICAL MYELOPATHY,"lower cervical spinal CORD,",253-259-268-275,143-163-172,canal CERVICAL MYELOPATHY,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.",275,163 172,275,163,-1,279,182,TWrex-cause,802405,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy",cord,cervical myelopathy
725373105,5/24/2015 20:05:52,1642755338,5/24/2015 20:05:20,false,neodev,1,30749660,USA,NC,Durham,24.211.188.217,275,163,,,279,182,CORD,CERVICAL MYELOPATHY,"CORD,",275,163-172,CERVICAL MYELOPATHY,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.",275,163 172,275,163,-1,279,182,TWrex-cause,802405,"CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes cervical myelopathy from encroachment of bony osteoarthritic growths (osteophytes) on the lower cervical spinal cord, sometimes with involvement of lower cervical nerve roots (radiculomyelopathy",cord,cervical myelopathy
725373106,5/24/2015 23:03:15,1642810009,5/24/2015 23:02:40,false,points4rewards,1,28703583,USA,,,97.73.85.52,87,0,,,100,2,BREAST CANCER,BC,multifaceted BREAST CANCER care.,74-87-94-101,0-74-87-94-101,BC] multifaceted breast cancer care.,BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care.,87 94,0,87,0,1,100,2,TWrex-cause,814850,BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care,breast cancer,BC
725373106,5/24/2015 23:04:39,1642810484,5/24/2015 23:04:06,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,87,0,,,100,2,BREAST CANCER,BC,BREAST CANCER,87-94,0-5,BC] 9.1,BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care.,87 94,0,87,0,1,100,2,TWrex-cause,814850,BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care,breast cancer,BC
725373106,5/24/2015 23:06:26,1642811008,5/24/2015 23:06:06,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,87,0,,,100,2,BREAST CANCER,BC,multifaceted BREAST CANCER,74-87-94,0,BC],BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care.,87 94,0,87,0,1,100,2,TWrex-cause,814850,BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care,breast cancer,BC
725373106,5/24/2015 23:21:38,1642814930,5/24/2015 23:19:55,false,bitcoinget,1,28503763,USA,CA,San Francisco,107.217.186.64,87,0,,,100,2,BREAST CANCER,BC,optimal multifaceted BREAST CANCER care.,66-74-87-94-101,0,BC],BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care.,87 94,0,87,0,1,100,2,TWrex-cause,814850,BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care,breast cancer,BC
725373106,5/24/2015 23:22:33,1642815216,5/24/2015 23:21:45,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,87,0,,,100,2,BREAST CANCER,BC,optimal multifaceted BREAST CANCER care.,66-74-87-94-101,0-17-29,BC] appropriate specialists,BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care.,87 94,0,87,0,1,100,2,TWrex-cause,814850,BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care,breast cancer,BC
725373106,5/24/2015 23:28:08,1642816584,5/24/2015 23:27:59,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,87,0,,,100,2,BREAST CANCER,BC,BREAST CANCER,87-94,0,BC],BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care.,87 94,0,87,0,1,100,2,TWrex-cause,814850,BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care,breast cancer,BC
725373106,5/24/2015 23:55:49,1642823934,5/24/2015 23:55:29,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,87,0,,,100,2,BREAST CANCER,BC,BREAST CANCER,87-94,0,BC],BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care.,87 94,0,87,0,1,100,2,TWrex-cause,814850,BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care,breast cancer,BC
725373106,5/24/2015 23:56:05,1642824016,5/24/2015 23:54:37,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,87,0,,,100,2,BREAST CANCER,BC,optimal multifaceted BREAST CANCER,66-74-87-94,0,BC],BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care.,87 94,0,87,0,1,100,2,TWrex-cause,814850,BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care,breast cancer,BC
725373106,5/25/2015 00:24:48,1642833240,5/25/2015 00:24:38,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,87,0,,,100,2,BREAST CANCER,BC,BREAST CANCER,87-94,0,BC],BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care.,87 94,0,87,0,1,100,2,TWrex-cause,814850,BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care,breast cancer,BC
725373106,5/25/2015 00:25:24,1642833417,5/25/2015 00:25:17,false,clixsense,1,6340330,USA,NY,Canajoharie,67.248.115.74,87,0,,,100,2,BREAST CANCER,BC,BREAST CANCER,87-94,0,BC],BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care.,87 94,0,87,0,1,100,2,TWrex-cause,814850,BC]  9.1 Consult appropriate specialists to provide patients with optimal multifaceted breast cancer care,breast cancer,BC
725373107,5/24/2015 19:54:07,1642752174,5/24/2015 19:53:53,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,208,144,,,216,152,EMBOLISM,WARFARIN,EMBOLISM.,208,144,WARFARIN,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism.,208,144,208,144,-1,216,152,TWrex-cause,803662,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism,embolism,warfarin
725373107,5/24/2015 19:55:20,1642752596,5/24/2015 19:55:08,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,208,144,,,216,152,EMBOLISM,WARFARIN,pulmonary EMBOLISM.,198-208,144,WARFARIN,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism.,208,144,208,144,-1,216,152,TWrex-cause,803662,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism,embolism,warfarin
725373107,5/24/2015 19:55:26,1642752610,5/24/2015 19:55:11,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,208,144,,,216,152,EMBOLISM,WARFARIN,EMBOLISM.,208,144,WARFARIN,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism.,208,144,208,144,-1,216,152,TWrex-cause,803662,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism,embolism,warfarin
725373107,5/24/2015 20:02:26,1642754501,5/24/2015 20:02:15,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,208,144,,,216,152,EMBOLISM,WARFARIN,pulmonary EMBOLISM.,198-208,144,WARFARIN,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism.,208,144,208,144,-1,216,152,TWrex-cause,803662,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism,embolism,warfarin
725373107,5/24/2015 20:08:22,1642756103,5/24/2015 20:07:44,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,208,144,,,216,152,EMBOLISM,WARFARIN,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary EMBOLISM.,0-12-17-27-30-39-48-53-64-73-76-80-86-96-100-108-113-118-123-139-144-153-156-164-183-187-198-208-173,0-12-17-27-30-39-48-53-64-73-76-80-86-96-100-108-113-118-123-139-144-153-156-164-173-183-187-198-208,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with WARFARIN to prevent thrombus formation and subsequent pulmonary embolism.,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism.,208,144,208,144,-1,216,152,TWrex-cause,803662,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism,embolism,warfarin
725373107,5/24/2015 20:24:32,1642760171,5/24/2015 20:24:05,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,208,144,,,216,152,EMBOLISM,WARFARIN,pulmonary EMBOLISM.,198-208,144,WARFARIN,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism.,208,144,208,144,-1,216,152,TWrex-cause,803662,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism,embolism,warfarin
725373107,5/24/2015 20:28:19,1642761133,5/24/2015 20:28:04,false,instagc,1,19740138,CAN,,,50.69.96.237,208,144,,,216,152,EMBOLISM,WARFARIN,pulmonary EMBOLISM.,198-208,144,WARFARIN,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism.,208,144,208,144,-1,216,152,TWrex-cause,803662,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism,embolism,warfarin
725373107,5/24/2015 20:28:47,1642761341,5/24/2015 20:28:35,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,208,144,,,216,152,EMBOLISM,WARFARIN,EMBOLISM.,208,144,WARFARIN,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism.,208,144,208,144,-1,216,152,TWrex-cause,803662,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism,embolism,warfarin
725373107,5/24/2015 20:32:24,1642762250,5/24/2015 20:32:10,false,neodev,1,29074051,GBR,G5,Folkestone,80.6.67.18,208,144,,,216,152,EMBOLISM,WARFARIN,pulmonary EMBOLISM.,198-208,144,WARFARIN,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism.,208,144,208,144,-1,216,152,TWrex-cause,803662,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism,embolism,warfarin
725373107,5/24/2015 20:50:10,1642767130,5/24/2015 20:49:51,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,208,144,,,216,152,EMBOLISM,WARFARIN,pulmonary EMBOLISM.,198-208,144,WARFARIN,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism.,208,144,208,144,-1,216,152,TWrex-cause,803662,Individuals with decreased RV ejection fraction with dyskinetic portions of the right ventricle may benefit from long term anticoagulation with warfarin to prevent thrombus formation and subsequent pulmonary embolism,embolism,warfarin
725373108,5/24/2015 18:55:36,1642721304,5/24/2015 18:55:20,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,141,41,,,147,49,STROKE,WARFARIN,STROKE.,141,41,WARFARIN,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke.,141,41,141,41,-1,147,49,TWrex-cause,804297,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke,stroke,warfarin
725373108,5/24/2015 18:56:09,1642721556,5/24/2015 18:55:53,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,141,41,,,147,49,STROKE,WARFARIN,STROKE.,141,41,WARFARIN,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke.,141,41,141,41,-1,147,49,TWrex-cause,804297,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke,stroke,warfarin
725373108,5/24/2015 18:56:15,1642721597,5/24/2015 18:55:58,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,141,41,,,147,49,STROKE,WARFARIN,STROKE.,141,41,WARFARIN,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke.,141,41,141,41,-1,147,49,TWrex-cause,804297,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke,stroke,warfarin
725373108,5/24/2015 18:57:33,1642722258,5/24/2015 18:57:00,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,141,41,,,147,49,STROKE,WARFARIN,STROKE.,141,41,WARFARIN,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke.,141,41,141,41,-1,147,49,TWrex-cause,804297,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke,stroke,warfarin
725373108,5/24/2015 18:57:54,1642722417,5/24/2015 18:57:26,false,neodev,1,32456300,USA,CA,Laguna Niguel,216.177.129.227,141,41,,,147,49,STROKE,WARFARIN,MI to achieve international normalized ratio of 2.0 to 3.0 reduced risk for STROKE.,62-65-68-79-93-104-113-117-120-124-132-137-141-110,7-16-19-26-30-36-41-50-56-62-21,analysis of 3 RCTs has shown that WARFARIN given after MI,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke.,141,41,141,41,-1,147,49,TWrex-cause,804297,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke,stroke,warfarin
725373108,5/24/2015 19:01:02,1642723886,5/24/2015 19:00:29,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,141,41,,,147,49,STROKE,WARFARIN,STROKE.,141,41,WARFARIN,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke.,141,41,141,41,-1,147,49,TWrex-cause,804297,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke,stroke,warfarin
725373108,5/24/2015 19:18:17,1642732607,5/24/2015 19:17:56,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,141,41,,,147,49,STROKE,WARFARIN,STROKE.,141,41,WARFARIN,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke.,141,41,141,41,-1,147,49,TWrex-cause,804297,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke,stroke,warfarin
725373108,5/24/2015 19:19:37,1642734276,5/24/2015 19:18:47,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,141,41,,,147,49,STROKE,WARFARIN,STROKE.,141,41,WARFARIN,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke.,141,41,141,41,-1,147,49,TWrex-cause,804297,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke,stroke,warfarin
725373108,5/24/2015 19:21:16,1642736576,5/24/2015 19:20:51,false,pocketmoneygpt,1,32162555,CAN,BC,Vancouver,108.180.194.80,141,41,,,147,49,STROKE,WARFARIN,STROKE.,141,41,WARFARIN,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke.,141,41,141,41,-1,147,49,TWrex-cause,804297,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke,stroke,warfarin
725373108,5/24/2015 19:23:23,1642739397,5/24/2015 19:23:16,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,141,41,,,147,49,STROKE,WARFARIN,STROKE.,141,41,WARFARIN,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke.,141,41,141,41,-1,147,49,TWrex-cause,804297,A meta-analysis of 3 RCTs has shown that warfarin given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for stroke,stroke,warfarin
725373109,5/24/2015 19:50:23,1642751128,5/24/2015 19:49:33,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,109,147,,,124,154,THROMBOEMBOLISM,HEPARIN,The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous THROMBOEMBOLISM Low - molecular - weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy:,18-22-27-31-37-47-56-62-76-90-98-102-109-126-129-130-139-140-147-155-162-174-184-188-207-213-218,18-22-27-31-37-47-56-62-76-90-98-102-109-126-129-130-140-147-155-162-174-184-188-207-213-218,The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism Low - molecular weight HEPARIN versus compression stockings for thromboprophylaxis after knee arthroscopy:,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,109,147,109,147,-1,124,154,TWrex-cause,804670,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial,thromboembolism,heparin
725373109,5/24/2015 19:51:17,1642751368,5/24/2015 19:51:01,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,109,147,,,124,154,THROMBOEMBOLISM,HEPARIN,THROMBOEMBOLISM,109,147,HEPARIN,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,109,147,109,147,-1,124,154,TWrex-cause,804670,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial,thromboembolism,heparin
725373109,5/24/2015 19:51:26,1642751407,5/24/2015 19:50:53,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,109,147,,,124,154,THROMBOEMBOLISM,HEPARIN,therapy for venous THROMBOEMBOLISM,90-98-102-109,126-130-140-147-155-162-174,Low molecular weight HEPARIN versus compression stockings,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,109,147,109,147,-1,124,154,TWrex-cause,804670,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial,thromboembolism,heparin
725373109,5/24/2015 19:52:04,1642751519,5/24/2015 19:51:37,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,109,147,,,124,154,THROMBOEMBOLISM,HEPARIN,venous THROMBOEMBOLISM,109-102,147,HEPARIN,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,109,147,109,147,-1,124,154,TWrex-cause,804670,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial,thromboembolism,heparin
725373109,5/24/2015 19:52:13,1642751542,5/24/2015 19:51:57,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,109,147,,,124,154,THROMBOEMBOLISM,HEPARIN,THROMBOEMBOLISM,109,147,HEPARIN,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,109,147,109,147,-1,124,154,TWrex-cause,804670,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial,thromboembolism,heparin
725373109,5/24/2015 19:58:59,1642753591,5/24/2015 19:58:36,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,109,147,,,124,154,THROMBOEMBOLISM,HEPARIN,venous THROMBOEMBOLISM,102-109,147,HEPARIN,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,109,147,109,147,-1,124,154,TWrex-cause,804670,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial,thromboembolism,heparin
725373109,5/24/2015 20:11:38,1642756996,5/24/2015 20:11:20,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,109,147,,,124,154,THROMBOEMBOLISM,HEPARIN,THROMBOEMBOLISM,109,147,HEPARIN,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,109,147,109,147,-1,124,154,TWrex-cause,804670,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial,thromboembolism,heparin
725373109,5/24/2015 20:13:02,1642757426,5/24/2015 20:12:37,false,instagc,1,19740138,CAN,,,50.69.96.237,109,147,,,124,154,THROMBOEMBOLISM,HEPARIN,venous THROMBOEMBOLISM,102-109,147,HEPARIN,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,109,147,109,147,-1,124,154,TWrex-cause,804670,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial,thromboembolism,heparin
725373109,5/24/2015 20:15:48,1642758157,5/24/2015 20:15:07,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,109,147,,,124,154,THROMBOEMBOLISM,HEPARIN,venous THROMBOEMBOLISM,102-109,126-130-140-147,Low molecular weight HEPARIN,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,109,147,109,147,-1,124,154,TWrex-cause,804670,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial,thromboembolism,heparin
725373109,5/24/2015 20:20:03,1642759063,5/24/2015 20:19:39,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,109,147,,,124,154,THROMBOEMBOLISM,HEPARIN,venous THROMBOEMBOLISM,102-109,126-130-140-147,Low molecular weight HEPARIN,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.,109,147,109,147,-1,124,154,TWrex-cause,804670,randomized trial  The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism  Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial,thromboembolism,heparin
725373110,5/24/2015 19:51:45,1642751484,5/24/2015 19:51:34,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,64,0,,,76,8,HYPERTENSION,LOSARTAN,HYPERTENSION,64,0,LOSARTAN,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club.,64,0,64,0,-1,76,8,TWrex-cause,804455,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club,hypertension,losartan
725373110,5/24/2015 19:52:04,1642751517,5/24/2015 19:51:34,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,64,0,,,76,8,HYPERTENSION,LOSARTAN,Losartan was more effective than atenolol for isolated systolic HYPERTENSION and left ventricular hypertrophy,0-9-13-18-28-33-42-46-55-64-77-81-86-98,0-9-13-18-28-33-42-46-55-64-77-81-86-98,LOSARTAN was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club.,64,0,64,0,-1,76,8,TWrex-cause,804455,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club,hypertension,losartan
725373110,5/24/2015 19:52:35,1642751616,5/24/2015 19:52:21,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,64,0,,,76,8,HYPERTENSION,LOSARTAN,HYPERTENSION,64,0,LOSARTAN,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club.,64,0,64,0,-1,76,8,TWrex-cause,804455,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club,hypertension,losartan
725373110,5/24/2015 19:52:45,1642751641,5/24/2015 19:52:33,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,64,0,,,76,8,HYPERTENSION,LOSARTAN,HYPERTENSION,64,0,LOSARTAN,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club.,64,0,64,0,-1,76,8,TWrex-cause,804455,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club,hypertension,losartan
725373110,5/24/2015 19:53:25,1642751921,5/24/2015 19:52:10,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,64,0,,,76,8,HYPERTENSION,LOSARTAN,for isolated systolic HYPERTENSION,42-46-55-64,0-9-13-18,LOSARTAN was more effective,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club.,64,0,64,0,-1,76,8,TWrex-cause,804455,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club,hypertension,losartan
725373110,5/24/2015 19:59:30,1642753725,5/24/2015 19:59:17,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,64,0,,,76,8,HYPERTENSION,LOSARTAN,systolic HYPERTENSION,55-64,0,LOSARTAN,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club.,64,0,64,0,-1,76,8,TWrex-cause,804455,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club,hypertension,losartan
725373110,5/24/2015 20:12:19,1642757262,5/24/2015 20:12:06,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,64,0,,,76,8,HYPERTENSION,LOSARTAN,HYPERTENSION,64,0,LOSARTAN,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club.,64,0,64,0,-1,76,8,TWrex-cause,804455,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club,hypertension,losartan
725373110,5/24/2015 20:13:52,1642757610,5/24/2015 20:13:30,false,instagc,1,19740138,CAN,,,50.69.96.237,64,0,,,76,8,HYPERTENSION,LOSARTAN,systolic HYPERTENSION,55-64,0,LOSARTAN,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club.,64,0,64,0,-1,76,8,TWrex-cause,804455,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club,hypertension,losartan
725373110,5/24/2015 20:16:40,1642758382,5/24/2015 20:16:19,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,64,0,,,76,8,HYPERTENSION,LOSARTAN,isolated systolic HYPERTENSION,46-55-64,0,LOSARTAN,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club.,64,0,64,0,-1,76,8,TWrex-cause,804455,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club,hypertension,losartan
725373110,5/24/2015 20:20:46,1642759283,5/24/2015 20:20:33,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,64,0,,,76,8,HYPERTENSION,LOSARTAN,isolated systolic HYPERTENSION,46-55-64,0,LOSARTAN,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club.,64,0,64,0,-1,76,8,TWrex-cause,804455,Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension Losartan  ACP Journal Club,hypertension,losartan
725373111,5/24/2015 19:53:52,1642752126,5/24/2015 19:53:41,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,108,77,,,126,95,PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE,PRECOCIOUS PUBERTY.,108-119,77-88,LEUPROLIDE ACETATE,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.",108 119,77 88,108,77,-1,126,95,TWrex-cause,803694,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty",precocious puberty,leuprolide acetate
725373111,5/24/2015 19:55:07,1642752474,5/24/2015 19:54:53,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,108,77,,,126,95,PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE,PRECOCIOUS PUBERTY.,108-119,77-88,LEUPROLIDE ACETATE,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.",108 119,77 88,108,77,-1,126,95,TWrex-cause,803694,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty",precocious puberty,leuprolide acetate
725373111,5/24/2015 19:55:10,1642752494,5/24/2015 19:54:57,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,108,77,,,126,95,PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE,PRECOCIOUS PUBERTY.,108-119,77-88,LEUPROLIDE ACETATE,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.",108 119,77 88,108,77,-1,126,95,TWrex-cause,803694,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty",precocious puberty,leuprolide acetate
725373111,5/24/2015 20:02:10,1642754446,5/24/2015 20:01:56,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,108,77,,,126,95,PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE,PRECOCIOUS PUBERTY.,108-119,77-88,LEUPROLIDE ACETATE,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.",108 119,77 88,108,77,-1,126,95,TWrex-cause,803694,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty",precocious puberty,leuprolide acetate
725373111,5/24/2015 20:07:42,1642755886,5/24/2015 20:07:23,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,108,77,,,126,95,PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE,Two - year results of treatment with depot leuprolide acetate for central PRECOCIOUS PUBERTY.,36-39-40-45-53-56-66-71-88-96-100-108-119-77,36-39-40-45-53-56-66-71-77-88-96-100-108-119,Two - year results of treatment with depot LEUPROLIDE ACETATE for central precocious puberty.,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.",108 119,77 88,108,77,-1,126,95,TWrex-cause,803694,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty",precocious puberty,leuprolide acetate
725373111,5/24/2015 20:23:58,1642760027,5/24/2015 20:23:37,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,108,77,,,126,95,PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE,PRECOCIOUS PUBERTY.,108-119,77-88,LEUPROLIDE ACETATE,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.",108 119,77 88,108,77,-1,126,95,TWrex-cause,803694,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty",precocious puberty,leuprolide acetate
725373111,5/24/2015 20:28:01,1642760989,5/24/2015 20:27:45,false,instagc,1,19740138,CAN,,,50.69.96.237,108,77,,,126,95,PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE,PRECOCIOUS PUBERTY.,108-119,77-88,LEUPROLIDE ACETATE,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.",108 119,77 88,108,77,-1,126,95,TWrex-cause,803694,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty",precocious puberty,leuprolide acetate
725373111,5/24/2015 20:28:34,1642761252,5/24/2015 20:28:21,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,108,77,,,126,95,PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE,PRECOCIOUS PUBERTY.,108-119,77-88,LEUPROLIDE ACETATE,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.",108 119,77 88,108,77,-1,126,95,TWrex-cause,803694,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty",precocious puberty,leuprolide acetate
725373111,5/24/2015 20:32:09,1642762166,5/24/2015 20:31:56,false,neodev,1,29074051,GBR,G5,Folkestone,80.6.67.18,108,77,,,126,95,PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE,PRECOCIOUS PUBERTY.,108-119,77-88,LEUPROLIDE ACETATE,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.",108 119,77 88,108,77,-1,126,95,TWrex-cause,803694,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty",precocious puberty,leuprolide acetate
725373111,5/24/2015 20:41:31,1642764499,5/24/2015 20:41:23,false,clixsense,1,23197581,NLD,11,Den Haag,82.217.5.55,108,77,,,126,95,PRECOCIOUS PUBERTY,LEUPROLIDE ACETATE,PRECOCIOUS PUBERTY.,108-119,77-88,LEUPROLIDE ACETATE,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.",108 119,77 88,108,77,-1,126,95,TWrex-cause,803694,"Neely EK, Hintz RL, Parker B et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty",precocious puberty,leuprolide acetate
725373112,5/24/2015 19:05:03,1642725853,5/24/2015 19:04:46,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,87,132,,,92,148,FEVER,SALMONELLA TYPHI,FEVER,87,132-143,SALMONELLA TYPHI.,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi.,87,132 143,87,132,1,92,148,TWrex-cause,811574,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi,fever,salmonella typhi
725373112,5/24/2015 19:06:38,1642726585,5/24/2015 19:06:19,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,87,132,,,92,148,FEVER,SALMONELLA TYPHI,typhoid FEVER,79-87,132-143,SALMONELLA TYPHI.,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi.,87,132 143,87,132,1,92,148,TWrex-cause,811574,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi,fever,salmonella typhi
725373112,5/24/2015 19:07:46,1642727019,5/24/2015 19:07:16,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,87,132,,,92,148,FEVER,SALMONELLA TYPHI,typhoid FEVER (enteric fever),79-87-93-102,132-143,SALMONELLA TYPHI.,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi.,87,132 143,87,132,1,92,148,TWrex-cause,811574,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi,fever,salmonella typhi
725373112,5/24/2015 19:20:41,1642735657,5/24/2015 19:20:17,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,87,132,,,92,148,FEVER,SALMONELLA TYPHI,typhoid FEVER (enteric fever),79-87-93-102,119-132-143,susceptible SALMONELLA TYPHI.,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi.,87,132 143,87,132,1,92,148,TWrex-cause,811574,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi,fever,salmonella typhi
725373112,5/24/2015 19:26:08,1642740919,5/24/2015 19:25:57,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,87,132,,,92,148,FEVER,SALMONELLA TYPHI,typhoid FEVER (enteric fever),79-87-93-102,119-132-143,susceptible SALMONELLA TYPHI.,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi.,87,132 143,87,132,1,92,148,TWrex-cause,811574,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi,fever,salmonella typhi
725373112,5/24/2015 19:39:35,1642747339,5/24/2015 19:39:21,false,clixsense,1,31482589,NLD,,,31.201.11.16,87,132,,,92,148,FEVER,SALMONELLA TYPHI,typhoid FEVER,79-87,119-132-143,susceptible SALMONELLA TYPHI.,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi.,87,132 143,87,132,1,92,148,TWrex-cause,811574,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi,fever,salmonella typhi
725373112,5/24/2015 19:41:13,1642747985,5/24/2015 19:40:29,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,87,132,,,92,148,FEVER,SALMONELLA TYPHI,treatment of typhoid FEVER,66-76-79-87,109-116-119-132-143,caused by susceptible SALMONELLA TYPHI.,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi.,87,132 143,87,132,1,92,148,TWrex-cause,811574,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi,fever,salmonella typhi
725373112,5/24/2015 19:43:08,1642748695,5/24/2015 19:42:43,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,87,132,,,92,148,FEVER,SALMONELLA TYPHI,Typhoid Fever and Other Salmonella Infections Alternative for treatment of typhoid FEVER (enteric fever) caused by susceptible Salmonella typhi.,3-11-17-21-27-38-50-62-66-76-79-87-93-102-109-116-119-143-132,3-11-17-21-27-38-50-62-66-76-79-87-93-109-116-119-132-143-102,Typhoid Fever and Other Salmonella Infections Alternative for treatment of typhoid fever (enteric fever) caused by susceptible SALMONELLA TYPHI.,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi.,87,132 143,87,132,1,92,148,TWrex-cause,811574,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi,fever,salmonella typhi
725373112,5/24/2015 19:43:17,1642748738,5/24/2015 19:42:58,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,87,132,,,92,148,FEVER,SALMONELLA TYPHI,typhoid FEVER (enteric fever),79-87-93-102,119-132-143,susceptible SALMONELLA TYPHI.,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi.,87,132 143,87,132,1,92,148,TWrex-cause,811574,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi,fever,salmonella typhi
725373112,5/24/2015 19:48:22,1642750525,5/24/2015 19:48:12,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,87,132,,,92,148,FEVER,SALMONELLA TYPHI,typhoid FEVER,79-87,132-143,SALMONELLA TYPHI.,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi.,87,132 143,87,132,1,92,148,TWrex-cause,811574,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of typhoid fever (enteric fever) caused by susceptible  Salmonella typhi,fever,salmonella typhi
725373113,5/24/2015 20:28:46,1642761340,5/24/2015 20:28:32,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,159,113,,,167,125,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER.,137-148-159,113,CLOMIPRAMINE,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder.",159,113,159,113,-1,167,125,TWrex-cause,803425,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder",disorder,clomipramine
725373113,5/24/2015 20:33:19,1642762449,5/24/2015 20:33:08,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,159,113,,,167,125,DISORDER,CLOMIPRAMINE,DISORDER.,159,113,CLOMIPRAMINE,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder.",159,113,159,113,-1,167,125,TWrex-cause,803425,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder",disorder,clomipramine
725373113,5/24/2015 20:59:26,1642770581,5/24/2015 20:59:15,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,159,113,,,167,125,DISORDER,CLOMIPRAMINE,DISORDER.,159,113,CLOMIPRAMINE,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder.",159,113,159,113,-1,167,125,TWrex-cause,803425,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder",disorder,clomipramine
725373113,5/24/2015 20:59:32,1642770589,5/24/2015 20:59:19,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,159,113,,,167,125,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER.,137-148-159,113-126,CLOMIPRAMINE therapy,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder.",159,113,159,113,-1,167,125,TWrex-cause,803425,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder",disorder,clomipramine
725373113,5/24/2015 21:02:04,1642771531,5/24/2015 21:01:50,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,159,113,,,167,125,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER.,137-148-159,113-137-148-159,CLOMIPRAMINE obsessive compulsive disorder.,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder.",159,113,159,113,-1,167,125,TWrex-cause,803425,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder",disorder,clomipramine
725373113,5/24/2015 21:10:02,1642774318,5/24/2015 21:09:50,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,159,113,,,167,125,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER.,137-148-159,113,CLOMIPRAMINE,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder.",159,113,159,113,-1,167,125,TWrex-cause,803425,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder",disorder,clomipramine
725373113,5/24/2015 21:12:41,1642775171,5/24/2015 21:12:27,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,159,113,,,167,125,DISORDER,CLOMIPRAMINE,obsessive - compulsive DISORDER.,137-148-159-146,90-102-110-113,therapeutic effects of CLOMIPRAMINE,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder.",159,113,159,113,-1,167,125,TWrex-cause,803425,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder",disorder,clomipramine
725373113,5/24/2015 21:17:25,1642776552,5/24/2015 21:16:34,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,159,113,,,167,125,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER.,137-148-159,113-126,CLOMIPRAMINE therapy,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder.",159,113,159,113,-1,167,125,TWrex-cause,803425,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder",disorder,clomipramine
725373113,5/24/2015 21:24:15,1642778520,5/24/2015 21:23:27,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,159,113,,,167,125,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER.,137-148-159,113-126,CLOMIPRAMINE therapy,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder.",159,113,159,113,-1,167,125,TWrex-cause,803425,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder",disorder,clomipramine
725373113,5/24/2015 21:24:39,1642778611,5/24/2015 21:24:28,false,clixsense,1,26492726,GBR,C2,Halifax,2.103.117.226,159,113,,,167,125,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER.,137-148-159,113,CLOMIPRAMINE,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder.",159,113,159,113,-1,167,125,TWrex-cause,803425,"Ackerman DL, Greenland S, Bystritsky A et al. Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive- compulsive disorder",disorder,clomipramine
725373114,5/24/2015 21:03:13,1642771948,5/24/2015 21:02:53,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,93,66,,,105,69,DEXTROCARDIA,PCD,"DEXTROCARDIA,",93,66,PCD,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward.",93,66,93,66,1,105,69,TWrex-cause,812974,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward",dextrocardia,PCD
725373114,5/24/2015 21:04:00,1642772260,5/24/2015 21:03:31,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,93,66,,,105,69,DEXTROCARDIA,PCD,"DEXTROCARDIA,",93,66,PCD,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward.",93,66,93,66,1,105,69,TWrex-cause,812974,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward",dextrocardia,PCD
725373114,5/24/2015 21:15:53,1642776106,5/24/2015 21:15:42,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,93,66,,,105,69,DEXTROCARDIA,PCD,"DEXTROCARDIA,",93,66,PCD,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward.",93,66,93,66,1,105,69,TWrex-cause,812974,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward",dextrocardia,PCD
725373114,5/24/2015 21:16:52,1642776410,5/24/2015 21:16:15,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,93,66,,,105,69,DEXTROCARDIA,PCD,"DEXTROCARDIA,",93,48-63-66-77-93-107-111-116,"manifestations of PCD bronchiectasis, dextrocardia, and male infertility)","PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward.",93,66,93,66,1,105,69,TWrex-cause,812974,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward",dextrocardia,PCD
725373114,5/24/2015 21:29:13,1642780031,5/24/2015 21:29:03,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,93,66,,,105,69,DEXTROCARDIA,PCD,"DEXTROCARDIA,",93,66,PCD,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward.",93,66,93,66,1,105,69,TWrex-cause,812974,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward",dextrocardia,PCD
725373114,5/24/2015 21:29:53,1642780237,5/24/2015 21:29:31,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,93,66,,,105,69,DEXTROCARDIA,PCD,"DEXTROCARDIA,",93,66,PCD,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward.",93,66,93,66,1,105,69,TWrex-cause,812974,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward",dextrocardia,PCD
725373114,5/24/2015 21:32:24,1642781178,5/24/2015 21:31:19,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,93,66,,,105,69,DEXTROCARDIA,PCD,"DEXTROCARDIA,",93,66,PCD,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward.",93,66,93,66,1,105,69,TWrex-cause,812974,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward",dextrocardia,PCD
725373114,5/24/2015 22:06:18,1642791237,5/24/2015 22:05:32,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,93,66,,,105,69,DEXTROCARDIA,PCD,"DEXTROCARDIA,",93,66,PCD,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward.",93,66,93,66,1,105,69,TWrex-cause,812974,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward",dextrocardia,PCD
725373114,5/24/2015 22:31:07,1642800798,5/24/2015 22:30:44,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,93,66,,,105,69,DEXTROCARDIA,PCD,"DEXTROCARDIA,",93,66,PCD,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward.",93,66,93,66,1,105,69,TWrex-cause,812974,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward",dextrocardia,PCD
725373114,5/24/2015 22:44:15,1642804907,5/24/2015 22:43:50,false,clixsense,1,6344072,CAN,BC,Burnaby,172.218.166.58,93,66,,,105,69,DEXTROCARDIA,PCD,"PCD (i.e., bronchiectasis, DEXTROCARDIA, and male infertility)",66-70-77-93-107-111-116,42-48-63-66-77-93,"three manifestations of PCD bronchiectasis, dextrocardia,","PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward.",93,66,93,66,1,105,69,TWrex-cause,812974,"PATHOGENESIS  The underlying cause of all three manifestations of PCD (i.e., bronchiectasis, dextrocardia, and male infertility) is the loss of adequate ciliary beating; this defect results in an inability (1) to escalate respiratory secretions from small airways; (2) to drive the flow of extraembryonic fluid that establishes left-right symmetry in the embryo; and (3) to propel spermatzoa forward",dextrocardia,PCD
725373115,5/24/2015 23:04:52,1642810541,5/24/2015 23:04:06,false,points4rewards,1,28703583,USA,,,97.73.85.52,152,107,,,176,122,MENINGOCOCCAL MENINGITIS,CHLORAMPHENICOL,MENINGOCOCCAL MENINGITIS,152-166,107-152-166,CHLORAMPHENICOL meningococcal meningitis,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.",152 166,107,152,107,-1,176,122,TWrex-cause,800453,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study",meningococcal meningitis,chloramphenicol
725373115,5/24/2015 23:05:59,1642810917,5/24/2015 23:04:57,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,152,107,,,176,122,MENINGOCOCCAL MENINGITIS,CHLORAMPHENICOL,MENINGOCOCCAL MENINGITIS,152-166,95-100-107,long acting CHLORAMPHENICOL,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.",152 166,107,152,107,-1,176,122,TWrex-cause,800453,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study",meningococcal meningitis,chloramphenicol
725373115,5/24/2015 23:09:29,1642811888,5/24/2015 23:08:30,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,152,107,,,176,122,MENINGOCOCCAL MENINGITIS,CHLORAMPHENICOL,short course treatment of MENINGOCOCCAL MENINGITIS,126-132-139-149-152-166,95-100-107,long acting CHLORAMPHENICOL,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.",152 166,107,152,107,-1,176,122,TWrex-cause,800453,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study",meningococcal meningitis,chloramphenicol
725373115,5/24/2015 23:22:11,1642815132,5/24/2015 23:21:56,false,bitcoinget,1,28503763,USA,CA,San Francisco,107.217.186.64,152,107,,,176,122,MENINGOCOCCAL MENINGITIS,CHLORAMPHENICOL,MENINGOCOCCAL MENINGITIS,152-166,107,CHLORAMPHENICOL,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.",152 166,107,152,107,-1,176,122,TWrex-cause,800453,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study",meningococcal meningitis,chloramphenicol
725373115,5/24/2015 23:23:18,1642815424,5/24/2015 23:23:02,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,152,107,,,176,122,MENINGOCOCCAL MENINGITIS,CHLORAMPHENICOL,course treatment of MENINGOCOCCAL MENINGITIS during epidemics:,132-139-149-152-166-177-184,95-100-107-123-126-132-139,long acting CHLORAMPHENICOL in short course treatment,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.",152 166,107,152,107,-1,176,122,TWrex-cause,800453,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study",meningococcal meningitis,chloramphenicol
725373115,5/24/2015 23:56:25,1642824128,5/24/2015 23:56:09,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,152,107,,,176,122,MENINGOCOCCAL MENINGITIS,CHLORAMPHENICOL,MENINGOCOCCAL MENINGITIS,152-166,95-100-107,long acting CHLORAMPHENICOL,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.",152 166,107,152,107,-1,176,122,TWrex-cause,800453,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study",meningococcal meningitis,chloramphenicol
725373115,5/24/2015 23:57:28,1642824475,5/24/2015 23:56:45,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,152,107,,,176,122,MENINGOCOCCAL MENINGITIS,CHLORAMPHENICOL,MENINGOCOCCAL MENINGITIS,152-166,107,CHLORAMPHENICOL,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.",152 166,107,152,107,-1,176,122,TWrex-cause,800453,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study",meningococcal meningitis,chloramphenicol
725373115,5/25/2015 00:26:09,1642833672,5/25/2015 00:25:40,false,elite,1,32173500,GBR,E4,Rayleigh,90.219.97.221,152,107,,,176,122,MENINGOCOCCAL MENINGITIS,CHLORAMPHENICOL,short course treatment of MENINGOCOCCAL MENINGITIS,126-132-139-149-152-166,95-100-107,long acting CHLORAMPHENICOL,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.",152 166,107,152,107,-1,176,122,TWrex-cause,800453,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study",meningococcal meningitis,chloramphenicol
725373115,5/25/2015 00:27:52,1642834245,5/25/2015 00:27:50,false,prodege,1,12656479,CAN,NB,Moncton,142.167.60.47,152,107,,,176,122,MENINGOCOCCAL MENINGITIS,CHLORAMPHENICOL,course treatment of MENINGOCOCCAL MENINGITIS during epidemics: a,132-139-149-152-166-177-184-195,92-95-100-107-123-126-132,as long acting CHLORAMPHENICOL in short course,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.",152 166,107,152,107,-1,176,122,TWrex-cause,800453,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study",meningococcal meningitis,chloramphenicol
725373115,5/25/2015 00:34:42,1642836141,5/25/2015 00:34:30,false,clixsense,1,21933552,CAN,ON,Ottawa,70.49.14.161,152,107,,,176,122,MENINGOCOCCAL MENINGITIS,CHLORAMPHENICOL,MENINGOCOCCAL MENINGITIS,152-166,107,CHLORAMPHENICOL,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.",152 166,107,152,107,-1,176,122,TWrex-cause,800453,"1]  Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study",meningococcal meningitis,chloramphenicol
725373116,5/24/2015 20:28:02,1642761010,5/24/2015 20:27:46,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,93,44,,,108,52,TYPE 2 DIABETES,GLARGINE,TYPE 2 DIABETES:,93-98-100,30-36-44,basal insulin GLARGINE,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.,93 98 100,44,93,44,-1,108,52,TWrex-cause,800894,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial,type 2 diabetes,glargine
725373116,5/24/2015 20:32:34,1642762260,5/24/2015 20:32:07,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,93,44,,,108,52,TYPE 2 DIABETES,GLARGINE,TYPE 2 DIABETES:,93-98-100,44,GLARGINE,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.,93 98 100,44,93,44,-1,108,52,TWrex-cause,800894,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial,type 2 diabetes,glargine
725373116,5/24/2015 20:34:39,1642762758,5/24/2015 20:33:56,false,instagc,1,19740138,CAN,,,50.69.96.237,93,44,,,108,52,TYPE 2 DIABETES,GLARGINE,TYPE 2 DIABETES:,93-98-100,44,GLARGINE,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.,93 98 100,44,93,44,-1,108,52,TWrex-cause,800894,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial,type 2 diabetes,glargine
725373116,5/24/2015 20:57:46,1642769976,5/24/2015 20:56:39,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,93,44,,,108,52,TYPE 2 DIABETES,GLARGINE,Prandial inhaled insulin basal insulin glargine biaspart insulin TYPE 2 DIABETES: multicentre randomised trial.,0-9-17-30-36-44-72-81-93-98-100-112-124-135,0-9-17-30-36-44-72-81-93-98-100-112-124-135,Prandial inhaled insulin basal insulin GLARGINE biaspart insulin type 2 diabetes: multicentre randomised trial.,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.,93 98 100,44,93,44,-1,108,52,TWrex-cause,800894,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial,type 2 diabetes,glargine
725373116,5/24/2015 20:58:45,1642770303,5/24/2015 20:58:33,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,93,44,,,108,52,TYPE 2 DIABETES,GLARGINE,TYPE 2 DIABETES:,93-98-100,44,GLARGINE,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.,93 98 100,44,93,44,-1,108,52,TWrex-cause,800894,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial,type 2 diabetes,glargine
725373116,5/24/2015 20:58:49,1642770312,5/24/2015 20:58:36,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,93,44,,,108,52,TYPE 2 DIABETES,GLARGINE,TYPE 2 DIABETES:,93-98-100,44,GLARGINE,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.,93 98 100,44,93,44,-1,108,52,TWrex-cause,800894,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial,type 2 diabetes,glargine
725373116,5/24/2015 21:00:18,1642770874,5/24/2015 20:59:13,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,93,44,,,108,52,TYPE 2 DIABETES,GLARGINE,TYPE 2 DIABETES:,93-98-100,44,GLARGINE,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.,93 98 100,44,93,44,-1,108,52,TWrex-cause,800894,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial,type 2 diabetes,glargine
725373116,5/24/2015 21:07:08,1642773442,5/24/2015 21:05:57,false,neodev,1,17426565,CAN,BC,Burnaby,70.79.18.187,93,44,,,108,52,TYPE 2 DIABETES,GLARGINE,TYPE 2 DIABETES:,93-98-100,30-36-44,basal insulin GLARGINE,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.,93 98 100,44,93,44,-1,108,52,TWrex-cause,800894,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial,type 2 diabetes,glargine
725373116,5/24/2015 21:09:22,1642774154,5/24/2015 21:09:01,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,93,44,,,108,52,TYPE 2 DIABETES,GLARGINE,TYPE 2 DIABETES:,93-98-100,30-36-44,basal insulin GLARGINE,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.,93 98 100,44,93,44,-1,108,52,TWrex-cause,800894,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial,type 2 diabetes,glargine
725373116,5/24/2015 21:13:07,1642775366,5/24/2015 21:11:52,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,93,44,,,108,52,TYPE 2 DIABETES,GLARGINE,biaspart insulin for TYPE 2 DIABETES:,72-81-89-93-98-100,30-36-44,basal insulin GLARGINE,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.,93 98 100,44,93,44,-1,108,52,TWrex-cause,800894,Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial,type 2 diabetes,glargine
725373117,5/24/2015 21:35:43,1642782269,5/24/2015 21:35:22,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,34,63,,,42,71,DISORDER,ZOLPIDEM,shift work sleep DISORDER,17-23-28-34,63,ZOLPIDEM,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms.,34,63,34,63,-1,42,71,TWrex-cause,803459,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms,disorder,zolpidem
725373117,5/24/2015 23:01:17,1642809535,5/24/2015 23:00:39,false,points4rewards,1,28703583,USA,,,97.73.85.52,34,63,,,42,71,DISORDER,ZOLPIDEM,sleep DISORDER insomnia,28-34-76,63-76,ZOLPIDEM insomnia,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms.,34,63,34,63,-1,42,71,TWrex-cause,803459,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms,disorder,zolpidem
725373117,5/24/2015 23:03:25,1642810070,5/24/2015 23:03:13,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,34,63,,,42,71,DISORDER,ZOLPIDEM,shift work sleep DISORDER,17-23-28-34,63,ZOLPIDEM,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms.,34,63,34,63,-1,42,71,TWrex-cause,803459,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms,disorder,zolpidem
725373117,5/24/2015 23:04:39,1642810490,5/24/2015 23:03:51,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,34,63,,,42,71,DISORDER,ZOLPIDEM,Jet lag and shift work sleep DISORDER,5-9-13-17-23-28-34,63,ZOLPIDEM,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms.,34,63,34,63,-1,42,71,TWrex-cause,803459,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms,disorder,zolpidem
725373117,5/24/2015 23:18:03,1642813968,5/24/2015 23:17:15,false,bitcoinget,1,28503763,USA,CA,San Francisco,107.217.186.64,34,63,,,42,71,DISORDER,ZOLPIDEM,shift work sleep DISORDER,17-23-28-34,63,ZOLPIDEM,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms.,34,63,34,63,-1,42,71,TWrex-cause,803459,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms,disorder,zolpidem
725373117,5/24/2015 23:20:38,1642814592,5/24/2015 23:19:51,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,34,63,,,42,71,DISORDER,ZOLPIDEM,shift work sleep DISORDER may be treated,17-23-28-34-43-47-50,50-63-72-76-85,treated ZOLPIDEM for insomnia symptoms.,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms.,34,63,34,63,-1,42,71,TWrex-cause,803459,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms,disorder,zolpidem
725373117,5/24/2015 23:26:48,1642816250,5/24/2015 23:25:51,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,34,63,,,42,71,DISORDER,ZOLPIDEM,shift work sleep DISORDER,17-23-28-34,63,ZOLPIDEM,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms.,34,63,34,63,-1,42,71,TWrex-cause,803459,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms,disorder,zolpidem
725373117,5/24/2015 23:36:39,1642818656,5/24/2015 23:36:33,false,instagc,1,31861996,USA,FL,Homestead,73.46.199.178,34,63,,,42,71,DISORDER,ZOLPIDEM,shift work sleep DISORDER may be treated,17-23-28-34-43-47-50,47-50-58-63-72-76-85,be treated with ZOLPIDEM for insomnia symptoms.,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms.,34,63,34,63,-1,42,71,TWrex-cause,803459,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms,disorder,zolpidem
725373117,5/24/2015 23:38:42,1642819302,5/24/2015 23:38:04,false,quickrewards,1,8672587,USA,TX,El Paso,209.194.208.150,34,63,,,42,71,DISORDER,ZOLPIDEM,DISORDER,34,63,ZOLPIDEM,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms.,34,63,34,63,-1,42,71,TWrex-cause,803459,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms,disorder,zolpidem
725373117,5/24/2015 23:52:51,1642822874,5/24/2015 23:51:42,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,34,63,,,42,71,DISORDER,ZOLPIDEM,shift work sleep DISORDER,23-28-34-17,63,ZOLPIDEM,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms.,34,63,34,63,-1,42,71,TWrex-cause,803459,38   Jet lag and shift-work sleep disorder may be treated with zolpidem for insomnia symptoms,disorder,zolpidem
725373118,5/24/2015 21:05:29,1642772756,5/24/2015 21:05:12,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,20,99,,,32,128,TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS,20,99-116,SUPRAVENTRICULAR TACHYCARDIAS.,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias.,20,99 116,20,99,1,32,128,TWrex-cause,813279,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias,tachycardia,supraventricular tachycardia
725373118,5/24/2015 21:05:45,1642772911,5/24/2015 21:05:34,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,20,99,,,32,128,TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS,20,99-116,SUPRAVENTRICULAR TACHYCARDIAS.,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias.,20,99 116,20,99,1,32,128,TWrex-cause,813279,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias,tachycardia,supraventricular tachycardia
725373118,5/24/2015 21:18:30,1642776841,5/24/2015 21:18:17,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,20,99,,,32,128,TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS,20,99-116,SUPRAVENTRICULAR TACHYCARDIAS.,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias.,20,99 116,20,99,1,32,128,TWrex-cause,813279,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias,tachycardia,supraventricular tachycardia
725373118,5/24/2015 21:32:09,1642781076,5/24/2015 21:31:47,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,20,99,,,32,128,TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS,20,99-116,SUPRAVENTRICULAR TACHYCARDIAS.,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias.,20,99 116,20,99,1,32,128,TWrex-cause,813279,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias,tachycardia,supraventricular tachycardia
725373118,5/24/2015 21:41:45,1642784088,5/24/2015 21:40:13,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,20,99,,,32,128,TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,narrow complex TACHYCARDIAS,5-12-20,99-116,SUPRAVENTRICULAR TACHYCARDIAS.,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias.,20,99 116,20,99,1,32,128,TWrex-cause,813279,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias,tachycardia,supraventricular tachycardia
725373118,5/24/2015 22:08:13,1642791961,5/24/2015 22:08:00,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,20,99,,,32,128,TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS,20,99-116,SUPRAVENTRICULAR TACHYCARDIAS.,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias.,20,99 116,20,99,1,32,128,TWrex-cause,813279,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias,tachycardia,supraventricular tachycardia
725373118,5/24/2015 22:49:51,1642806490,5/24/2015 22:49:33,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,20,99,,,32,128,TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,narrow complex TACHYCARDIAS,5-12-20,99-116,SUPRAVENTRICULAR TACHYCARDIAS.,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias.,20,99 116,20,99,1,32,128,TWrex-cause,813279,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias,tachycardia,supraventricular tachycardia
725373118,5/24/2015 22:54:04,1642807659,5/24/2015 22:53:24,false,points4rewards,1,28703583,USA,,,97.73.85.52,20,99,,,32,128,TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS supraventricular tachycardias.,20-99-116,99-116,SUPRAVENTRICULAR TACHYCARDIAS.,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias.,20,99 116,20,99,1,32,128,TWrex-cause,813279,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias,tachycardia,supraventricular tachycardia
725373118,5/24/2015 22:55:22,1642808029,5/24/2015 22:54:47,false,clixsense,1,26770238,CAN,ON,Ilderton,209.183.157.27,20,99,,,32,128,TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIAS supraventricular tachycardias.,20-99-116,20-33-43-50-99-116-48,tachycardias originate from a pacemaker SUPRAVENTRICULAR TACHYCARDIAS.,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias.,20,99 116,20,99,1,32,128,TWrex-cause,813279,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias,tachycardia,supraventricular tachycardia
725373118,5/24/2015 22:56:54,1642808445,5/24/2015 22:56:24,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,20,99,,,32,128,TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,narrow complex TACHYCARDIAS,5-20-12,99-116,SUPRAVENTRICULAR TACHYCARDIAS.,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias.,20,99 116,20,99,1,32,128,TWrex-cause,813279,Most narrow complex tachycardias originate from a pacemaker above the ventricles and are therefore supraventricular tachycardias,tachycardia,supraventricular tachycardia
725373119,5/24/2015 19:55:11,1642752507,5/24/2015 19:55:02,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,0,74,,,16,77,KERATOACANTHOMA,MT,KERATOACANTHOMAS,0,74,MTS.,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS.,0,74,0,74,1,16,77,TWrex-cause,813561,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS,keratoacanthoma,mt
725373119,5/24/2015 19:56:36,1642752988,5/24/2015 19:56:27,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,0,74,,,16,77,KERATOACANTHOMA,MT,KERATOACANTHOMAS,0,74,MTS.,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS.,0,74,0,74,1,16,77,TWrex-cause,813561,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS,keratoacanthoma,mt
725373119,5/24/2015 19:56:43,1642753036,5/24/2015 19:56:33,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,0,74,,,16,77,KERATOACANTHOMA,MT,KERATOACANTHOMAS,0,74,MTS.,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS.,0,74,0,74,1,16,77,TWrex-cause,813561,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS,keratoacanthoma,mt
725373119,5/24/2015 20:10:33,1642756703,5/24/2015 20:10:14,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,0,74,,,16,77,KERATOACANTHOMA,MT,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS.,0-17-21-31-43-47-52-57-60-74-69,0-17-21-31-43-47-57-60-69-74-52,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS.,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS.,0,74,0,74,1,16,77,TWrex-cause,813561,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS,keratoacanthoma,mt
725373119,5/24/2015 20:26:04,1642760405,5/24/2015 20:25:49,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,0,74,,,16,77,KERATOACANTHOMA,MT,KERATOACANTHOMAS,0,21-74-31,sebaceous hyperplasia MTS.,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS.,0,74,0,74,1,16,77,TWrex-cause,813561,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS,keratoacanthoma,mt
725373119,5/24/2015 20:29:57,1642761662,5/24/2015 20:29:47,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,0,74,,,16,77,KERATOACANTHOMA,MT,KERATOACANTHOMAS,0,74,MTS.,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS.,0,74,0,74,1,16,77,TWrex-cause,813561,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS,keratoacanthoma,mt
725373119,5/24/2015 20:30:24,1642761821,5/24/2015 20:30:04,false,instagc,1,19740138,CAN,,,50.69.96.237,0,74,,,16,77,KERATOACANTHOMA,MT,KERATOACANTHOMAS,0,74,MTS.,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS.,0,74,0,74,1,16,77,TWrex-cause,813561,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS,keratoacanthoma,mt
725373119,5/24/2015 20:33:44,1642762568,5/24/2015 20:33:35,false,neodev,1,29074051,GBR,G5,Folkestone,80.6.67.18,0,74,,,16,77,KERATOACANTHOMA,MT,KERATOACANTHOMAS,0,74,MTS.,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS.,0,74,0,74,1,16,77,TWrex-cause,813561,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS,keratoacanthoma,mt
725373119,5/24/2015 20:53:19,1642768430,5/24/2015 20:53:00,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,0,74,,,16,77,KERATOACANTHOMA,MT,KERATOACANTHOMAS sebaceous hyperplasia patients MTS.,0-21-31-60-74,0-21-31-60-74,Keratoacanthomas sebaceous hyperplasia patients MTS.,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS.,0,74,0,74,1,16,77,TWrex-cause,813561,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS,keratoacanthoma,mt
725373119,5/24/2015 20:54:23,1642768870,5/24/2015 20:54:05,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,0,74,,,16,77,KERATOACANTHOMA,MT,KERATOACANTHOMAS MTS.,0-74,74,MTS.,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS.,0,74,0,74,1,16,77,TWrex-cause,813561,Keratoacanthomas and sebaceous hyperplasia are also seen in patients with MTS,keratoacanthoma,mt
725373120,5/24/2015 19:52:01,1642751507,5/24/2015 19:51:47,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,143,68,,,147,89,PAIN,MERALGIA PARESTHETICA,PAIN,143,68-77,MERALGIA PARESTHETICA,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh.,143,68 77,143,68,1,147,89,TWrex-cause,814634,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh,pain,meralgia paresthetica
725373120,5/24/2015 19:52:32,1642751584,5/24/2015 19:52:05,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,143,68,,,147,89,PAIN,MERALGIA PARESTHETICA,Occasionally followed by shoulder girdle muscle atrophy Entrapment Meralgia paresthetica Lateral femoral cutaneous Thigh Yes No Stinging PAIN in the anterolateral thigh.,0-13-22-25-34-41-48-57-68-77-91-99-107-118-125-130-134-143-148-151-155-169,0-13-22-25-34-41-48-57-68-77-91-99-107-118-125-130-134-143-148-151-155-169,Occasionally followed by shoulder girdle muscle atrophy Entrapment MERALGIA PARESTHETICA Lateral femoral cutaneous Thigh Yes No Stinging pain in the anterolateral thigh.,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh.,143,68 77,143,68,1,147,89,TWrex-cause,814634,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh,pain,meralgia paresthetica
725373120,5/24/2015 19:52:53,1642751683,5/24/2015 19:52:36,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,143,68,,,147,89,PAIN,MERALGIA PARESTHETICA,PAIN,143,68-77,MERALGIA PARESTHETICA,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh.,143,68 77,143,68,1,147,89,TWrex-cause,814634,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh,pain,meralgia paresthetica
725373120,5/24/2015 19:53:08,1642751784,5/24/2015 19:52:46,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,143,68,,,147,89,PAIN,MERALGIA PARESTHETICA,PAIN,143,68-77,MERALGIA PARESTHETICA,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh.,143,68 77,143,68,1,147,89,TWrex-cause,814634,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh,pain,meralgia paresthetica
725373120,5/24/2015 19:54:02,1642752158,5/24/2015 19:53:26,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,143,68,,,147,89,PAIN,MERALGIA PARESTHETICA,Yes No Stinging PAIN in the anterolateral thigh.,125-130-134-143-148-151-155-169,41-48-57-68-77,muscle atrophy Entrapment MERALGIA PARESTHETICA,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh.,143,68 77,143,68,1,147,89,TWrex-cause,814634,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh,pain,meralgia paresthetica
725373120,5/24/2015 19:59:51,1642753859,5/24/2015 19:59:31,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,143,68,,,147,89,PAIN,MERALGIA PARESTHETICA,Stinging PAIN,134-143,68-77,MERALGIA PARESTHETICA,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh.,143,68 77,143,68,1,147,89,TWrex-cause,814634,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh,pain,meralgia paresthetica
725373120,5/24/2015 20:12:37,1642757345,5/24/2015 20:12:20,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,143,68,,,147,89,PAIN,MERALGIA PARESTHETICA,PAIN,143,68-77,MERALGIA PARESTHETICA,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh.,143,68 77,143,68,1,147,89,TWrex-cause,814634,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh,pain,meralgia paresthetica
725373120,5/24/2015 20:14:10,1642757709,5/24/2015 20:13:53,false,instagc,1,19740138,CAN,,,50.69.96.237,143,68,,,147,89,PAIN,MERALGIA PARESTHETICA,PAIN,143,68-77,MERALGIA PARESTHETICA,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh.,143,68 77,143,68,1,147,89,TWrex-cause,814634,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh,pain,meralgia paresthetica
725373120,5/24/2015 20:21:07,1642759338,5/24/2015 20:20:48,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,143,68,,,147,89,PAIN,MERALGIA PARESTHETICA,PAIN,143,48-57-68-77,atrophy Entrapment MERALGIA PARESTHETICA,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh.,143,68 77,143,68,1,147,89,TWrex-cause,814634,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh,pain,meralgia paresthetica
725373120,5/24/2015 20:23:06,1642759856,5/24/2015 20:22:59,false,neodev,1,31789301,USA,NY,New York,162.243.173.147,143,68,,,147,89,PAIN,MERALGIA PARESTHETICA,Yes No Stinging PAIN in the anterolateral,125-130-134-143-148-151-155,41-48-57-68-77-91-99-107,muscle atrophy Entrapment MERALGIA PARESTHETICA Lateral femoral cutaneous,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh.,143,68 77,143,68,1,147,89,TWrex-cause,814634,Occasionally followed by shoulder girdle muscle atrophy  Entrapment Meralgia paresthetica  Lateral femoral cutaneous  Thigh  Yes  No  Stinging pain in the anterolateral thigh,pain,meralgia paresthetica
725373121,5/24/2015 19:54:32,1642752262,5/24/2015 19:54:22,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,57,0,,,78,17,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY.,57-68,0,MACROGLOBULINEMIA,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy.,57 68,0,57,0,1,78,17,TWrex-cause,814523,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy,monoclonal gammopathy,macroglobulinemia
725373121,5/24/2015 19:55:48,1642752719,5/24/2015 19:55:37,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,57,0,,,78,17,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY.,57-68,0,MACROGLOBULINEMIA,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy.,57 68,0,57,0,1,78,17,TWrex-cause,814523,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy,monoclonal gammopathy,macroglobulinemia
725373121,5/24/2015 19:55:54,1642752767,5/24/2015 19:55:44,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,57,0,,,78,17,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY.,57-68,0,MACROGLOBULINEMIA,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy.,57 68,0,57,0,1,78,17,TWrex-cause,814523,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy,monoclonal gammopathy,macroglobulinemia
725373121,5/24/2015 20:02:50,1642754638,5/24/2015 20:02:41,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,57,0,,,78,17,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY.,57-68,0,MACROGLOBULINEMIA,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy.,57 68,0,57,0,1,78,17,TWrex-cause,814523,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy,monoclonal gammopathy,macroglobulinemia
725373121,5/24/2015 20:09:00,1642756219,5/24/2015 20:08:45,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,57,0,,,78,17,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,Macroglobulinemia develops in about 12% of patients with MONOCLONAL GAMMOPATHY.,0-18-27-30-40-43-52-57-68-36,0-18-27-30-36-40-43-52-57-68,MACROGLOBULINEMIA develops in about 12% of patients with monoclonal gammopathy.,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy.,57 68,0,57,0,1,78,17,TWrex-cause,814523,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy,monoclonal gammopathy,macroglobulinemia
725373121,5/24/2015 20:25:19,1642760298,5/24/2015 20:25:09,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,57,0,,,78,17,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY.,57-68,0,MACROGLOBULINEMIA,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy.,57 68,0,57,0,1,78,17,TWrex-cause,814523,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy,monoclonal gammopathy,macroglobulinemia
725373121,5/24/2015 20:29:13,1642761475,5/24/2015 20:29:02,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,57,0,,,78,17,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY.,57-68,0,MACROGLOBULINEMIA,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy.,57 68,0,57,0,1,78,17,TWrex-cause,814523,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy,monoclonal gammopathy,macroglobulinemia
725373121,5/24/2015 20:29:14,1642761497,5/24/2015 20:28:34,false,instagc,1,19740138,CAN,,,50.69.96.237,57,0,,,78,17,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY.,57-68,0,MACROGLOBULINEMIA,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy.,57 68,0,57,0,1,78,17,TWrex-cause,814523,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy,monoclonal gammopathy,macroglobulinemia
725373121,5/24/2015 20:32:56,1642762344,5/24/2015 20:32:42,false,neodev,1,29074051,GBR,G5,Folkestone,80.6.67.18,57,0,,,78,17,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY.,57-68,0,MACROGLOBULINEMIA,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy.,57 68,0,57,0,1,78,17,TWrex-cause,814523,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy,monoclonal gammopathy,macroglobulinemia
725373121,5/24/2015 20:50:35,1642767263,5/24/2015 20:50:27,false,instagc,1,20845955,GBR,I2,Manchester,90.214.24.62,57,0,,,78,17,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,MONOCLONAL GAMMOPATHY.,57-68,0,MACROGLOBULINEMIA,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy.,57 68,0,57,0,1,78,17,TWrex-cause,814523,Macroglobulinemia develops in about 12% of patients with monoclonal gammopathy,monoclonal gammopathy,macroglobulinemia
725373122,5/24/2015 21:05:50,1642772932,5/24/2015 21:05:34,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,91,75,,,97,79,ANEMIA,IRON,"iron deficiency ANEMIA,",75-80-91,75-80-91,"IRON deficiency anemia,","For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman.",91,75,91,75,-1,97,79,TWrex-cause,804919,"For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman",anemia,iron
725373122,5/24/2015 21:06:02,1642773057,5/24/2015 21:05:46,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,91,75,,,97,79,ANEMIA,IRON,"ANEMIA,",91,75,IRON,"For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman.",91,75,91,75,-1,97,79,TWrex-cause,804919,"For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman",anemia,iron
725373122,5/24/2015 21:18:43,1642776955,5/24/2015 21:18:31,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,91,75,,,97,79,ANEMIA,IRON,"iron deficiency ANEMIA,",75-80-91,75-80-91,"IRON deficiency anemia,","For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman.",91,75,91,75,-1,97,79,TWrex-cause,804919,"For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman",anemia,iron
725373122,5/24/2015 21:32:34,1642781213,5/24/2015 21:32:10,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,91,75,,,97,79,ANEMIA,IRON,"iron deficiency ANEMIA,",75-91-80,75-80-91,"IRON deficiency anemia,","For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman.",91,75,91,75,-1,97,79,TWrex-cause,804919,"For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman",anemia,iron
725373122,5/24/2015 21:42:23,1642784293,5/24/2015 21:41:45,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,91,75,,,97,79,ANEMIA,IRON,"iron deficiency ANEMIA,",75-80-91,75-80-91,"IRON deficiency anemia,","For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman.",91,75,91,75,-1,97,79,TWrex-cause,804919,"For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman",anemia,iron
725373122,5/24/2015 22:08:47,1642792227,5/24/2015 22:08:14,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,91,75,,,97,79,ANEMIA,IRON,"ANEMIA,",91,75-80,IRON deficiency,"For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman.",91,75,91,75,-1,97,79,TWrex-cause,804919,"For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman",anemia,iron
725373122,5/24/2015 22:50:06,1642806586,5/24/2015 22:49:51,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,91,75,,,97,79,ANEMIA,IRON,"iron deficiency ANEMIA,",75-80-91,75-80-91,"IRON deficiency anemia,","For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman.",91,75,91,75,-1,97,79,TWrex-cause,804919,"For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman",anemia,iron
725373122,5/24/2015 22:54:42,1642807823,5/24/2015 22:54:09,false,points4rewards,1,28703583,USA,,,97.73.85.52,91,75,,,97,79,ANEMIA,IRON,"iron deficiency ANEMIA,",75-80-91,75-80-91,"IRON deficiency anemia,","For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman.",91,75,91,75,-1,97,79,TWrex-cause,804919,"For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman",anemia,iron
725373122,5/24/2015 22:55:37,1642808076,5/24/2015 22:55:23,false,clixsense,1,26770238,CAN,ON,Ilderton,209.183.157.27,91,75,,,97,79,ANEMIA,IRON,"develops iron deficiency ANEMIA,",66-75-80-91,75-80-91,"IRON deficiency anemia,","For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman.",91,75,91,75,-1,97,79,TWrex-cause,804919,"For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman",anemia,iron
725373122,5/24/2015 22:56:42,1642808409,5/24/2015 22:56:31,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,91,75,,,97,79,ANEMIA,IRON,"ANEMIA,",91,75-80,IRON deficiency,"For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman.",91,75,91,75,-1,97,79,TWrex-cause,804919,"For that reason, colonoscopy should be performed in any adult who develops iron deficiency anemia, perhaps with the exception of a young menstruating woman",anemia,iron
725373123,5/24/2015 19:53:07,1642751757,5/24/2015 19:52:56,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,3,69,,,10,83,OBESITY,SEVERE OBESITY,OBESITY,3,69-76,SEVERE OBESITY.,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity.,3,69 76,3,69,1,10,83,TWrex-cause,814646,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity,obesity,severe obesity
725373123,5/24/2015 19:54:19,1642752213,5/24/2015 19:54:06,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,3,69,,,10,83,OBESITY,SEVERE OBESITY,OBESITY,3,69-76,SEVERE OBESITY.,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity.,3,69 76,3,69,1,10,83,TWrex-cause,814646,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity,obesity,severe obesity
725373123,5/24/2015 19:54:21,1642752215,5/24/2015 19:54:11,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,3,69,,,10,83,OBESITY,SEVERE OBESITY,OBESITY,3,69-76,SEVERE OBESITY.,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity.,3,69 76,3,69,1,10,83,TWrex-cause,814646,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity,obesity,severe obesity
725373123,5/24/2015 20:01:24,1642754208,5/24/2015 20:01:05,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,3,69,,,10,83,OBESITY,SEVERE OBESITY,OBESITY,3,69-76,SEVERE OBESITY.,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity.,3,69 76,3,69,1,10,83,TWrex-cause,814646,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity,obesity,severe obesity
725373123,5/24/2015 20:06:01,1642755387,5/24/2015 20:05:34,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,3,69,,,10,83,OBESITY,SEVERE OBESITY,OBESITY Possible airway or ventilatory problems in patients with severe obesity.,3-12-21-28-31-43-52-55-64-69-76,3-12-21-28-31-52-55-64-69-76-43,Obesity Possible airway or ventilatory problems in patients with SEVERE OBESITY.,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity.,3,69 76,3,69,1,10,83,TWrex-cause,814646,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity,obesity,severe obesity
725373123,5/24/2015 20:13:53,1642757622,5/24/2015 20:13:44,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,3,69,,,10,83,OBESITY,SEVERE OBESITY,OBESITY,3,69-76,SEVERE OBESITY.,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity.,3,69 76,3,69,1,10,83,TWrex-cause,814646,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity,obesity,severe obesity
725373123,5/24/2015 20:22:32,1642759724,5/24/2015 20:22:14,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,3,69,,,10,83,OBESITY,SEVERE OBESITY,OBESITY,3,69-76,SEVERE OBESITY.,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity.,3,69 76,3,69,1,10,83,TWrex-cause,814646,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity,obesity,severe obesity
725373123,5/24/2015 20:26:46,1642760588,5/24/2015 20:25:49,false,instagc,1,19740138,CAN,,,50.69.96.237,3,69,,,10,83,OBESITY,SEVERE OBESITY,OBESITY,3,69-76,SEVERE OBESITY.,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity.,3,69 76,3,69,1,10,83,TWrex-cause,814646,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity,obesity,severe obesity
725373123,5/24/2015 20:27:42,1642760923,5/24/2015 20:27:30,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,3,69,,,10,83,OBESITY,SEVERE OBESITY,c OBESITY,0-3,69-76,SEVERE OBESITY.,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity.,3,69 76,3,69,1,10,83,TWrex-cause,814646,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity,obesity,severe obesity
725373123,5/24/2015 20:28:33,1642761224,5/24/2015 20:28:24,false,cointasker,1,21783324,NLD,,,31.151.239.133,3,69,,,10,83,OBESITY,SEVERE OBESITY,c OBESITY,0-3,69-76,SEVERE OBESITY.,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity.,3,69 76,3,69,1,10,83,TWrex-cause,814646,c  Obesity  Possible airway or ventilatory problems in patients with severe obesity,obesity,severe obesity
725373124,5/24/2015 19:03:22,1642724981,5/24/2015 19:03:00,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,90,65,,,96,76,TREMOR,PROPRANOLOL,TREMOR:,90,65,PROPRANOLOL,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial.",90,65,90,65,-1,96,76,TWrex-cause,803353,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial",tremor,propranolol
725373124,5/24/2015 19:04:47,1642725700,5/24/2015 19:04:13,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,90,65,,,96,76,TREMOR,PROPRANOLOL,essential TREMOR:,80-90,65,PROPRANOLOL,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial.",90,65,90,65,-1,96,76,TWrex-cause,803353,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial",tremor,propranolol
725373124,5/24/2015 19:05:38,1642726183,5/24/2015 19:05:17,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,90,65,,,96,76,TREMOR,PROPRANOLOL,TREMOR:,90,65,PROPRANOLOL,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial.",90,65,90,65,-1,96,76,TWrex-cause,803353,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial",tremor,propranolol
725373124,5/24/2015 19:17:44,1642732015,5/24/2015 19:17:11,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,90,65,,,96,76,TREMOR,PROPRANOLOL,essential TREMOR:,80-90,65,PROPRANOLOL,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial.",90,65,90,65,-1,96,76,TWrex-cause,803353,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial",tremor,propranolol
725373124,5/24/2015 19:25:06,1642740463,5/24/2015 19:24:45,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,90,65,,,96,76,TREMOR,PROPRANOLOL,essential TREMOR:,80-90,65,PROPRANOLOL,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial.",90,65,90,65,-1,96,76,TWrex-cause,803353,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial",tremor,propranolol
725373124,5/24/2015 19:38:14,1642746946,5/24/2015 19:36:38,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,90,65,,,96,76,TREMOR,PROPRANOLOL,propranolol in essential TREMOR:,65-77-80-90,47-61-65-77-80-90,Phenobarbital and PROPRANOLOL in essential tremor:,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial.",90,65,90,65,-1,96,76,TWrex-cause,803353,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial",tremor,propranolol
725373124,5/24/2015 19:38:28,1642747004,5/24/2015 19:38:17,false,clixsense,1,31482589,NLD,,,31.201.11.16,90,65,,,96,76,TREMOR,PROPRANOLOL,TREMOR:,90,65,PROPRANOLOL,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial.",90,65,90,65,-1,96,76,TWrex-cause,803353,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial",tremor,propranolol
725373124,5/24/2015 19:38:59,1642747165,5/24/2015 19:38:40,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,90,65,,,96,76,TREMOR,PROPRANOLOL,essential TREMOR:,90-80,65,PROPRANOLOL,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial.",90,65,90,65,-1,96,76,TWrex-cause,803353,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial",tremor,propranolol
725373124,5/24/2015 19:39:31,1642747325,5/24/2015 19:38:02,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,90,65,,,96,76,TREMOR,PROPRANOLOL,essential TREMOR:,80-90,65,PROPRANOLOL,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial.",90,65,90,65,-1,96,76,TWrex-cause,803353,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial",tremor,propranolol
725373124,5/24/2015 19:40:03,1642747571,5/24/2015 19:39:09,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,90,65,,,96,76,TREMOR,PROPRANOLOL,essential TREMOR:,80-90,65,PROPRANOLOL,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial.",90,65,90,65,-1,96,76,TWrex-cause,803353,"Baruzzi A, Procaccianti G, Martinelli P et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial",tremor,propranolol
725373125,5/24/2015 19:01:37,1642724085,5/24/2015 19:01:16,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,95,119,,,105,135,LEUKOPENIA,GRANULOCYTOPENIA,LEUKOPENIA,95,119,GRANULOCYTOPENIA);,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow.",95,119,95,119,1,105,135,TWrex-cause,812572,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow",leukopenia,granulocytopenia
725373125,5/24/2015 19:02:22,1642724477,5/24/2015 19:01:54,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,95,119,,,105,135,LEUKOPENIA,GRANULOCYTOPENIA,LEUKOPENIA,95,119,GRANULOCYTOPENIA);,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow.",95,119,95,119,1,105,135,TWrex-cause,812572,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow",leukopenia,granulocytopenia
725373125,5/24/2015 19:03:18,1642724946,5/24/2015 19:02:59,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,95,119,,,105,135,LEUKOPENIA,GRANULOCYTOPENIA,LEUKOPENIA,95,119,GRANULOCYTOPENIA);,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow.",95,119,95,119,1,105,135,TWrex-cause,812572,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow",leukopenia,granulocytopenia
725373125,5/24/2015 19:03:39,1642725112,5/24/2015 19:03:11,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,95,119,,,105,135,LEUKOPENIA,GRANULOCYTOPENIA,LEUKOPENIA,95,119,GRANULOCYTOPENIA);,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow.",95,119,95,119,1,105,135,TWrex-cause,812572,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow",leukopenia,granulocytopenia
725373125,5/24/2015 19:13:55,1642729676,5/24/2015 19:11:54,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,95,119,,,105,135,LEUKOPENIA,GRANULOCYTOPENIA,LEUKOPENIA,95,119,GRANULOCYTOPENIA);,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow.",95,119,95,119,1,105,135,TWrex-cause,812572,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow",leukopenia,granulocytopenia
725373125,5/24/2015 19:23:37,1642739613,5/24/2015 19:22:59,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,95,119,,,105,135,LEUKOPENIA,GRANULOCYTOPENIA,LEUKOPENIA (principally granulocytopenia);,95-106-119,95-106-119,leukopenia (principally GRANULOCYTOPENIA);,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow.",95,119,95,119,1,105,135,TWrex-cause,812572,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow",leukopenia,granulocytopenia
725373125,5/24/2015 19:27:37,1642741736,5/24/2015 19:27:17,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,95,119,,,105,135,LEUKOPENIA,GRANULOCYTOPENIA,LEUKOPENIA,95,119,GRANULOCYTOPENIA);,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow.",95,119,95,119,1,105,135,TWrex-cause,812572,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow",leukopenia,granulocytopenia
725373125,5/24/2015 19:33:41,1642744853,5/24/2015 19:32:12,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,95,119,,,105,135,LEUKOPENIA,GRANULOCYTOPENIA,LEUKOPENIA (principally granulocytopenia);,95-106-119,95-106-119,leukopenia (principally GRANULOCYTOPENIA);,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow.",95,119,95,119,1,105,135,TWrex-cause,812572,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow",leukopenia,granulocytopenia
725373125,5/24/2015 19:34:07,1642745042,5/24/2015 19:33:22,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,95,119,,,105,135,LEUKOPENIA,GRANULOCYTOPENIA,manifested predominantly as LEUKOPENIA,67-78-92-95,95-106-119-138-147,leukopenia (principally GRANULOCYTOPENIA); severity depends,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow.",95,119,95,119,1,105,135,TWrex-cause,812572,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow",leukopenia,granulocytopenia
725373125,5/24/2015 19:35:06,1642745453,5/24/2015 19:34:48,false,clixsense,1,6417722,USA,MI,Taylor,99.170.106.105,95,119,,,105,135,LEUKOPENIA,GRANULOCYTOPENIA,LEUKOPENIA,95,119,GRANULOCYTOPENIA);,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow.",95,119,95,119,1,105,135,TWrex-cause,812572,"b  Hematologic Effects  High incidence of bone marrow suppression, manifested predominantly as leukopenia (principally granulocytopenia); severity depends on dose of drug and on regenerative capacity of bone marrow",leukopenia,granulocytopenia
725373126,5/24/2015 18:59:18,1642723032,5/24/2015 18:58:40,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,284,43,,,297,57,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS,284,43-56,AMPHOTERICIN B,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals.",284,43 56,284,43,-1,297,57,TWrex-cause,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals",blastomycosis,amphotericin b
725373126,5/24/2015 18:59:55,1642723323,5/24/2015 18:58:34,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,284,43,,,297,57,BLASTOMYCOSIS,AMPHOTERICIN B,presumptive BLASTOMYCOSIS,272-284,43-56,AMPHOTERICIN B,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals.",284,43 56,284,43,-1,297,57,TWrex-cause,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals",blastomycosis,amphotericin b
725373126,5/24/2015 19:01:29,1642724037,5/24/2015 19:01:10,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,284,43,,,297,57,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS,284,31-43-56,", AMPHOTERICIN B","36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals.",284,43 56,284,43,-1,297,57,TWrex-cause,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals",blastomycosis,amphotericin b
725373126,5/24/2015 19:01:34,1642724080,5/24/2015 19:01:06,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,284,43,,,297,57,BLASTOMYCOSIS,AMPHOTERICIN B,presumptive BLASTOMYCOSIS,272-284,31-40-43-56,", IV AMPHOTERICIN B","36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals.",284,43 56,284,43,-1,297,57,TWrex-cause,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals",blastomycosis,amphotericin b
725373126,5/24/2015 19:08:58,1642727628,5/24/2015 19:07:31,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,284,43,,,297,57,BLASTOMYCOSIS,AMPHOTERICIN B,presumptive BLASTOMYCOSIS,272-284,31-40-43-56,", IV AMPHOTERICIN B","36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals.",284,43 56,284,43,-1,297,57,TWrex-cause,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals",blastomycosis,amphotericin b
725373126,5/24/2015 19:21:00,1642736228,5/24/2015 19:20:44,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,284,43,,,297,57,BLASTOMYCOSIS,AMPHOTERICIN B,presumptive BLASTOMYCOSIS,272-284,40-43-56,IV AMPHOTERICIN B,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals.",284,43 56,284,43,-1,297,57,TWrex-cause,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals",blastomycosis,amphotericin b
725373126,5/24/2015 19:26:08,1642740915,5/24/2015 19:25:38,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,284,43,,,297,57,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS,284,43-56-40,IV AMPHOTERICIN B,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals.",284,43 56,284,43,-1,297,57,TWrex-cause,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals",blastomycosis,amphotericin b
725373126,5/24/2015 19:27:36,1642741750,5/24/2015 19:26:38,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,284,43,,,297,57,BLASTOMYCOSIS,AMPHOTERICIN B,presumptive BLASTOMYCOSIS,272-284,43-56,AMPHOTERICIN B,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals.",284,43 56,284,43,-1,297,57,TWrex-cause,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals",blastomycosis,amphotericin b
725373126,5/24/2015 19:28:00,1642741984,5/24/2015 19:27:41,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,284,43,,,297,57,BLASTOMYCOSIS,AMPHOTERICIN B,"treatment of presumptive BLASTOMYCOSIS in immunocompromised patients,",259-269-272-284-298-301-319,43-56-58-61,AMPHOTERICIN B is preferred,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals.",284,43 56,284,43,-1,297,57,TWrex-cause,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals",blastomycosis,amphotericin b
725373126,5/24/2015 19:37:59,1642746843,5/24/2015 19:37:43,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,284,43,,,297,57,BLASTOMYCOSIS,AMPHOTERICIN B,presumptive BLASTOMYCOSIS,272-284,43-56,AMPHOTERICIN B,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals.",284,43 56,284,43,-1,297,57,TWrex-cause,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV amphotericin B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of presumptive blastomycosis in immunocompromised patients, including HIV-infected individuals",blastomycosis,amphotericin b
725373127,5/24/2015 19:57:23,1642753208,5/24/2015 19:57:09,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,148,102,,,156,109,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,138-148,102,HEPARIN,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",148,102,148,102,-1,156,109,TWrex-cause,803651,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725373127,5/24/2015 20:26:47,1642760590,5/24/2015 20:26:34,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,148,102,,,156,109,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,138-148,75-87-102,intravenous unfractionated HEPARIN,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",148,102,148,102,-1,156,109,TWrex-cause,803651,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725373127,5/24/2015 20:30:45,1642761883,5/24/2015 20:30:31,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,148,102,,,156,109,EMBOLISM,HEPARIN,EMBOLISM.,148,102,HEPARIN,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",148,102,148,102,-1,156,109,TWrex-cause,803651,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725373127,5/24/2015 20:31:32,1642762019,5/24/2015 20:31:01,false,instagc,1,19740138,CAN,,,50.69.96.237,148,102,,,156,109,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,138-148,102,HEPARIN,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",148,102,148,102,-1,156,109,TWrex-cause,803651,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725373127,5/24/2015 20:54:54,1642769056,5/24/2015 20:54:15,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,148,102,,,156,109,EMBOLISM,HEPARIN,Subcutaneous fondaparinux intravenous unfractionated heparin initial treatment pulmonary EMBOLISM.,42-55-75-87-102-117-125-138-148,42-55-75-87-102-117-125-138-148,Subcutaneous fondaparinux intravenous unfractionated HEPARIN initial treatment pulmonary embolism.,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",148,102,148,102,-1,156,109,TWrex-cause,803651,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725373127,5/24/2015 20:55:34,1642769339,5/24/2015 20:55:23,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,148,102,,,156,109,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,138-148,102,HEPARIN,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",148,102,148,102,-1,156,109,TWrex-cause,803651,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725373127,5/24/2015 20:56:38,1642769637,5/24/2015 20:56:23,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,148,102,,,156,109,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,138-148,75-87-102,intravenous unfractionated HEPARIN,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",148,102,148,102,-1,156,109,TWrex-cause,803651,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725373127,5/24/2015 20:57:01,1642769720,5/24/2015 20:56:48,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,148,102,,,156,109,EMBOLISM,HEPARIN,EMBOLISM.,148,102,HEPARIN,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",148,102,148,102,-1,156,109,TWrex-cause,803651,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725373127,5/24/2015 21:01:43,1642771446,5/24/2015 20:59:36,false,neodev,1,17426565,CAN,BC,Burnaby,70.79.18.187,148,102,,,156,109,EMBOLISM,HEPARIN,pulmonary EMBOLISM.,138-148,75-87-102,intravenous unfractionated HEPARIN,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",148,102,148,102,-1,156,109,TWrex-cause,803651,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725373127,5/24/2015 21:05:06,1642772632,5/24/2015 21:04:26,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,148,102,,,156,109,EMBOLISM,HEPARIN,EMBOLISM.,148,102,HEPARIN,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.",148,102,148,102,-1,156,109,TWrex-cause,803651,"Buller HR, Davidson BL, Decousus H et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism",embolism,heparin
725373128,5/24/2015 21:27:38,1642779555,5/24/2015 21:27:20,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,184,207,,,194,214,INFECTION,SPECIES,Salmonella INFECTIONS;,173-184,196-207,Salmonella SPECIES;,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club.",184,207,184,207,1,194,214,TWrex-cause,810203,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club",infection,species
725373128,5/24/2015 21:35:21,1642782191,5/24/2015 21:34:47,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,184,207,,,194,214,INFECTION,SPECIES,Salmonella INFECTIONS;,173-184,196-207,Salmonella SPECIES;,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club.",184,207,184,207,1,194,214,TWrex-cause,810203,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club",infection,species
725373128,5/24/2015 23:00:35,1642809381,5/24/2015 22:59:31,false,points4rewards,1,28703583,USA,,,97.73.85.52,184,207,,,194,214,INFECTION,SPECIES,Salmonella INFECTIONS;,173-184,173-184-207,Salmonella infections; SPECIES;,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club.",184,207,184,207,1,194,214,TWrex-cause,810203,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club",infection,species
725373128,5/24/2015 23:03:12,1642809976,5/24/2015 23:02:43,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,184,207,,,194,214,INFECTION,SPECIES,Salmonella INFECTIONS;,173-184,196-207,Salmonella SPECIES;,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club.",184,207,184,207,1,194,214,TWrex-cause,810203,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club",infection,species
725373128,5/24/2015 23:03:50,1642810242,5/24/2015 23:03:36,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,184,207,,,194,214,INFECTION,SPECIES,Salmonella INFECTIONS;,173-184,196-207,Salmonella SPECIES;,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club.",184,207,184,207,1,194,214,TWrex-cause,810203,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club",infection,species
725373128,5/24/2015 23:11:05,1642812235,5/24/2015 23:10:56,false,neodev,1,11382239,AUS,2,Strathfield,60.241.129.81,184,207,,,194,214,INFECTION,SPECIES,Salmonella INFECTIONS;,173-184,196-207,Salmonella SPECIES;,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club.",184,207,184,207,1,194,214,TWrex-cause,810203,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club",infection,species
725373128,5/24/2015 23:17:13,1642813711,5/24/2015 23:15:57,false,bitcoinget,1,28503763,USA,CA,San Francisco,107.217.186.64,184,207,,,194,214,INFECTION,SPECIES,Salmonella INFECTIONS;,184-173,196-207,Salmonella SPECIES;,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club.",184,207,184,207,1,194,214,TWrex-cause,810203,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club",infection,species
725373128,5/24/2015 23:19:50,1642814389,5/24/2015 23:19:11,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,184,207,,,194,214,INFECTION,SPECIES,Recurrent infections; Salmonella INFECTIONS; Salmonella species; Searching MEDLINE;,151-161-173-184-196-207-216-226,173-184-196-207-216-226-235-245-251-260-277-291-300,Salmonella infections; Salmonella SPECIES; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole trimethoprim; Systemic infection;,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club.",184,207,184,207,1,194,214,TWrex-cause,810203,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club",infection,species
725373128,5/24/2015 23:25:51,1642816028,5/24/2015 23:23:40,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,184,207,,,194,214,INFECTION,SPECIES,Salmonella INFECTIONS;,173-184,196-207,Salmonella SPECIES;,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club.",184,207,184,207,1,194,214,TWrex-cause,810203,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club",infection,species
725373128,5/24/2015 23:26:04,1642816061,5/24/2015 23:25:55,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,184,207,,,194,214,INFECTION,SPECIES,Salmonella INFECTIONS;,173-184,196-207,Salmonella SPECIES;,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club.",184,207,184,207,1,194,214,TWrex-cause,810203,"Neomycin; Norfloxacin; Omnipen; Paramomycin; Paromomycin; Penicillin, aminobenzyl; Pentrexyl; Polycillin; Polymox; Pyrexia; Pyrexia of unknown origin; Recurrent infections; Salmonella infections; Salmonella species; Searching MEDLINE; Sickness; Stool culture; Sulfamethoxazole-trimethoprim; Systemic infection; TMP-SMX; Trimethoprim-sulfamethoxazole; Trimox; Utimox; Watery stools; World; Wymox  ACP Journal Club",infection,species
725373129,5/24/2015 23:02:35,1642809772,5/24/2015 23:01:56,false,points4rewards,1,28703583,USA,,,97.73.85.52,226,287,,,235,293,HEMOLYSIS,ANEMIA,normocytic anemia HEMOLYSIS,191-202-226,277-287,hemolytic ANEMIA,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling.",226,287,226,287,1,235,293,TWrex-cause,814462,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling",hemolysis,anemia
725373129,5/24/2015 23:04:04,1642810348,5/24/2015 23:03:44,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,226,287,,,235,293,HEMOLYSIS,ANEMIA,HEMOLYSIS,226,277-287,hemolytic ANEMIA,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling.",226,287,226,287,1,235,293,TWrex-cause,814462,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling",hemolysis,anemia
725373129,5/24/2015 23:06:05,1642810922,5/24/2015 23:05:23,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,226,287,,,235,293,HEMOLYSIS,ANEMIA,HEMOLYSIS,226,277-287,hemolytic ANEMIA,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling.",226,287,226,287,1,235,293,TWrex-cause,814462,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling",hemolysis,anemia
725373129,5/24/2015 23:19:54,1642814423,5/24/2015 23:19:38,false,bitcoinget,1,28503763,USA,CA,San Francisco,107.217.186.64,226,287,,,235,293,HEMOLYSIS,ANEMIA,HEMOLYSIS,226,277-287,hemolytic ANEMIA,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling.",226,287,226,287,1,235,293,TWrex-cause,814462,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling",hemolysis,anemia
725373129,5/24/2015 23:21:45,1642814977,5/24/2015 23:20:58,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,226,287,,,235,293,HEMOLYSIS,ANEMIA,normocytic anemia (particularly if HEMOLYSIS is present),191-202-209-223-226-236-239,202-248-267-273-277-287-256,anemia require laboratory tests for hemolytic ANEMIA,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling.",226,287,226,287,1,235,293,TWrex-cause,814462,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling",hemolysis,anemia
725373129,5/24/2015 23:27:59,1642816558,5/24/2015 23:27:20,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,226,287,,,235,293,HEMOLYSIS,ANEMIA,HEMOLYSIS,226,277-287,hemolytic ANEMIA,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling.",226,287,226,287,1,235,293,TWrex-cause,814462,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling",hemolysis,anemia
725373129,5/24/2015 23:54:36,1642823602,5/24/2015 23:53:47,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,226,287,,,235,293,HEMOLYSIS,ANEMIA,HEMOLYSIS,226,277-287,hemolytic ANEMIA,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling.",226,287,226,287,1,235,293,TWrex-cause,814462,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling",hemolysis,anemia
725373129,5/24/2015 23:55:28,1642823844,5/24/2015 23:55:10,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,226,287,,,235,293,HEMOLYSIS,ANEMIA,HEMOLYSIS,226,267-277-287,tests hemolytic ANEMIA,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling.",226,287,226,287,1,235,293,TWrex-cause,814462,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling",hemolysis,anemia
725373129,5/25/2015 00:16:55,1642830470,5/25/2015 00:16:22,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,226,287,,,235,293,HEMOLYSIS,ANEMIA,HEMOLYSIS,226,277-287,hemolytic ANEMIA,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling.",226,287,226,287,1,235,293,TWrex-cause,814462,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling",hemolysis,anemia
725373129,5/25/2015 00:25:16,1642833369,5/25/2015 00:25:01,false,clixsense,1,6340330,USA,NY,Canajoharie,67.248.115.74,226,287,,,235,293,HEMOLYSIS,ANEMIA,HEMOLYSIS,226,287,ANEMIA,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling.",226,287,226,287,1,235,293,TWrex-cause,814462,"Patients with symptoms or signs suggestive of the disorder or its complications (eg, poor growth; acute, unexplained bone pain; aseptic necrosis of the femoral head), and black patients with normocytic anemia (particularly if hemolysis is present) require laboratory tests for hemolytic anemia (see  Autoimmune Hemolytic Anemia ), Hb electrophoresis, and examination of RBCs for sickling",hemolysis,anemia
725373130,5/24/2015 21:20:43,1642777410,5/24/2015 21:20:11,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,97,79,,,105,86,DIABETES,INSULIN,insulin dependent DIABETES.,79-87-97,79-87-97,INSULIN dependent diabetes.,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes.,97,79,97,79,-1,105,86,TWrex-cause,800674,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes,diabetes,insulin
725373130,5/24/2015 21:34:46,1642782041,5/24/2015 21:34:33,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,97,79,,,105,86,DIABETES,INSULIN,insulin dependent DIABETES.,79-87-97,79-87-97,INSULIN dependent diabetes.,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes.,97,79,97,79,-1,105,86,TWrex-cause,800674,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes,diabetes,insulin
725373130,5/24/2015 21:47:32,1642785639,5/24/2015 21:46:30,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,97,79,,,105,86,DIABETES,INSULIN,insulin dependent DIABETES.,79-87-97,79-87-97,INSULIN dependent diabetes.,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes.,97,79,97,79,-1,105,86,TWrex-cause,800674,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes,diabetes,insulin
725373130,5/24/2015 22:10:24,1642792814,5/24/2015 22:10:15,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,97,79,,,105,86,DIABETES,INSULIN,DIABETES.,97,79,INSULIN,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes.,97,79,97,79,-1,105,86,TWrex-cause,800674,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes,diabetes,insulin
725373130,5/24/2015 22:51:28,1642806942,5/24/2015 22:51:19,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,97,79,,,105,86,DIABETES,INSULIN,insulin dependent DIABETES.,79-87-97,79-87-97,INSULIN dependent diabetes.,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes.,97,79,97,79,-1,105,86,TWrex-cause,800674,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes,diabetes,insulin
725373130,5/24/2015 22:58:04,1642808716,5/24/2015 22:57:50,false,clixsense,1,26770238,CAN,ON,Ilderton,209.183.157.27,97,79,,,105,86,DIABETES,INSULIN,with insulin dependent DIABETES.,74-79-87-97,79-87-97,INSULIN dependent diabetes.,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes.,97,79,97,79,-1,105,86,TWrex-cause,800674,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes,diabetes,insulin
725373130,5/24/2015 22:59:26,1642809140,5/24/2015 22:59:04,false,points4rewards,1,28703583,USA,,,97.73.85.52,97,79,,,105,86,DIABETES,INSULIN,microalbuminuria insulin dependent DIABETES.,34-79-87-97,34-79-87-97,microalbuminuria INSULIN dependent diabetes.,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes.,97,79,97,79,-1,105,86,TWrex-cause,800674,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes,diabetes,insulin
725373130,5/24/2015 23:02:42,1642809851,5/24/2015 23:02:24,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,97,79,,,105,86,DIABETES,INSULIN,insulin dependent DIABETES.,79-87-97,79,INSULIN,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes.,97,79,97,79,-1,105,86,TWrex-cause,800674,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes,diabetes,insulin
725373130,5/24/2015 23:03:35,1642810130,5/24/2015 23:02:35,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,97,79,,,105,86,DIABETES,INSULIN,insulin dependent DIABETES.,79-87-97,79-87-97,INSULIN dependent diabetes.,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes.,97,79,97,79,-1,105,86,TWrex-cause,800674,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes,diabetes,insulin
725373130,5/24/2015 23:10:55,1642812194,5/24/2015 23:10:31,false,neodev,1,11382239,AUS,2,Strathfield,60.241.129.81,97,79,,,105,86,DIABETES,INSULIN,insulin dependent DIABETES.,79-87-97,79,INSULIN,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes.,97,79,97,79,-1,105,86,TWrex-cause,800674,Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes,diabetes,insulin
725373131,5/24/2015 19:05:21,1642726044,5/24/2015 19:05:04,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,82,0,,,91,16,PREGNANCY,PROPYLTHIOURACIL,PREGNANCY,82,0,PROPYLTHIOURACIL,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk.,82,0,82,0,-1,91,16,TWrex-cause,803224,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk,pregnancy,propylthiouracil
725373131,5/24/2015 19:07:01,1642726755,5/24/2015 19:06:39,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,82,0,,,91,16,PREGNANCY,PROPYLTHIOURACIL,PREGNANCY,82,0,PROPYLTHIOURACIL,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk.,82,0,82,0,-1,91,16,TWrex-cause,803224,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk,pregnancy,propylthiouracil
725373131,5/24/2015 19:08:28,1642727435,5/24/2015 19:07:52,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,82,0,,,91,16,PREGNANCY,PROPYLTHIOURACIL,PREGNANCY,82,0,PROPYLTHIOURACIL,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk.,82,0,82,0,-1,91,16,TWrex-cause,803224,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk,pregnancy,propylthiouracil
725373131,5/24/2015 19:21:21,1642736716,5/24/2015 19:20:42,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,82,0,,,91,16,PREGNANCY,PROPYLTHIOURACIL,PREGNANCY,82,0,PROPYLTHIOURACIL,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk.,82,0,82,0,-1,91,16,TWrex-cause,803224,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk,pregnancy,propylthiouracil
725373131,5/24/2015 19:26:34,1642741104,5/24/2015 19:26:09,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,82,0,,,91,16,PREGNANCY,PROPYLTHIOURACIL,PREGNANCY,82,0,PROPYLTHIOURACIL,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk.,82,0,82,0,-1,91,16,TWrex-cause,803224,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk,pregnancy,propylthiouracil
725373131,5/24/2015 19:39:48,1642747476,5/24/2015 19:39:36,false,clixsense,1,31482589,NLD,,,31.201.11.16,82,0,,,91,16,PREGNANCY,PROPYLTHIOURACIL,PREGNANCY,82,0,PROPYLTHIOURACIL,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk.,82,0,82,0,-1,91,16,TWrex-cause,803224,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk,pregnancy,propylthiouracil
725373131,5/24/2015 19:43:46,1642748906,5/24/2015 19:41:15,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,82,0,,,91,16,PREGNANCY,PROPYLTHIOURACIL,PREGNANCY or breastfeeding,82-92-95,0-17-21-24,PROPYLTHIOURACIL may be preferred,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk.,82,0,82,0,-1,91,16,TWrex-cause,803224,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk,pregnancy,propylthiouracil
725373131,5/24/2015 19:43:48,1642748952,5/24/2015 19:43:09,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,82,0,,,91,16,PREGNANCY,PROPYLTHIOURACIL,Propylthiouracil may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,0-17-21-24-34-37-49-54-62-67-70-75-82-92-95-109-117-120-123-128-135-138-144-148-157-160-173-166,0-17-21-24-34-37-49-54-62-67-70-75-82-92-95-109-117-120-123-128-135-138-144-148-157-160-166-173,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk.,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk.,82,0,82,0,-1,91,16,TWrex-cause,803224,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk,pregnancy,propylthiouracil
725373131,5/24/2015 19:44:01,1642749010,5/24/2015 19:43:22,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,82,0,,,91,16,PREGNANCY,PROPYLTHIOURACIL,PREGNANCY,82,0,PROPYLTHIOURACIL,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk.,82,0,82,0,-1,91,16,TWrex-cause,803224,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk,pregnancy,propylthiouracil
725373131,5/24/2015 19:48:37,1642750615,5/24/2015 19:48:24,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,82,0,,,91,16,PREGNANCY,PROPYLTHIOURACIL,PREGNANCY,82,0,PROPYLTHIOURACIL,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk.,82,0,82,0,-1,91,16,TWrex-cause,803224,Propylthiouracil may be preferred if antithyroid drug therapy must be used during pregnancy or breastfeeding because it is less likely to cross the placenta or enter breast milk,pregnancy,propylthiouracil
725373132,5/24/2015 19:02:38,1642724604,5/24/2015 19:02:15,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,119,79,,,147,98,ACUTE PROMYELOCYTIC LEUKEMIA,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA.,119-125-139,79-85-94,TRANS RETINOIC ACID,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.",119 125 139,79 85 94,119,79,-1,147,98,TWrex-cause,803402,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia",acute promyelocytic leukemia,trans retinoic acid
725373132,5/24/2015 19:03:50,1642725228,5/24/2015 19:03:31,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,119,79,,,147,98,ACUTE PROMYELOCYTIC LEUKEMIA,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA.,119-125-139,75-79-85-94,all TRANS RETINOIC ACID,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.",119 125 139,79 85 94,119,79,-1,147,98,TWrex-cause,803402,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia",acute promyelocytic leukemia,trans retinoic acid
725373132,5/24/2015 19:04:45,1642725692,5/24/2015 19:04:21,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,119,79,,,147,98,ACUTE PROMYELOCYTIC LEUKEMIA,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA.,119-125-139,79-85-94,TRANS RETINOIC ACID,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.",119 125 139,79 85 94,119,79,-1,147,98,TWrex-cause,803402,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia",acute promyelocytic leukemia,trans retinoic acid
725373132,5/24/2015 19:15:24,1642730354,5/24/2015 19:14:44,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,119,79,,,147,98,ACUTE PROMYELOCYTIC LEUKEMIA,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA.,119-125-139,75-79-85-94,all TRANS RETINOIC ACID,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.",119 125 139,79 85 94,119,79,-1,147,98,TWrex-cause,803402,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia",acute promyelocytic leukemia,trans retinoic acid
725373132,5/24/2015 19:24:27,1642740221,5/24/2015 19:24:15,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,119,79,,,147,98,ACUTE PROMYELOCYTIC LEUKEMIA,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA.,119-125-139,75-79-85-94,all TRANS RETINOIC ACID,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.",119 125 139,79 85 94,119,79,-1,147,98,TWrex-cause,803402,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia",acute promyelocytic leukemia,trans retinoic acid
725373132,5/24/2015 19:36:12,1642745974,5/24/2015 19:35:25,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,119,79,,,147,98,ACUTE PROMYELOCYTIC LEUKEMIA,TRANS RETINOIC ACID,the treatment of ACUTE PROMYELOCYTIC LEUKEMIA.,102-106-116-119-125-139,79-85-94,TRANS RETINOIC ACID,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.",119 125 139,79 85 94,119,79,-1,147,98,TWrex-cause,803402,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia",acute promyelocytic leukemia,trans retinoic acid
725373132,5/24/2015 19:37:09,1642746275,5/24/2015 19:35:25,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,119,79,,,147,98,ACUTE PROMYELOCYTIC LEUKEMIA,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA.,119-125-139,75-79-85-94,all TRANS RETINOIC ACID,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.",119 125 139,79 85 94,119,79,-1,147,98,TWrex-cause,803402,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia",acute promyelocytic leukemia,trans retinoic acid
725373132,5/24/2015 19:37:57,1642746827,5/24/2015 19:37:45,false,clixsense,1,31482589,NLD,,,31.201.11.16,119,79,,,147,98,ACUTE PROMYELOCYTIC LEUKEMIA,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA.,119-125-139,75-79-85-94,all TRANS RETINOIC ACID,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.",119 125 139,79 85 94,119,79,-1,147,98,TWrex-cause,803402,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia",acute promyelocytic leukemia,trans retinoic acid
725373132,5/24/2015 19:38:16,1642746955,5/24/2015 19:37:56,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,119,79,,,147,98,ACUTE PROMYELOCYTIC LEUKEMIA,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA.,119-125-139,75-79-85-94,all TRANS RETINOIC ACID,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.",119 125 139,79 85 94,119,79,-1,147,98,TWrex-cause,803402,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia",acute promyelocytic leukemia,trans retinoic acid
725373132,5/24/2015 19:38:17,1642746956,5/24/2015 19:38:00,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,119,79,,,147,98,ACUTE PROMYELOCYTIC LEUKEMIA,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA.,119-125-139,79-84-85-94,TRANS - RETINOIC ACID,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.",119 125 139,79 85 94,119,79,-1,147,98,TWrex-cause,803402,"Hakimian D, Tallman MS, Zugerman C et al. Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia",acute promyelocytic leukemia,trans retinoic acid
725373133,5/24/2015 23:03:59,1642810308,5/24/2015 23:03:20,false,points4rewards,1,28703583,USA,,,97.73.85.52,162,201,,,173,208,CANDIDIASIS,CANDIDA,vulvovaginal CANDIDIASIS,149-162,201-149,vulvovaginal CANDIDA,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions.",162,201,162,201,1,173,208,TWrex-cause,812304,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions",candidiasis,candida
725373133,5/24/2015 23:04:57,1642810569,5/24/2015 23:04:39,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,162,201,,,173,208,CANDIDIASIS,CANDIDA,vulvovaginal CANDIDIASIS,149-162,201,CANDIDA,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions.",162,201,162,201,1,173,208,TWrex-cause,812304,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions",candidiasis,candida
725373133,5/24/2015 23:08:29,1642811618,5/24/2015 23:06:27,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,162,201,,,173,208,CANDIDIASIS,CANDIDA,vulvovaginal CANDIDIASIS,149-162,201,CANDIDA,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions.",162,201,162,201,1,173,208,TWrex-cause,812304,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions",candidiasis,candida
725373133,5/24/2015 23:21:55,1642815057,5/24/2015 23:21:39,false,bitcoinget,1,28503763,USA,CA,San Francisco,107.217.186.64,162,201,,,173,208,CANDIDIASIS,CANDIDA,vulvovaginal CANDIDIASIS,149-162,201,CANDIDA,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions.",162,201,162,201,1,173,208,TWrex-cause,812304,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions",candidiasis,candida
725373133,5/24/2015 23:23:01,1642815342,5/24/2015 23:22:35,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,162,201,,,173,208,CANDIDIASIS,CANDIDA,azole for vulvovaginal CANDIDIASIS,139-145-149-162,182-190-197-201,"severe, caused by CANDIDA","108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions.",162,201,162,201,1,173,208,TWrex-cause,812304,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions",candidiasis,candida
725373133,5/24/2015 23:56:08,1642824032,5/24/2015 23:55:50,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,162,201,,,173,208,CANDIDIASIS,CANDIDA,vulvovaginal CANDIDIASIS,149-162,201,CANDIDA,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions.",162,201,162,201,1,173,208,TWrex-cause,812304,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions",candidiasis,candida
725373133,5/24/2015 23:56:44,1642824206,5/24/2015 23:56:06,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,162,201,,,173,208,CANDIDIASIS,CANDIDA,vulvovaginal CANDIDIASIS,149-162,201,CANDIDA,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions.",162,201,162,201,1,173,208,TWrex-cause,812304,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions",candidiasis,candida
725373133,5/25/2015 00:25:39,1642833506,5/25/2015 00:25:18,false,elite,1,32173500,GBR,E4,Rayleigh,90.219.97.221,162,201,,,173,208,CANDIDIASIS,CANDIDA,vulvovaginal CANDIDIASIS,149-162,190-197-201,caused by CANDIDA,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions.",162,201,162,201,1,173,208,TWrex-cause,812304,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions",candidiasis,candida
725373133,5/25/2015 00:27:49,1642834218,5/25/2015 00:27:36,false,prodege,1,12656479,CAN,NB,Moncton,142.167.60.47,162,201,,,173,208,CANDIDIASIS,CANDIDA,"azole for vulvovaginal CANDIDIASIS that is severe,",139-145-149-162-174-179-182,182-190-197-201-210-216-222,"severe, caused by CANDIDA other than C.","108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions.",162,201,162,201,1,173,208,TWrex-cause,812304,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions",candidiasis,candida
725373133,5/25/2015 00:29:44,1642834764,5/25/2015 00:28:37,false,instagc,1,15285653,USA,,,172.164.27.59,162,201,,,173,208,CANDIDIASIS,CANDIDA,"intravaginal azole for vulvovaginal CANDIDIASIS that is severe, caused by Candida other than C.",126-139-145-149-162-174-179-182-190-197-201-210-216-222,162-174-179-182-190-197-201-210-216-222-149,"vulvovaginal candidiasis that is severe, caused by CANDIDA other than C.","108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions.",162,201,162,201,1,173,208,TWrex-cause,812304,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7-14 days of an intravaginal azole for vulvovaginal candidiasis that is severe, caused by  Candida  other than  C. albicans , or occurring in women with underlying medical conditions",candidiasis,candida
725373134,5/24/2015 23:08:25,1642811586,5/24/2015 23:07:45,false,points4rewards,1,28703583,USA,,,97.73.85.52,137,19,,,171,29,ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,Kaposi sarcoma ACQUIRED IMMUNODEFICIENCY SYNDROME,102-109-137-146-163,19-137-146-163,ZIDOVUDINE: acquired immunodeficiency syndrome,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS.",137 146 163,19,137,19,-1,171,29,TWrex-cause,800417,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS",acquired immunodeficiency syndrome,zidovudine
725373134,5/24/2015 23:09:27,1642811887,5/24/2015 23:08:01,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,137,19,,,171,29,ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,the ACQUIRED IMMUNODEFICIENCY SYNDROME,137-146-163-133,19,ZIDOVUDINE:,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS.",137 146 163,19,137,19,-1,171,29,TWrex-cause,800417,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS",acquired immunodeficiency syndrome,zidovudine
725373134,5/24/2015 23:12:49,1642812732,5/24/2015 23:12:11,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,137,19,,,171,29,ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,ACQUIRED IMMUNODEFICIENCY SYNDROME,137-146-163,0-12-14-19,Interferon α with ZIDOVUDINE:,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS.",137 146 163,19,137,19,-1,171,29,TWrex-cause,800417,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS",acquired immunodeficiency syndrome,zidovudine
725373134,5/24/2015 23:25:36,1642815977,5/24/2015 23:24:34,false,bitcoinget,1,28503763,USA,CA,San Francisco,107.217.186.64,137,19,,,171,29,ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,ACQUIRED IMMUNODEFICIENCY SYNDROME,137-146-163,19,ZIDOVUDINE:,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS.",137 146 163,19,137,19,-1,171,29,TWrex-cause,800417,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS",acquired immunodeficiency syndrome,zidovudine
725373134,5/24/2015 23:25:41,1642815985,5/24/2015 23:25:03,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,137,19,,,171,29,ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME,67-77-88-97-102-109-117-128-133-137-146-163-85,0-12-14-19-31-39-50-54-63-67-77,"Interferon α with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects","Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS.",137 146 163,19,137,19,-1,171,29,TWrex-cause,800417,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS",acquired immunodeficiency syndrome,zidovudine
725373134,5/24/2015 23:57:38,1642824515,5/24/2015 23:57:17,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,137,19,,,171,29,ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,ACQUIRED IMMUNODEFICIENCY SYNDROME,137-146-163,19,ZIDOVUDINE:,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS.",137 146 163,19,137,19,-1,171,29,TWrex-cause,800417,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS",acquired immunodeficiency syndrome,zidovudine
725373134,5/25/2015 00:27:26,1642834109,5/25/2015 00:27:07,false,elite,1,32173500,GBR,E4,Rayleigh,90.219.97.221,137,19,,,171,29,ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.,133-137-146-163-172,0-12-14-19,Interferon α with ZIDOVUDINE:,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS.",137 146 163,19,137,19,-1,171,29,TWrex-cause,800417,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS",acquired immunodeficiency syndrome,zidovudine
725373134,5/25/2015 00:32:27,1642835510,5/25/2015 00:32:12,false,clixsense,1,21933552,CAN,ON,Ottawa,70.49.14.161,137,19,,,171,29,ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.,137-146-163-172,19,ZIDOVUDINE:,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS.",137 146 163,19,137,19,-1,171,29,TWrex-cause,800417,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS",acquired immunodeficiency syndrome,zidovudine
725373134,5/25/2015 00:39:18,1642837608,5/25/2015 00:38:59,false,memolink,1,6556053,USA,IL,Zion,76.245.204.32,137,19,,,171,29,ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,ACQUIRED IMMUNODEFICIENCY SYNDROME,137-146-163,19,ZIDOVUDINE:,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS.",137 146 163,19,137,19,-1,171,29,TWrex-cause,800417,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS",acquired immunodeficiency syndrome,zidovudine
725373134,5/25/2015 00:40:13,1642837864,5/25/2015 00:39:37,false,instagc,1,15285653,USA,,,172.164.27.59,137,19,,,171,29,ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,ACQUIRED IMMUNODEFICIENCY SYNDROME,137-146-163,19-146-163,ZIDOVUDINE: immunodeficiency syndrome,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS.",137 146 163,19,137,19,-1,171,29,TWrex-cause,800417,"Interferon- α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS",acquired immunodeficiency syndrome,zidovudine
725373135,5/24/2015 19:04:21,1642725550,5/24/2015 19:03:41,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,286,80,,,295,98,PREGNANCY,LEUPROLIDE ACETATE,PREGNANCY,286,80-91,LEUPROLIDE ACETATE,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy.",286,80 91,286,80,-1,295,98,TWrex-cause,803123,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy",pregnancy,leuprolide acetate
725373135,5/24/2015 19:05:55,1642726258,5/24/2015 19:05:10,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,286,80,,,295,98,PREGNANCY,LEUPROLIDE ACETATE,PREGNANCY,286,80-91,LEUPROLIDE ACETATE,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy.",286,80 91,286,80,-1,295,98,TWrex-cause,803123,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy",pregnancy,leuprolide acetate
725373135,5/24/2015 19:06:53,1642726689,5/24/2015 19:06:36,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,286,80,,,295,98,PREGNANCY,LEUPROLIDE ACETATE,", PREGNANCY",270-286,80-91,LEUPROLIDE ACETATE,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy.",286,80 91,286,80,-1,295,98,TWrex-cause,803123,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy",pregnancy,leuprolide acetate
725373135,5/24/2015 19:19:39,1642734317,5/24/2015 19:18:17,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,286,80,,,295,98,PREGNANCY,LEUPROLIDE ACETATE,PREGNANCY,286,80-91-99,LEUPROLIDE ACETATE injection,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy.",286,80 91,286,80,-1,295,98,TWrex-cause,803123,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy",pregnancy,leuprolide acetate
725373135,5/24/2015 19:25:40,1642740733,5/24/2015 19:25:21,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,286,80,,,295,98,PREGNANCY,LEUPROLIDE ACETATE,PREGNANCY,286,80-91-99,LEUPROLIDE ACETATE injection,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy.",286,80 91,286,80,-1,295,98,TWrex-cause,803123,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy",pregnancy,leuprolide acetate
725373135,5/24/2015 19:39:02,1642747162,5/24/2015 19:38:45,false,clixsense,1,31482589,NLD,,,31.201.11.16,286,80,,,295,98,PREGNANCY,LEUPROLIDE ACETATE,PREGNANCY,286,80-91-99,LEUPROLIDE ACETATE injection,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy.",286,80 91,286,80,-1,295,98,TWrex-cause,803123,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy",pregnancy,leuprolide acetate
725373135,5/24/2015 19:39:16,1642747225,5/24/2015 19:38:36,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,286,80,,,295,98,PREGNANCY,LEUPROLIDE ACETATE,PREGNANCY before initiating therapy.,286-296-303-314,80-91-99-109-113-124,LEUPROLIDE ACETATE injection and injectable suspension,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy.",286,80 91,286,80,-1,295,98,TWrex-cause,803123,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy",pregnancy,leuprolide acetate
725373135,5/24/2015 19:41:47,1642748206,5/24/2015 19:40:42,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,286,80,,,295,98,PREGNANCY,LEUPROLIDE ACETATE,Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy; exclude PREGNANCY before initiating therapy.,80-91-99-109-113-124-135-139-155-158-164-168-172-175-179-186-195-202-278-286-296-303-314,80-91-99-109-113-124-135-139-155-158-164-168-172-175-179-186-195-202-278-286-296-303-314,LEUPROLIDE ACETATE injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy; exclude pregnancy before initiating therapy.,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy.",286,80 91,286,80,-1,295,98,TWrex-cause,803123,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy",pregnancy,leuprolide acetate
725373135,5/24/2015 19:42:20,1642748423,5/24/2015 19:41:15,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,286,80,,,295,98,PREGNANCY,LEUPROLIDE ACETATE,PREGNANCY,286,80-91-99,LEUPROLIDE ACETATE injection,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy.",286,80 91,286,80,-1,295,98,TWrex-cause,803123,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy",pregnancy,leuprolide acetate
725373135,5/24/2015 19:43:35,1642748837,5/24/2015 19:41:05,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,286,80,,,295,98,PREGNANCY,LEUPROLIDE ACETATE,", PREGNANCY",270-286,80-91-99,LEUPROLIDE ACETATE injection,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy.",286,80 91,286,80,-1,295,98,TWrex-cause,803123,"1 ,   100 ,   155 ,   156 ,   180 ,   187 ,   f ,   p ,   q ,   r ,   s ,   t   Leuprolide acetate injection and injectable suspension are contraindicated in women who are or may become pregnant during therapy;  1 ,   100 ,   116 ,   116 ,   155 ,   156 ,   180 ,   187 ,   f   exclude pregnancy before initiating therapy",pregnancy,leuprolide acetate
725373136,5/24/2015 19:53:39,1642751991,5/24/2015 19:53:24,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,16,36,,,18,38,MD,VA,"MD,",16,36,VA,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1.",16,36,16,36,-1,18,38,TWrex-cause,803514,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1",MD,VA
725373136,5/24/2015 19:54:52,1642752389,5/24/2015 19:54:40,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,16,36,,,18,38,MD,VA,"MD,",16,36,VA,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1.",16,36,16,36,-1,18,38,TWrex-cause,803514,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1",MD,VA
725373136,5/24/2015 19:54:56,1642752431,5/24/2015 19:54:37,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,16,36,,,18,38,MD,VA,"MD,",16,36-39-47,VA Medical Center,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1.",16,36,16,36,-1,18,38,TWrex-cause,803514,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1",MD,VA
725373136,5/24/2015 20:01:55,1642754359,5/24/2015 20:01:40,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,16,36,,,18,38,MD,VA,"Richard MD,",0-16,36,VA,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1.",16,36,16,36,-1,18,38,TWrex-cause,803514,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1",MD,VA
725373136,5/24/2015 20:07:22,1642755768,5/24/2015 20:06:40,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,16,36,,,18,38,MD,VA,"MD, MPH Albuquerque VA",16-20-24-36,16-20-24-36,"MD, MPH Albuquerque VA","Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1.",16,36,16,36,-1,18,38,TWrex-cause,803514,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1",MD,VA
725373136,5/24/2015 20:23:25,1642759901,5/24/2015 20:23:01,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,16,36,,,18,38,MD,VA,"MD,",16,36,VA,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1.",16,36,16,36,-1,18,38,TWrex-cause,803514,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1",MD,VA
725373136,5/24/2015 20:27:44,1642760914,5/24/2015 20:27:09,false,instagc,1,19740138,CAN,,,50.69.96.237,16,36,,,18,38,MD,VA,"MD,",16,24-36-39-47,Albuquerque VA Medical Center,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1.",16,36,16,36,-1,18,38,TWrex-cause,803514,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1",MD,VA
725373136,5/24/2015 20:28:20,1642761135,5/24/2015 20:28:00,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,16,36,,,18,38,MD,VA,"MD,",16,24-36,Albuquerque VA,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1.",16,36,16,36,-1,18,38,TWrex-cause,803514,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1",MD,VA
725373136,5/24/2015 20:31:55,1642762133,5/24/2015 20:31:42,false,neodev,1,29074051,GBR,G5,Folkestone,80.6.67.18,16,36,,,18,38,MD,VA,"MD,",16,36,VA,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1.",16,36,16,36,-1,18,38,TWrex-cause,803514,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1",MD,VA
725373136,5/24/2015 20:41:20,1642764419,5/24/2015 20:41:05,false,clixsense,1,23197581,NLD,11,Den Haag,82.217.5.55,16,36,,,18,38,MD,VA,"MD,",16,36-39-47-54,"VA Medical Center Albuquerque,","Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1.",16,36,16,36,-1,18,38,TWrex-cause,803514,"Richard Hoffman MD, MPH Albuquerque VA Medical Center Albuquerque, New Mexico, USA    REFERENCES  1",MD,VA
725373137,5/24/2015 19:04:45,1642725687,5/24/2015 19:04:22,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,265,156,,,270,165,SPINE,DEFORMITY,SPINE.,265,156,DEFORMITY,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine.",265,156,265,156,-1,270,165,TWrex-cause,802113,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine",spine,deformity
725373137,5/24/2015 19:06:18,1642726448,5/24/2015 19:06:01,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,265,156,,,270,165,SPINE,DEFORMITY,SPINE.,265,149-156,Spinal DEFORMITY,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine.",265,156,265,156,-1,270,165,TWrex-cause,802113,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine",spine,deformity
725373137,5/24/2015 19:07:13,1642726854,5/24/2015 19:06:56,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,265,156,,,270,165,SPINE,DEFORMITY,SPINE.,265,149-156,Spinal DEFORMITY,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine.",265,156,265,156,-1,270,165,TWrex-cause,802113,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine",spine,deformity
725373137,5/24/2015 19:20:15,1642735101,5/24/2015 19:19:40,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,265,156,,,270,165,SPINE,DEFORMITY,SPINE.,265,149-156,Spinal DEFORMITY,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine.",265,156,265,156,-1,270,165,TWrex-cause,802113,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine",spine,deformity
725373137,5/24/2015 19:25:55,1642740869,5/24/2015 19:25:42,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,265,156,,,270,165,SPINE,DEFORMITY,SPINE.,265,149-156,Spinal DEFORMITY,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine.",265,156,265,156,-1,270,165,TWrex-cause,802113,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine",spine,deformity
725373137,5/24/2015 19:39:20,1642747240,5/24/2015 19:39:02,false,clixsense,1,31482589,NLD,,,31.201.11.16,265,156,,,270,165,SPINE,DEFORMITY,SPINE.,265,149-156,Spinal DEFORMITY,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine.",265,156,265,156,-1,270,165,TWrex-cause,802113,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine",spine,deformity
725373137,5/24/2015 19:40:28,1642747720,5/24/2015 19:39:18,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,265,156,,,270,165,SPINE,DEFORMITY,protrudes through the SPINE.,243-253-261-265,132-139-149-156,"tumor, swelling] Spinal DEFORMITY","hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine.",265,156,265,156,-1,270,165,TWrex-cause,802113,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine",spine,deformity
725373137,5/24/2015 19:42:42,1642748511,5/24/2015 19:41:47,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,265,156,,,270,165,SPINE,DEFORMITY,"hydromyelomeningocele [&amp;dblprime; + myelos , marrow, + meninx , membrane, + kele , tumor, swelling] Spinal deformity in which a fluid - filled sac containing spinal cord and surrounding membranes protrudes through the SPINE.",0-68-80-83-90-92-100-103-110-112-122-125-130-132-139-149-156-166-169-175-177-182-183-190-194-205-212-217-221-243-253-261-265-233,0-68-80-83-92-100-103-110-112-122-125-130-132-139-149-156-166-169-175-177-183-190-194-205-212-217-221-233-243-253-261-265,"hydromyelomeningocele [&amp;dblprime; + myelos marrow, + meninx , membrane, + kele , tumor, swelling] Spinal DEFORMITY in which a fluid filled sac containing spinal cord and surrounding membranes protrudes through the spine.","hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine.",265,156,265,156,-1,270,165,TWrex-cause,802113,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine",spine,deformity
725373137,5/24/2015 19:42:54,1642748591,5/24/2015 19:42:24,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,265,156,,,270,165,SPINE,DEFORMITY,SPINE.,265,149-156,Spinal DEFORMITY,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine.",265,156,265,156,-1,270,165,TWrex-cause,802113,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine",spine,deformity
725373137,5/24/2015 19:48:11,1642750470,5/24/2015 19:47:53,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,265,156,,,270,165,SPINE,DEFORMITY,SPINE.,265,156-149,Spinal DEFORMITY,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine.",265,156,265,156,-1,270,165,TWrex-cause,802113,"hydromyelomeningocele    (                                 audio )  [&dblprime; +  myelos , marrow, +  meninx , membrane, +  kele , tumor, swelling] Spinal deformity in which a fluid-filled sac containing spinal cord and surrounding membranes protrudes through the spine",spine,deformity
725373138,5/24/2015 21:02:51,1642771787,5/24/2015 21:02:38,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,33,69,,,55,81,SEBORRHOEIC DERMATITIS,KETOCONAZOLE,SEBORRHOEIC DERMATITIS,33-45,69,KETOCONAZOLE.,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole.",33 45,69,33,69,-1,55,81,TWrex-cause,803426,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole",seborrhoeic dermatitis,ketoconazole
725373138,5/24/2015 21:03:30,1642772053,5/24/2015 21:03:17,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,33,69,,,55,81,SEBORRHOEIC DERMATITIS,KETOCONAZOLE,SEBORRHOEIC DERMATITIS,33-45,69,KETOCONAZOLE.,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole.",33 45,69,33,69,-1,55,81,TWrex-cause,803426,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole",seborrhoeic dermatitis,ketoconazole
725373138,5/24/2015 21:15:41,1642776059,5/24/2015 21:15:32,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,33,69,,,55,81,SEBORRHOEIC DERMATITIS,KETOCONAZOLE,SEBORRHOEIC DERMATITIS,33-45,69,KETOCONAZOLE.,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole.",33 45,69,33,69,-1,55,81,TWrex-cause,803426,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole",seborrhoeic dermatitis,ketoconazole
725373138,5/24/2015 21:16:14,1642776247,5/24/2015 21:16:02,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,33,69,,,55,81,SEBORRHOEIC DERMATITIS,KETOCONAZOLE,SEBORRHOEIC DERMATITIS,33-45,61-69,topical KETOCONAZOLE.,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole.",33 45,69,33,69,-1,55,81,TWrex-cause,803426,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole",seborrhoeic dermatitis,ketoconazole
725373138,5/24/2015 21:29:02,1642779971,5/24/2015 21:28:51,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,33,69,,,55,81,SEBORRHOEIC DERMATITIS,KETOCONAZOLE,SEBORRHOEIC DERMATITIS,33-45,61-69,topical KETOCONAZOLE.,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole.",33 45,69,33,69,-1,55,81,TWrex-cause,803426,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole",seborrhoeic dermatitis,ketoconazole
725373138,5/24/2015 21:29:30,1642780114,5/24/2015 21:29:02,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,33,69,,,55,81,SEBORRHOEIC DERMATITIS,KETOCONAZOLE,SEBORRHOEIC DERMATITIS,33-45,61-69,topical KETOCONAZOLE.,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole.",33 45,69,33,69,-1,55,81,TWrex-cause,803426,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole",seborrhoeic dermatitis,ketoconazole
725373138,5/24/2015 21:31:17,1642780661,5/24/2015 21:29:55,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,33,69,,,55,81,SEBORRHOEIC DERMATITIS,KETOCONAZOLE,SEBORRHOEIC DERMATITIS,33-45,61-69,topical KETOCONAZOLE.,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole.",33 45,69,33,69,-1,55,81,TWrex-cause,803426,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole",seborrhoeic dermatitis,ketoconazole
725373138,5/24/2015 22:05:28,1642791035,5/24/2015 22:05:07,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,33,69,,,55,81,SEBORRHOEIC DERMATITIS,KETOCONAZOLE,SEBORRHOEIC DERMATITIS,33-45,61-69,topical KETOCONAZOLE.,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole.",33 45,69,33,69,-1,55,81,TWrex-cause,803426,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole",seborrhoeic dermatitis,ketoconazole
725373138,5/24/2015 22:24:40,1642798839,5/24/2015 22:24:31,false,tremorgames,1,17272211,USA,PA,Havertown,173.49.116.92,33,69,,,55,81,SEBORRHOEIC DERMATITIS,KETOCONAZOLE,SEBORRHOEIC DERMATITIS,33-45,61-69,topical KETOCONAZOLE.,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole.",33 45,69,33,69,-1,55,81,TWrex-cause,803426,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole",seborrhoeic dermatitis,ketoconazole
725373138,5/24/2015 22:30:43,1642800635,5/24/2015 22:30:25,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,33,69,,,55,81,SEBORRHOEIC DERMATITIS,KETOCONAZOLE,SEBORRHOEIC DERMATITIS,33-45,61-69,topical KETOCONAZOLE.,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole.",33 45,69,33,69,-1,55,81,TWrex-cause,803426,"Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole",seborrhoeic dermatitis,ketoconazole
725373139,5/24/2015 23:07:41,1642811452,5/24/2015 23:06:38,false,points4rewards,1,28703583,USA,,,97.73.85.52,84,156,,,91,180,ASCITES,HEPATOCELLULAR CARCINOMA,"ASCITES, portal systemic encephalopathy),",84-93-100-109,156-171-84,"ascites, HEPATOCELLULAR CARCINOMA","Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present.",84,156 171,84,156,1,91,180,TWrex-cause,814293,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present",ascites,hepatocellular carcinoma
725373139,5/24/2015 23:07:59,1642811480,5/24/2015 23:06:47,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,84,156,,,91,180,ASCITES,HEPATOCELLULAR CARCINOMA,"ASCITES,",84,156-171,HEPATOCELLULAR CARCINOMA,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present.",84,156 171,84,156,1,91,180,TWrex-cause,814293,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present",ascites,hepatocellular carcinoma
725373139,5/24/2015 23:12:10,1642812577,5/24/2015 23:11:43,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,84,156,,,91,180,ASCITES,HEPATOCELLULAR CARCINOMA,"ASCITES,",84,156-171,HEPATOCELLULAR CARCINOMA,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present.",84,156 171,84,156,1,91,180,TWrex-cause,814293,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present",ascites,hepatocellular carcinoma
725373139,5/24/2015 23:24:33,1642815667,5/24/2015 23:24:17,false,bitcoinget,1,28503763,USA,CA,San Francisco,107.217.186.64,84,156,,,91,180,ASCITES,HEPATOCELLULAR CARCINOMA,"ASCITES,",84,156-171,HEPATOCELLULAR CARCINOMA,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present.",84,156 171,84,156,1,91,180,TWrex-cause,814293,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present",ascites,hepatocellular carcinoma
725373139,5/24/2015 23:25:03,1642815851,5/24/2015 23:24:33,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,84,156,,,91,180,ASCITES,HEPATOCELLULAR CARCINOMA,"upper GI bleeding, ASCITES, portal systemic encephalopathy),",65-71-74-84-93-100-109,138-148-151-156-171-126,"hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA","Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present.",84,156 171,84,156,1,91,180,TWrex-cause,814293,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present",ascites,hepatocellular carcinoma
725373139,5/24/2015 23:57:16,1642824376,5/24/2015 23:56:58,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,84,156,,,91,180,ASCITES,HEPATOCELLULAR CARCINOMA,"ASCITES,",84,156-171,HEPATOCELLULAR CARCINOMA,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present.",84,156 171,84,156,1,91,180,TWrex-cause,814293,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present",ascites,hepatocellular carcinoma
725373139,5/25/2015 00:27:06,1642833983,5/25/2015 00:26:49,false,elite,1,32173500,GBR,E4,Rayleigh,90.219.97.221,84,156,,,91,180,ASCITES,HEPATOCELLULAR CARCINOMA,"ASCITES,",84,156-171,HEPATOCELLULAR CARCINOMA,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present.",84,156 171,84,156,1,91,180,TWrex-cause,814293,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present",ascites,hepatocellular carcinoma
725373139,5/25/2015 00:32:11,1642835379,5/25/2015 00:31:59,false,clixsense,1,21933552,CAN,ON,Ottawa,70.49.14.161,84,156,,,91,180,ASCITES,HEPATOCELLULAR CARCINOMA,"ASCITES,",84,156-171,HEPATOCELLULAR CARCINOMA,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present.",84,156 171,84,156,1,91,180,TWrex-cause,814293,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present",ascites,hepatocellular carcinoma
725373139,5/25/2015 00:39:35,1642837709,5/25/2015 00:38:56,false,instagc,1,15285653,USA,,,172.164.27.59,84,156,,,91,180,ASCITES,HEPATOCELLULAR CARCINOMA,"hypertension ASCITES, hepatocellular carcinoma",17-84-156-171,138-148-151-156-171-181-184-17,"hypertension syndrome, or even HEPATOCELLULAR CARCINOMA is present.","Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present.",84,156 171,84,156,1,91,180,TWrex-cause,814293,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present",ascites,hepatocellular carcinoma
725373139,5/25/2015 00:41:39,1642838354,5/25/2015 00:38:47,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,84,156,,,91,180,ASCITES,HEPATOCELLULAR CARCINOMA,"ASCITES,",84,156-171,HEPATOCELLULAR CARCINOMA,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present.",84,156 171,84,156,1,91,180,TWrex-cause,814293,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ascites, portal-systemic encephalopathy), hepatorenal syndrome, or even hepatocellular carcinoma is present",ascites,hepatocellular carcinoma
725373140,5/24/2015 18:55:19,1642721175,5/24/2015 18:54:49,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,162,92,,,168,96,SEPSIS,ALFA,severe SEPSIS.,155-162,68-80-92,concomitant drotrecogin ALFA,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis.",162,92,162,92,-1,168,96,TWrex-cause,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis",sepsis,alfa
725373140,5/24/2015 18:55:52,1642721384,5/24/2015 18:55:33,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,162,92,,,168,96,SEPSIS,ALFA,SEPSIS.,162,92,ALFA,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis.",162,92,162,92,-1,168,96,TWrex-cause,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis",sepsis,alfa
725373140,5/24/2015 18:55:58,1642721431,5/24/2015 18:55:32,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,162,92,,,168,96,SEPSIS,ALFA,SEPSIS.,162,92,ALFA,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis.",162,92,162,92,-1,168,96,TWrex-cause,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis",sepsis,alfa
725373140,5/24/2015 18:56:58,1642721914,5/24/2015 18:56:35,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,162,92,,,168,96,SEPSIS,ALFA,SEPSIS.,162,68-80-92-97,concomitant drotrecogin ALFA (activated),"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis.",162,92,162,92,-1,168,96,TWrex-cause,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis",sepsis,alfa
725373140,5/24/2015 18:57:24,1642722179,5/24/2015 18:57:08,false,neodev,1,32456300,USA,CA,Laguna Niguel,216.177.129.227,162,92,,,168,96,SEPSIS,ALFA,patients with severe SEPSIS.,141-150-155-162,65-68-80-92-109-113,of concomitant drotrecogin ALFA and prophylactic,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis.",162,92,162,92,-1,168,96,TWrex-cause,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis",sepsis,alfa
725373140,5/24/2015 19:00:27,1642723619,5/24/2015 18:59:12,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,162,92,,,168,96,SEPSIS,ALFA,severe SEPSIS.,155-162,68-80-92,concomitant drotrecogin ALFA,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis.",162,92,162,92,-1,168,96,TWrex-cause,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis",sepsis,alfa
725373140,5/24/2015 19:01:24,1642724001,5/24/2015 19:01:15,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,162,92,,,168,96,SEPSIS,ALFA,patients with severe SEPSIS.,141-150-155-162,65-68-80-92-109-113-155-162,of concomitant drotrecogin ALFA and prophylactic severe sepsis.,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis.",162,92,162,92,-1,168,96,TWrex-cause,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis",sepsis,alfa
725373140,5/24/2015 19:17:54,1642732239,5/24/2015 19:17:38,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,162,92,,,168,96,SEPSIS,ALFA,severe SEPSIS.,155-162,68-80-92,concomitant drotrecogin ALFA,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis.",162,92,162,92,-1,168,96,TWrex-cause,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis",sepsis,alfa
725373140,5/24/2015 19:18:41,1642733170,5/24/2015 19:18:20,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,162,92,,,168,96,SEPSIS,ALFA,severe SEPSIS.,155-162,68-80-92-97,concomitant drotrecogin ALFA (activated),"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis.",162,92,162,92,-1,168,96,TWrex-cause,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis",sepsis,alfa
725373140,5/24/2015 19:19:39,1642734310,5/24/2015 19:18:26,false,pocketmoneygpt,1,32162555,CAN,BC,Vancouver,108.180.194.80,162,92,,,168,96,SEPSIS,ALFA,SEPSIS.,162,92,ALFA,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis.",162,92,162,92,-1,168,96,TWrex-cause,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis",sepsis,alfa
725373141,5/24/2015 19:48:46,1642750638,5/24/2015 19:48:13,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,5,72,,,18,84,BLASTOMYCOSIS,AMPHOTERICIN,BLASTOMYCOSIS &gt; Treatment of Blastomycosis IV: Conventional amphotericin B: 0.5 - 1 mg / kg daily.,5-20-26-36-39-54-59-72-85-88-91-92-94-96-97-100,5-20-26-36-39-54-59-72-85-88-91-92-94-96-97-100,Blastomycosis &gt; Treatment of Blastomycosis IV: Conventional AMPHOTERICIN B: 0.5 - 1 mg / kg daily.,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily.,5,72,5,72,-1,18,84,TWrex-cause,803836,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily,blastomycosis,amphotericin
725373141,5/24/2015 19:49:57,1642750965,5/24/2015 19:48:46,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,5,72,,,18,84,BLASTOMYCOSIS,AMPHOTERICIN,BLASTOMYCOSIS Treatment of Blastomycosis,5-26-36-39,39-54-59-72,Blastomycosis IV: Conventional AMPHOTERICIN,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily.,5,72,5,72,-1,18,84,TWrex-cause,803836,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily,blastomycosis,amphotericin
725373141,5/24/2015 19:50:25,1642751139,5/24/2015 19:50:18,false,neodev,1,31743852,GBR,G5,Faversham,85.210.123.52,5,72,,,18,84,BLASTOMYCOSIS,AMPHOTERICIN,423 BLASTOMYCOSIS Treatment of Blastomycosis Conventional amphotericin,0-5-26-36-39-59-72,39-54-59-72-85-88-92-5,Blastomycosis Blastomycosis IV: Conventional AMPHOTERICIN B: 0.5 1,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily.,5,72,5,72,-1,18,84,TWrex-cause,803836,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily,blastomycosis,amphotericin
725373141,5/24/2015 19:50:46,1642751258,5/24/2015 19:50:34,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,5,72,,,18,84,BLASTOMYCOSIS,AMPHOTERICIN,BLASTOMYCOSIS,5,72,AMPHOTERICIN,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily.,5,72,5,72,-1,18,84,TWrex-cause,803836,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily,blastomycosis,amphotericin
725373141,5/24/2015 19:51:16,1642751369,5/24/2015 19:50:53,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,5,72,,,18,84,BLASTOMYCOSIS,AMPHOTERICIN,BLASTOMYCOSIS,5,72,AMPHOTERICIN,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily.,5,72,5,72,-1,18,84,TWrex-cause,803836,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily,blastomycosis,amphotericin
725373141,5/24/2015 19:51:37,1642751440,5/24/2015 19:51:25,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,5,72,,,18,84,BLASTOMYCOSIS,AMPHOTERICIN,BLASTOMYCOSIS,5,72,AMPHOTERICIN,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily.,5,72,5,72,-1,18,84,TWrex-cause,803836,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily,blastomycosis,amphotericin
725373141,5/24/2015 19:58:21,1642753430,5/24/2015 19:56:46,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,5,72,,,18,84,BLASTOMYCOSIS,AMPHOTERICIN,BLASTOMYCOSIS,5,72,AMPHOTERICIN,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily.,5,72,5,72,-1,18,84,TWrex-cause,803836,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily,blastomycosis,amphotericin
725373141,5/24/2015 20:10:52,1642756788,5/24/2015 20:10:38,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,5,72,,,18,84,BLASTOMYCOSIS,AMPHOTERICIN,BLASTOMYCOSIS,5,72,AMPHOTERICIN,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily.,5,72,5,72,-1,18,84,TWrex-cause,803836,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily,blastomycosis,amphotericin
725373141,5/24/2015 20:12:15,1642757199,5/24/2015 20:11:51,false,instagc,1,19740138,CAN,,,50.69.96.237,5,72,,,18,84,BLASTOMYCOSIS,AMPHOTERICIN,BLASTOMYCOSIS,5,72,AMPHOTERICIN,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily.,5,72,5,72,-1,18,84,TWrex-cause,803836,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily,blastomycosis,amphotericin
725373141,5/24/2015 20:14:30,1642757866,5/24/2015 20:13:52,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,5,72,,,18,84,BLASTOMYCOSIS,AMPHOTERICIN,BLASTOMYCOSIS,5,59-72-85-88-92-94-97-100,Conventional AMPHOTERICIN B: 0.5 1 mg kg daily.,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily.,5,72,5,72,-1,18,84,TWrex-cause,803836,423  Blastomycosis  >     Treatment of Blastomycosis  IV:  Conventional amphotericin B: 0.5-1 mg/kg daily,blastomycosis,amphotericin
725373142,5/24/2015 20:34:54,1642762827,5/24/2015 20:34:40,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,108,41,,,120,44,SPLENOMEGALY,CML,"SPLENOMEGALY,",108,41,CML,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",108,41,108,41,1,120,44,TWrex-cause,812709,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone",splenomegaly,CML
725373142,5/24/2015 21:00:38,1642771046,5/24/2015 21:00:24,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,108,41,,,120,44,SPLENOMEGALY,CML,"SPLENOMEGALY,",108,41,CML,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",108,41,108,41,1,120,44,TWrex-cause,812709,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone",splenomegaly,CML
725373142,5/24/2015 21:00:52,1642771092,5/24/2015 21:00:35,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,108,41,,,120,44,SPLENOMEGALY,CML,"SPLENOMEGALY,",108,41,CML,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",108,41,108,41,1,120,44,TWrex-cause,812709,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone",splenomegaly,CML
725373142,5/24/2015 21:13:54,1642775532,5/24/2015 21:13:42,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,108,41,,,120,44,SPLENOMEGALY,CML,"SPLENOMEGALY,",108,41,CML,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",108,41,108,41,1,120,44,TWrex-cause,812709,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone",splenomegaly,CML
725373142,5/24/2015 21:14:16,1642775621,5/24/2015 21:14:02,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,108,41,,,120,44,SPLENOMEGALY,CML,"hyperproliferation, extramedullary hematopoiesis, SPLENOMEGALY, and cytokine release",58-78-93-108-122-126-135,14-29-38-41-45-53-58,"constitutional symptoms in CML reflect cell hyperproliferation,","• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",108,41,108,41,1,120,44,TWrex-cause,812709,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone",splenomegaly,CML
725373142,5/24/2015 21:24:50,1642778716,5/24/2015 21:23:57,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,108,41,,,120,44,SPLENOMEGALY,CML,"SPLENOMEGALY,",108,41,CML,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",108,41,108,41,1,120,44,TWrex-cause,812709,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone",splenomegaly,CML
725373142,5/24/2015 21:26:57,1642779349,5/24/2015 21:26:33,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,108,41,,,120,44,SPLENOMEGALY,CML,"SPLENOMEGALY,",108,41,CML,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",108,41,108,41,1,120,44,TWrex-cause,812709,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone",splenomegaly,CML
725373142,5/24/2015 21:27:34,1642779504,5/24/2015 21:27:23,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,108,41,,,120,44,SPLENOMEGALY,CML,"SPLENOMEGALY,",108,41,CML,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",108,41,108,41,1,120,44,TWrex-cause,812709,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone",splenomegaly,CML
725373142,5/24/2015 21:47:46,1642785707,5/24/2015 21:46:45,false,neodev,1,17426565,CAN,BC,Burnaby,70.79.18.187,108,41,,,120,44,SPLENOMEGALY,CML,"SPLENOMEGALY,",108,41,CML,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",108,41,108,41,1,120,44,TWrex-cause,812709,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone",splenomegaly,CML
725373142,5/24/2015 21:58:48,1642789114,5/24/2015 21:57:48,false,neodev,1,31670127,USA,FL,Key West,162.233.108.112,108,41,,,120,44,SPLENOMEGALY,CML,"SPLENOMEGALY,",108,41,CML,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone.",108,41,108,41,1,120,44,TWrex-cause,812709,"• Systemic or constitutional symptoms in CML reflect cell hyperproliferation, extramedullary hematopoiesis, splenomegaly, and cytokine release or bone marrow failure due to the expansion of the neoplastic clone",splenomegaly,CML
725373143,5/24/2015 18:54:17,1642720671,5/24/2015 18:53:57,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,58,100,,,66,121,HEADACHE,TENSION TYPE HEADACHE,primary HEADACHE,50-58,100-108-113,TENSION TYPE HEADACHE.,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache.,58,100 108 113,58,100,1,66,121,TWrex-cause,814009,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache,headache,tension type headache
725373143,5/24/2015 18:55:11,1642721112,5/24/2015 18:54:52,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,58,100,,,66,121,HEADACHE,TENSION TYPE HEADACHE,HEADACHE,58,100-108-113,TENSION TYPE HEADACHE.,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache.,58,100 108 113,58,100,1,66,121,TWrex-cause,814009,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache,headache,tension type headache
725373143,5/24/2015 18:55:15,1642721155,5/24/2015 18:54:52,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,58,100,,,66,121,HEADACHE,TENSION TYPE HEADACHE,HEADACHE,58,100-108-113,TENSION TYPE HEADACHE.,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache.,58,100 108 113,58,100,1,66,121,TWrex-cause,814009,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache,headache,tension type headache
725373143,5/24/2015 18:56:09,1642721557,5/24/2015 18:55:50,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,58,100,,,66,121,HEADACHE,TENSION TYPE HEADACHE,HEADACHE,58,100-108-113,TENSION TYPE HEADACHE.,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache.,58,100 108 113,58,100,1,66,121,TWrex-cause,814009,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache,headache,tension type headache
725373143,5/24/2015 18:56:47,1642721822,5/24/2015 18:56:24,false,neodev,1,32456300,USA,CA,Laguna Niguel,216.177.129.227,58,100,,,66,121,HEADACHE,TENSION TYPE HEADACHE,patients with primary HEADACHE may have coexistent,36-45-50-58-67-71-76,76-87-96-100-108-113,coexistent migraine and TENSION TYPE HEADACHE.,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache.,58,100 108 113,58,100,1,66,121,TWrex-cause,814009,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache,headache,tension type headache
725373143,5/24/2015 18:58:31,1642722709,5/24/2015 18:58:04,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,58,100,,,66,121,HEADACHE,TENSION TYPE HEADACHE,primary HEADACHE,50-58,100-108-113,TENSION TYPE HEADACHE.,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache.,58,100 108 113,58,100,1,66,121,TWrex-cause,814009,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache,headache,tension type headache
725373143,5/24/2015 19:00:57,1642723841,5/24/2015 19:00:26,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,58,100,,,66,121,HEADACHE,TENSION TYPE HEADACHE,patients with primary HEADACHE may have coexistent,36-45-50-58-67-71-76,76-87-96-100-108-113,coexistent migraine and TENSION TYPE HEADACHE.,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache.,58,100 108 113,58,100,1,66,121,TWrex-cause,814009,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache,headache,tension type headache
725373143,5/24/2015 19:08:32,1642727447,5/24/2015 19:08:23,false,instagc,1,22535866,GBR,M2,Solihull,80.195.193.86,58,100,,,66,121,HEADACHE,TENSION TYPE HEADACHE,primary HEADACHE migraine,50-58-87,76-87-100-108-113,coexistent migraine TENSION TYPE HEADACHE.,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache.,58,100 108 113,58,100,1,66,121,TWrex-cause,814009,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache,headache,tension type headache
725373143,5/24/2015 19:15:01,1642730204,5/24/2015 19:14:52,false,bitcoinget,1,21614812,USA,NJ,Burlington,50.153.125.0,58,100,,,66,121,HEADACHE,TENSION TYPE HEADACHE,primary HEADACHE,50-58,100-108-113,TENSION TYPE HEADACHE.,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache.,58,100 108 113,58,100,1,66,121,TWrex-cause,814009,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache,headache,tension type headache
725373143,5/24/2015 19:17:02,1642731300,5/24/2015 19:15:41,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,58,100,,,66,121,HEADACHE,TENSION TYPE HEADACHE,primary HEADACHE,50-58,100-108-113,TENSION TYPE HEADACHE.,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache.,58,100 108 113,58,100,1,66,121,TWrex-cause,814009,Comments: • A significant number of patients with primary headache may have coexistent migraine and tension-type headache,headache,tension type headache
725373144,5/24/2015 19:58:13,1642753417,5/24/2015 19:58:01,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,119,89,,,131,100,OSTEOPOROSIS,ALENDRONATE,OSTEOPOROSIS.,119,89,ALENDRONATE,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.",119,89,119,89,-1,131,100,TWrex-cause,803474,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis",osteoporosis,alendronate
725373144,5/24/2015 20:27:34,1642760829,5/24/2015 20:27:17,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,119,89,,,131,100,OSTEOPOROSIS,ALENDRONATE,postmenopausal OSTEOPOROSIS.,104-119,84-89,oral ALENDRONATE,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.",119,89,119,89,-1,131,100,TWrex-cause,803474,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis",osteoporosis,alendronate
725373144,5/24/2015 20:31:53,1642762118,5/24/2015 20:31:41,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,119,89,,,131,100,OSTEOPOROSIS,ALENDRONATE,OSTEOPOROSIS.,119,89,ALENDRONATE,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.",119,89,119,89,-1,131,100,TWrex-cause,803474,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis",osteoporosis,alendronate
725373144,5/24/2015 20:33:16,1642762443,5/24/2015 20:32:57,false,instagc,1,19740138,CAN,,,50.69.96.237,119,89,,,131,100,OSTEOPOROSIS,ALENDRONATE,OSTEOPOROSIS.,119,89,ALENDRONATE,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.",119,89,119,89,-1,131,100,TWrex-cause,803474,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis",osteoporosis,alendronate
725373144,5/24/2015 20:56:17,1642769555,5/24/2015 20:55:52,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,119,89,,,131,100,OSTEOPOROSIS,ALENDRONATE,Long term effects treatment oral alendronate postmenopausal OSTEOPOROSIS.,39-44-49-62-84-89-104-119,39-44-49-62-84-89-104-119,Long term effects treatment oral ALENDRONATE postmenopausal osteoporosis.,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.",119,89,119,89,-1,131,100,TWrex-cause,803474,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis",osteoporosis,alendronate
725373144,5/24/2015 20:58:20,1642770187,5/24/2015 20:58:09,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,119,89,,,131,100,OSTEOPOROSIS,ALENDRONATE,OSTEOPOROSIS.,119,89,ALENDRONATE,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.",119,89,119,89,-1,131,100,TWrex-cause,803474,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis",osteoporosis,alendronate
725373144,5/24/2015 20:58:23,1642770210,5/24/2015 20:58:10,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,119,89,,,131,100,OSTEOPOROSIS,ALENDRONATE,OSTEOPOROSIS.,119,89,ALENDRONATE,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.",119,89,119,89,-1,131,100,TWrex-cause,803474,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis",osteoporosis,alendronate
725373144,5/24/2015 20:58:59,1642770375,5/24/2015 20:58:47,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,119,89,,,131,100,OSTEOPOROSIS,ALENDRONATE,OSTEOPOROSIS.,119,89-104-119,ALENDRONATE postmenopausal osteoporosis.,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.",119,89,119,89,-1,131,100,TWrex-cause,803474,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis",osteoporosis,alendronate
725373144,5/24/2015 21:05:04,1642772624,5/24/2015 21:04:21,false,neodev,1,17426565,CAN,BC,Burnaby,70.79.18.187,119,89,,,131,100,OSTEOPOROSIS,ALENDRONATE,postmenopausal OSTEOPOROSIS.,104-119,84-89,oral ALENDRONATE,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.",119,89,119,89,-1,131,100,TWrex-cause,803474,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis",osteoporosis,alendronate
725373144,5/24/2015 21:07:52,1642773660,5/24/2015 21:06:14,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,119,89,,,131,100,OSTEOPOROSIS,ALENDRONATE,postmenopausal OSTEOPOROSIS.,104-119,84-89,oral ALENDRONATE,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.",119,89,119,89,-1,131,100,TWrex-cause,803474,"Rossini M, Gatti D, Zamberlan N et al. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis",osteoporosis,alendronate
725373145,5/24/2015 19:57:59,1642753389,5/24/2015 19:57:45,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,125,167,,,134,183,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHES,",125,167,PHEOCHROMOCYTOMA,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare.",125,167,125,167,1,134,183,TWrex-cause,812717,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare",headache,pheochromocytoma
725373145,5/24/2015 20:27:16,1642760753,5/24/2015 20:27:01,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,125,167,,,134,183,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHES,",125,167,PHEOCHROMOCYTOMA,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare.",125,167,125,167,1,134,183,TWrex-cause,812717,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare",headache,pheochromocytoma
725373145,5/24/2015 20:31:35,1642762024,5/24/2015 20:30:59,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,125,167,,,134,183,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHES,",125,167,PHEOCHROMOCYTOMA,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare.",125,167,125,167,1,134,183,TWrex-cause,812717,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare",headache,pheochromocytoma
725373145,5/24/2015 20:32:55,1642762342,5/24/2015 20:32:42,false,instagc,1,19740138,CAN,,,50.69.96.237,125,167,,,134,183,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHES,",125,167-154,diaphoresis PHEOCHROMOCYTOMA,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare.",125,167,125,167,1,134,183,TWrex-cause,812717,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare",headache,pheochromocytoma
725373145,5/24/2015 20:55:50,1642769433,5/24/2015 20:55:12,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,125,167,,,134,183,HEADACHE,PHEOCHROMOCYTOMA,"mental status tvml Pheochromocytomatvml Adrenergic symptoms blood pressure, HEADACHES, palpitations, diaphoresis Pheochromocytoma",33-40-47-52-75-86-109-115-125-136-154-167,33-40-47-52-75-86-109-115-125-136-154-167,"mental status tvml Pheochromocytomatvml Adrenergic symptoms blood pressure, headaches, palpitations, diaphoresis PHEOCHROMOCYTOMA","Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare.",125,167,125,167,1,134,183,TWrex-cause,812717,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare",headache,pheochromocytoma
725373145,5/24/2015 20:58:04,1642770086,5/24/2015 20:57:47,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,125,167,,,134,183,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHES,",125,167,PHEOCHROMOCYTOMA,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare.",125,167,125,167,1,134,183,TWrex-cause,812717,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare",headache,pheochromocytoma
725373145,5/24/2015 20:58:06,1642770104,5/24/2015 20:57:37,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,125,167,,,134,183,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHES,",125,154-167,diaphoresis PHEOCHROMOCYTOMA,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare.",125,167,125,167,1,134,183,TWrex-cause,812717,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare",headache,pheochromocytoma
725373145,5/24/2015 20:58:46,1642770307,5/24/2015 20:58:33,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,125,167,,,134,183,HEADACHE,PHEOCHROMOCYTOMA,"blood pressure, HEADACHES, palpitations, and diaphoresis",115-125-136-150-154-109,136-150-154-167,"palpitations, and diaphoresis PHEOCHROMOCYTOMA","Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare.",125,167,125,167,1,134,183,TWrex-cause,812717,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare",headache,pheochromocytoma
725373145,5/24/2015 21:04:20,1642772378,5/24/2015 21:02:35,false,neodev,1,17426565,CAN,BC,Burnaby,70.79.18.187,125,167,,,134,183,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHES,",125,150-154-167,and diaphoresis PHEOCHROMOCYTOMA,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare.",125,167,125,167,1,134,183,TWrex-cause,812717,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare",headache,pheochromocytoma
725373145,5/24/2015 21:06:12,1642773130,5/24/2015 21:05:49,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,125,167,,,134,183,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHES,",125,154-167,diaphoresis PHEOCHROMOCYTOMA,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare.",125,167,125,167,1,134,183,TWrex-cause,812717,"Usually accompanied by change in mental status tvml Pheochromocytomatvml   Adrenergic symptoms with elevated blood pressure, headaches, palpitations, and diaphoresis  Pheochromocytoma is rare",headache,pheochromocytoma
725373146,5/24/2015 18:57:48,1642722362,5/24/2015 18:57:28,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,101,73,,,108,77,MYCOSIS,ALFA,MYCOSIS fungoides.,101-109,40-52-62-73-78,Recombinant leukocyte interferon ALFA 2A,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides.",101,73,101,73,-1,108,77,TWrex-cause,803372,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides",mycosis,alfa
725373146,5/24/2015 18:57:56,1642722441,5/24/2015 18:57:36,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,101,73,,,108,77,MYCOSIS,ALFA,MYCOSIS,101,73,ALFA,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides.",101,73,101,73,-1,108,77,TWrex-cause,803372,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides",mycosis,alfa
725373146,5/24/2015 18:59:59,1642723379,5/24/2015 18:59:35,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,101,73,,,108,77,MYCOSIS,ALFA,MYCOSIS fungoides.,101-109,52-62-73-78,leukocyte interferon ALFA 2A,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides.",101,73,101,73,-1,108,77,TWrex-cause,803372,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides",mycosis,alfa
725373146,5/24/2015 19:00:17,1642723524,5/24/2015 18:59:56,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,101,73,,,108,77,MYCOSIS,ALFA,MYCOSIS fungoides.,101-109,73-78,ALFA 2A,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides.",101,73,101,73,-1,108,77,TWrex-cause,803372,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides",mycosis,alfa
725373146,5/24/2015 19:00:30,1642723626,5/24/2015 18:59:54,false,neodev,1,32456300,USA,CA,Laguna Niguel,216.177.129.227,101,73,,,108,77,MYCOSIS,ALFA,the treatment of MYCOSIS fungoides.,84-88-98-101-109,40-52-62-73-78-81-84,Recombinant leukocyte interferon ALFA 2A in the,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides.",101,73,101,73,-1,108,77,TWrex-cause,803372,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides",mycosis,alfa
725373146,5/24/2015 19:06:00,1642726323,5/24/2015 19:04:56,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,101,73,,,108,77,MYCOSIS,ALFA,MYCOSIS fungoides.,101-109,40-52-62-73-78,Recombinant leukocyte interferon ALFA 2A,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides.",101,73,101,73,-1,108,77,TWrex-cause,803372,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides",mycosis,alfa
725373146,5/24/2015 19:19:45,1642734443,5/24/2015 19:19:31,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,101,73,,,108,77,MYCOSIS,ALFA,MYCOSIS fungoides.,101-109,40-52-62-73-78,Recombinant leukocyte interferon ALFA 2A,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides.",101,73,101,73,-1,108,77,TWrex-cause,803372,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides",mycosis,alfa
725373146,5/24/2015 19:24:40,1642740298,5/24/2015 19:24:26,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,101,73,,,108,77,MYCOSIS,ALFA,MYCOSIS,101,73,ALFA,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides.",101,73,101,73,-1,108,77,TWrex-cause,803372,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides",mycosis,alfa
725373146,5/24/2015 19:25:02,1642740446,5/24/2015 19:24:46,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,101,73,,,108,77,MYCOSIS,ALFA,MYCOSIS fungoides.,101-109,52-62-73-78,leukocyte interferon ALFA 2A,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides.",101,73,101,73,-1,108,77,TWrex-cause,803372,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides",mycosis,alfa
725373146,5/24/2015 19:26:04,1642740908,5/24/2015 19:25:12,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,101,73,,,108,77,MYCOSIS,ALFA,MYCOSIS fungoides.,101-109,40-52-62-73-78,Recombinant leukocyte interferon ALFA 2A,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides.",101,73,101,73,-1,108,77,TWrex-cause,803372,"Simoni R, Cavalieri R, Coppola G et al. Recombinant leukocyte interferon alfa-2A in the treatment of mycosis fungoides",mycosis,alfa
725373147,5/24/2015 19:00:25,1642723583,5/24/2015 18:59:46,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,85,60,,,96,70,NEPHROPATHY,ANALGESIC,NEPHROPATHY:,85,60,ANALGESICS,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.",85,60,85,60,1,96,70,TWrex-cause,810496,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study",nephropathy,analgesic
725373147,5/24/2015 19:00:52,1642723815,5/24/2015 19:00:26,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,85,60,,,96,70,NEPHROPATHY,ANALGESIC,analgesic NEPHROPATHY:,75-85,46-60,Nonphenacetin ANALGESICS,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.",85,60,85,60,1,96,70,TWrex-cause,810496,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study",nephropathy,analgesic
725373147,5/24/2015 19:02:18,1642724433,5/24/2015 19:02:02,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,85,60,,,96,70,NEPHROPATHY,ANALGESIC,NEPHROPATHY:,85,60,ANALGESICS,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.",85,60,85,60,1,96,70,TWrex-cause,810496,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study",nephropathy,analgesic
725373147,5/24/2015 19:02:18,1642724434,5/24/2015 19:01:57,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,85,60,,,96,70,NEPHROPATHY,ANALGESIC,analgesics and analgesic NEPHROPATHY:,60-71-75-85,46-60,Nonphenacetin ANALGESICS,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.",85,60,85,60,1,96,70,TWrex-cause,810496,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study",nephropathy,analgesic
725373147,5/24/2015 19:10:29,1642728311,5/24/2015 19:09:50,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,85,60,,,96,70,NEPHROPATHY,ANALGESIC,analgesic NEPHROPATHY:,75-85,46-60,Nonphenacetin ANALGESICS,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.",85,60,85,60,1,96,70,TWrex-cause,810496,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study",nephropathy,analgesic
725373147,5/24/2015 19:21:34,1642736982,5/24/2015 19:21:16,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,85,60,,,96,70,NEPHROPATHY,ANALGESIC,analgesic NEPHROPATHY:,75-85,46-60,Nonphenacetin ANALGESICS,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.",85,60,85,60,1,96,70,TWrex-cause,810496,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study",nephropathy,analgesic
725373147,5/24/2015 19:26:40,1642741159,5/24/2015 19:26:25,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,85,60,,,96,70,NEPHROPATHY,ANALGESIC,analgesic NEPHROPATHY:,75-85,46-60,Nonphenacetin ANALGESICS,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.",85,60,85,60,1,96,70,TWrex-cause,810496,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study",nephropathy,analgesic
725373147,5/24/2015 19:29:21,1642742650,5/24/2015 19:28:06,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,85,60,,,96,70,NEPHROPATHY,ANALGESIC,analgesic NEPHROPATHY:,75-85,46-60,Nonphenacetin ANALGESICS,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.",85,60,85,60,1,96,70,TWrex-cause,810496,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study",nephropathy,analgesic
725373147,5/24/2015 19:30:53,1642743440,5/24/2015 19:29:58,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,85,60,,,96,70,NEPHROPATHY,ANALGESIC,analgesics and analgesic NEPHROPATHY:,60-71-75-85,46-60-71-75-85,Nonphenacetin ANALGESICS and analgesic nephropathy:,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.",85,60,85,60,1,96,70,TWrex-cause,810496,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study",nephropathy,analgesic
725373147,5/24/2015 19:33:53,1642744927,5/24/2015 19:33:35,false,clixsense,1,6417722,USA,MI,Taylor,99.170.106.105,85,60,,,96,70,NEPHROPATHY,ANALGESIC,analgesics and analgesic NEPHROPATHY:,60-71-75-85,46-60-71-75-85,Nonphenacetin ANALGESICS and analgesic nephropathy:,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.",85,60,85,60,1,96,70,TWrex-cause,810496,"Michielsen P, Heinemann L, Mihatsch M, et al. Nonphenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study",nephropathy,analgesic
725373148,5/24/2015 21:01:32,1642771346,5/24/2015 21:01:17,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,56,111,,,61,122,JOINT,DYSFUNCTION,JOINT,56,111,DYSFUNCTION.,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction.",56,111,56,111,-1,61,122,TWrex-cause,802845,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction",joint,dysfunction
725373148,5/24/2015 21:02:03,1642771535,5/24/2015 21:01:45,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,56,111,,,61,122,JOINT,DYSFUNCTION,JOINT,56,105-111,joint DYSFUNCTION.,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction.",56,111,56,111,-1,61,122,TWrex-cause,802845,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction",joint,dysfunction
725373148,5/24/2015 21:14:42,1642775758,5/24/2015 21:14:31,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,56,111,,,61,122,JOINT,DYSFUNCTION,JOINT,56,105-111,joint DYSFUNCTION.,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction.",56,111,56,111,-1,61,122,TWrex-cause,802845,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction",joint,dysfunction
725373148,5/24/2015 21:15:09,1642775854,5/24/2015 21:14:47,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,56,111,,,61,122,JOINT,DYSFUNCTION,"temporomandibular JOINT movement,",38-56-62,97-102-105-111,pain or joint DYSFUNCTION.,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction.",56,111,56,111,-1,61,122,TWrex-cause,802845,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction",joint,dysfunction
725373148,5/24/2015 21:28:03,1642779647,5/24/2015 21:26:51,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,56,111,,,61,122,JOINT,DYSFUNCTION,"temporomandibular JOINT movement,",38-56-62,105-111,joint DYSFUNCTION.,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction.",56,111,56,111,-1,61,122,TWrex-cause,802845,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction",joint,dysfunction
725373148,5/24/2015 21:28:08,1642779672,5/24/2015 21:27:49,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,56,111,,,61,122,JOINT,DYSFUNCTION,"temporomandibular JOINT movement,",38-56-62,105-111,joint DYSFUNCTION.,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction.",56,111,56,111,-1,61,122,TWrex-cause,802845,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction",joint,dysfunction
725373148,5/24/2015 21:28:17,1642779716,5/24/2015 21:28:04,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,56,111,,,61,122,JOINT,DYSFUNCTION,"temporomandibular JOINT movement,",38-56-62,105-111,joint DYSFUNCTION.,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction.",56,111,56,111,-1,61,122,TWrex-cause,802845,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction",joint,dysfunction
725373148,5/24/2015 22:00:10,1642789629,5/24/2015 21:59:49,false,neodev,1,31670127,USA,FL,Key West,162.233.108.112,56,111,,,61,122,JOINT,DYSFUNCTION,"temporomandibular JOINT movement,",38-56-62,105-111,joint DYSFUNCTION.,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction.",56,111,56,111,-1,61,122,TWrex-cause,802845,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction",joint,dysfunction
725373148,5/24/2015 22:04:05,1642790636,5/24/2015 22:03:41,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,56,111,,,61,122,JOINT,DYSFUNCTION,"temporomandibular JOINT movement,",38-56-62,111-105,joint DYSFUNCTION.,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction.",56,111,56,111,-1,61,122,TWrex-cause,802845,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction",joint,dysfunction
725373148,5/24/2015 22:08:48,1642792234,5/24/2015 22:08:00,false,neodev,1,24628757,CAN,,,107.179.231.99,56,111,,,61,122,JOINT,DYSFUNCTION,temporomandibular JOINT pain or joint dysfunction.,38-56-97-102-111-105,38-97-102-105-111-56,temporomandibular joint pain or joint DYSFUNCTION.,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction.",56,111,56,111,-1,61,122,TWrex-cause,802845,"In dentistry, a noise associated with temporomandibular joint movement, sometimes accompanied by pain or joint dysfunction",joint,dysfunction
725373149,5/24/2015 23:05:53,1642810873,5/24/2015 23:04:58,false,points4rewards,1,28703583,USA,,,97.73.85.52,146,171,,,150,183,BONE,OSTEOMALACIA,BONE osteomalacia.,146-171,51-164-171-57,"renal failure, severe OSTEOMALACIA.","Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia.",146,171,146,171,-1,150,183,TWrex-cause,802592,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia",bone,osteomalacia
725373149,5/24/2015 23:06:16,1642810946,5/24/2015 23:06:00,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,146,171,,,150,183,BONE,OSTEOMALACIA,BONE,146,164-171,severe OSTEOMALACIA.,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia.",146,171,146,171,-1,150,183,TWrex-cause,802592,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia",bone,osteomalacia
725373149,5/24/2015 23:10:18,1642812078,5/24/2015 23:09:30,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,146,171,,,150,183,BONE,OSTEOMALACIA,BONE,146,164-171,severe OSTEOMALACIA.,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia.",146,171,146,171,-1,150,183,TWrex-cause,802592,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia",bone,osteomalacia
725373149,5/24/2015 23:23:11,1642815396,5/24/2015 23:22:11,false,bitcoinget,1,28503763,USA,CA,San Francisco,107.217.186.64,146,171,,,150,183,BONE,OSTEOMALACIA,BONE,146,171,OSTEOMALACIA.,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia.",146,171,146,171,-1,150,183,TWrex-cause,802592,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia",bone,osteomalacia
725373149,5/24/2015 23:23:57,1642815533,5/24/2015 23:23:18,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,146,171,,,150,183,BONE,OSTEOMALACIA,prevent accumulation in BONE resulting in severe osteomalacia.,122-130-143-146-151-161-164-171,0-9-20-30-37-40-48-51-57-151-161-164-171,"Aluminum containing compounds should be avoided in renal failure, resulting in severe OSTEOMALACIA.","Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia.",146,171,146,171,-1,150,183,TWrex-cause,802592,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia",bone,osteomalacia
725373149,5/24/2015 23:56:39,1642824193,5/24/2015 23:56:26,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,146,171,,,150,183,BONE,OSTEOMALACIA,BONE,146,164-171,severe OSTEOMALACIA.,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia.",146,171,146,171,-1,150,183,TWrex-cause,802592,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia",bone,osteomalacia
725373149,5/24/2015 23:58:01,1642824619,5/24/2015 23:57:29,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,146,171,,,150,183,BONE,OSTEOMALACIA,BONE,146,164-171,severe OSTEOMALACIA.,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia.",146,171,146,171,-1,150,183,TWrex-cause,802592,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia",bone,osteomalacia
725373149,5/25/2015 00:26:29,1642833797,5/25/2015 00:26:10,false,elite,1,32173500,GBR,E4,Rayleigh,90.219.97.221,146,171,,,150,183,BONE,OSTEOMALACIA,accumulation in BONE,130-143-146,164-171,severe OSTEOMALACIA.,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia.",146,171,146,171,-1,150,183,TWrex-cause,802592,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia",bone,osteomalacia
725373149,5/25/2015 00:31:43,1642835225,5/25/2015 00:31:30,false,clixsense,1,21933552,CAN,ON,Ottawa,70.49.14.161,146,171,,,150,183,BONE,OSTEOMALACIA,BONE,146,171,OSTEOMALACIA.,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia.",146,171,146,171,-1,150,183,TWrex-cause,802592,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia",bone,osteomalacia
725373149,5/25/2015 00:38:41,1642837466,5/25/2015 00:38:25,false,memolink,1,6556053,USA,IL,Zion,76.245.204.32,146,171,,,150,183,BONE,OSTEOMALACIA,BONE,146,171,OSTEOMALACIA.,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia.",146,171,146,171,-1,150,183,TWrex-cause,802592,"Aluminum-containing compounds should be avoided in renal failure, especially in patients receiving long-term dialysis, to prevent accumulation in bone resulting in severe osteomalacia",bone,osteomalacia
725373150,5/24/2015 19:03:40,1642725127,5/24/2015 19:03:23,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,9,79,,,21,87,KETOACIDOSIS,DIABETES,KETOACIDOSIS,9,79,DIABETES.,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes.,9,79,9,79,1,21,87,TWrex-cause,812090,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes,ketoacidosis,diabetes
725373150,5/24/2015 19:05:09,1642725933,5/24/2015 19:04:47,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,9,79,,,21,87,KETOACIDOSIS,DIABETES,Diabetic KETOACIDOSIS,0-9,79,DIABETES.,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes.,9,79,9,79,1,21,87,TWrex-cause,812090,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes,ketoacidosis,diabetes
725373150,5/24/2015 19:06:33,1642726539,5/24/2015 19:05:51,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,9,79,,,21,87,KETOACIDOSIS,DIABETES,Diabetic KETOACIDOSIS,0-9,79,DIABETES.,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes.,9,79,9,79,1,21,87,TWrex-cause,812090,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes,ketoacidosis,diabetes
725373150,5/24/2015 19:18:16,1642732553,5/24/2015 19:17:44,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,9,79,,,21,87,KETOACIDOSIS,DIABETES,Diabetic KETOACIDOSIS,0-9,79,DIABETES.,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes.,9,79,9,79,1,21,87,TWrex-cause,812090,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes,ketoacidosis,diabetes
725373150,5/24/2015 19:25:20,1642740532,5/24/2015 19:25:07,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,9,79,,,21,87,KETOACIDOSIS,DIABETES,Diabetic KETOACIDOSIS,0-9,79,DIABETES.,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes.,9,79,9,79,1,21,87,TWrex-cause,812090,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes,ketoacidosis,diabetes
725373150,5/24/2015 19:38:35,1642747032,5/24/2015 19:38:15,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,9,79,,,21,87,KETOACIDOSIS,DIABETES,Diabetic KETOACIDOSIS,0-9,55-66-79,previously unrecognized DIABETES.,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes.,9,79,9,79,1,21,87,TWrex-cause,812090,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes,ketoacidosis,diabetes
725373150,5/24/2015 19:38:44,1642747092,5/24/2015 19:38:30,false,clixsense,1,31482589,NLD,,,31.201.11.16,9,79,,,21,87,KETOACIDOSIS,DIABETES,Diabetic KETOACIDOSIS,0-9,66-79,unrecognized DIABETES.,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes.,9,79,9,79,1,21,87,TWrex-cause,812090,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes,ketoacidosis,diabetes
725373150,5/24/2015 19:39:09,1642747185,5/24/2015 19:39:01,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,9,79,,,21,87,KETOACIDOSIS,DIABETES,Diabetic KETOACIDOSIS,0-9,79,DIABETES.,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes.,9,79,9,79,1,21,87,TWrex-cause,812090,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes,ketoacidosis,diabetes
725373150,5/24/2015 19:41:04,1642747950,5/24/2015 19:40:04,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,9,79,,,21,87,KETOACIDOSIS,DIABETES,Diabetic KETOACIDOSIS,0-9,79,DIABETES.,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes.,9,79,9,79,1,21,87,TWrex-cause,812090,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes,ketoacidosis,diabetes
725373150,5/24/2015 19:41:10,1642747983,5/24/2015 19:39:35,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,9,79,,,21,87,KETOACIDOSIS,DIABETES,Diabetic KETOACIDOSIS,0-9,79,DIABETES.,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes.,9,79,9,79,1,21,87,TWrex-cause,812090,Diabetic ketoacidosis may be the presenting feature of previously unrecognized diabetes,ketoacidosis,diabetes
725373151,5/24/2015 23:06:34,1642811090,5/24/2015 23:05:58,false,points4rewards,1,28703583,USA,,,97.73.85.52,51,142,,,59,147,SHINGLE,VIRUS,SHINGLES neuralgia,51-77,51-125-135-142,Shingles varicella zoster VIRUS,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion.,51,142,51,142,1,59,147,TWrex-cause,811528,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion,shingle,virus
725373151,5/24/2015 23:06:45,1642811145,5/24/2015 23:06:17,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,51,142,,,59,147,SHINGLE,VIRUS,Neuropathic Pain Syndromes SHINGLES,23-35-40-51,125-135-142,varicella zoster VIRUS,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion.,51,142,51,142,1,59,147,TWrex-cause,811528,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion,shingle,virus
725373151,5/24/2015 23:11:42,1642812382,5/24/2015 23:10:19,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,51,142,,,59,147,SHINGLE,VIRUS,Neuropathic Pain Syndromes SHINGLES,23-35-40-51,125-135-142,varicella zoster VIRUS,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion.,51,142,51,142,1,59,147,TWrex-cause,811528,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion,shingle,virus
725373151,5/24/2015 23:24:16,1642815584,5/24/2015 23:23:12,false,bitcoinget,1,28503763,USA,CA,San Francisco,107.217.186.64,51,142,,,59,147,SHINGLE,VIRUS,SHINGLES,51,125-135-142,varicella zoster VIRUS,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion.,51,142,51,142,1,59,147,TWrex-cause,811528,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion,shingle,virus
725373151,5/24/2015 23:24:32,1642815666,5/24/2015 23:23:58,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,51,142,,,59,147,SHINGLE,VIRUS,Neuropathic Pain Syndromes SHINGLES and postherpetic neuralgia,23-35-40-51-60-64-77,99-106-109-122-125-135-142,caused by reactivation of varicella zoster VIRUS,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion.,51,142,51,142,1,59,147,TWrex-cause,811528,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion,shingle,virus
725373151,5/24/2015 23:56:57,1642824250,5/24/2015 23:56:40,false,neodev,1,30940715,USA,IL,Lisle,50.247.189.225,51,142,,,59,147,SHINGLE,VIRUS,SHINGLES,51,125-135-142,varicella zoster VIRUS,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion.,51,142,51,142,1,59,147,TWrex-cause,811528,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion,shingle,virus
725373151,5/25/2015 00:26:48,1642833896,5/25/2015 00:26:30,false,elite,1,32173500,GBR,E4,Rayleigh,90.219.97.221,51,142,,,59,147,SHINGLE,VIRUS,SHINGLES,51,125-135-142,varicella zoster VIRUS,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion.,51,142,51,142,1,59,147,TWrex-cause,811528,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion,shingle,virus
725373151,5/25/2015 00:31:58,1642835329,5/25/2015 00:31:44,false,clixsense,1,21933552,CAN,ON,Ottawa,70.49.14.161,51,142,,,59,147,SHINGLE,VIRUS,SHINGLES,51,125-135-142,varicella zoster VIRUS,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion.,51,142,51,142,1,59,147,TWrex-cause,811528,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion,shingle,virus
725373151,5/25/2015 00:38:55,1642837527,5/25/2015 00:38:30,false,instagc,1,15285653,USA,,,172.164.27.59,51,142,,,59,147,SHINGLE,VIRUS,SHINGLES postherpetic neuralgia,51-64-77,51-64-142-77,Shingles postherpetic neuralgia VIRUS,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion.,51,142,51,142,1,59,147,TWrex-cause,811528,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion,shingle,virus
725373151,5/25/2015 00:38:58,1642837545,5/25/2015 00:38:42,false,memolink,1,6556053,USA,IL,Zion,76.245.204.32,51,142,,,59,147,SHINGLE,VIRUS,SHINGLES,51,125-135-142,varicella zoster VIRUS,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion.,51,142,51,142,1,59,147,TWrex-cause,811528,46  Focal and Regional Neuropathic Pain Syndromes  Shingles and postherpetic neuralgia (PHN)   are caused by reactivation of varicella-zoster virus (VZV) in a sensory ganglion,shingle,virus
725373152,5/24/2015 19:54:48,1642752376,5/24/2015 19:54:33,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,56,17,,,60,20,PAIN,FMS,Pain,59,18,FMS,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,,,56,17,1,60,20,TWrex-cause,813391,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,pain,FMS
725373152,5/24/2015 19:56:11,1642752841,5/24/2015 19:55:49,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,56,17,,,60,20,PAIN,FMS,Pain,59,18,FMS,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,,,56,17,1,60,20,TWrex-cause,813391,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,pain,FMS
725373152,5/24/2015 19:56:18,1642752883,5/24/2015 19:55:55,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,56,17,,,60,20,PAIN,FMS,Pain,59,18,FMS,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,,,56,17,1,60,20,TWrex-cause,813391,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,pain,FMS
725373152,5/24/2015 20:09:43,1642756467,5/24/2015 20:09:01,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,56,17,,,60,20,PAIN,FMS,• Emphasize that FMS does not 'kill or cripple' but tHE Pain is real and not imaginary.,3-13-18-22-27-31-38-41-51-55-59-64-67-72-76-80-0,3-13-18-22-27-31-38-41-51-55-59-64-67-72-76-80-0,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary.,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,,,56,17,1,60,20,TWrex-cause,813391,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,pain,FMS
725373152,5/24/2015 20:25:33,1642760321,5/24/2015 20:25:20,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,56,17,,,60,20,PAIN,FMS,Pain,59,0-18,• FMS,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,,,56,17,1,60,20,TWrex-cause,813391,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,pain,FMS
725373152,5/24/2015 20:29:32,1642761549,5/24/2015 20:29:14,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,56,17,,,60,20,PAIN,FMS,Pain,59,18,FMS,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,,,56,17,1,60,20,TWrex-cause,813391,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,pain,FMS
725373152,5/24/2015 20:29:40,1642761632,5/24/2015 20:29:16,false,instagc,1,19740138,CAN,,,50.69.96.237,56,17,,,60,20,PAIN,FMS,Pain,59,18,FMS,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,,,56,17,1,60,20,TWrex-cause,813391,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,pain,FMS
725373152,5/24/2015 20:33:16,1642762441,5/24/2015 20:32:57,false,neodev,1,29074051,GBR,G5,Folkestone,80.6.67.18,56,17,,,60,20,PAIN,FMS,Pain,59,18,FMS,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,,,56,17,1,60,20,TWrex-cause,813391,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,pain,FMS
725373152,5/24/2015 20:52:11,1642767959,5/24/2015 20:51:35,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,56,17,,,60,20,PAIN,FMS,FMS 'kill cripple' Pain,18-41-59-31,18-41-59-31,FMS 'kill cripple' pain,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,,,56,17,1,60,20,TWrex-cause,813391,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,pain,FMS
725373152,5/24/2015 20:53:54,1642768697,5/24/2015 20:52:32,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,56,17,,,60,20,PAIN,FMS,Pain,59,18,FMS,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,,,56,17,1,60,20,TWrex-cause,813391,• Emphasize that FMS does not 'kill or cripple' but the pain is real and not imaginary,pain,FMS
725373153,5/24/2015 19:52:41,1642751617,5/24/2015 19:52:29,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,170,126,,,181,132,DYSFUNCTION,ANEMIA,DYSFUNCTION.,170,126,"ANEMIA,","Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction.",170,126,170,126,1,181,132,TWrex-cause,812859,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction",dysfunction,anemia
725373153,5/24/2015 19:53:41,1642752008,5/24/2015 19:53:28,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,170,126,,,181,132,DYSFUNCTION,ANEMIA,DYSFUNCTION.,170,126,"ANEMIA,","Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction.",170,126,170,126,1,181,132,TWrex-cause,812859,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction",dysfunction,anemia
725373153,5/24/2015 19:53:53,1642752130,5/24/2015 19:53:41,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,170,126,,,181,132,DYSFUNCTION,ANEMIA,and renal DYSFUNCTION.,164-170-160,126,"ANEMIA,","Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction.",170,126,170,126,1,181,132,TWrex-cause,812859,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction",dysfunction,anemia
725373153,5/24/2015 20:00:44,1642754061,5/24/2015 20:00:30,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,170,126,,,181,132,DYSFUNCTION,ANEMIA,renal DYSFUNCTION.,164-170,116-126,"hemolytic ANEMIA,","Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction.",170,126,170,126,1,181,132,TWrex-cause,812859,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction",dysfunction,anemia
725373153,5/24/2015 20:04:45,1642754981,5/24/2015 20:03:57,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,170,126,,,181,132,DYSFUNCTION,ANEMIA,"Diagnosis Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal DYSFUNCTION.",0-12-25-29-32-40-43-45-52-55-64-74-81-99-116-126-145-160-164-170-134,0-12-25-29-32-40-43-45-52-55-64-74-81-99-116-126-134-145-160-164-170,"Diagnosis Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic ANEMIA, neurologic abnormalities, and renal dysfunction.","Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction.",170,126,170,126,1,181,132,TWrex-cause,812859,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction",dysfunction,anemia
725373153,5/24/2015 20:13:27,1642757535,5/24/2015 20:13:14,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,170,126,,,181,132,DYSFUNCTION,ANEMIA,DYSFUNCTION.,170,126,"ANEMIA,","Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction.",170,126,170,126,1,181,132,TWrex-cause,812859,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction",dysfunction,anemia
725373153,5/24/2015 20:15:11,1642758041,5/24/2015 20:14:50,false,instagc,1,19740138,CAN,,,50.69.96.237,170,126,,,181,132,DYSFUNCTION,ANEMIA,renal DYSFUNCTION.,164-170,116-126-99,"microangiopathic hemolytic ANEMIA,","Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction.",170,126,170,126,1,181,132,TWrex-cause,812859,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction",dysfunction,anemia
725373153,5/24/2015 20:21:55,1642759474,5/24/2015 20:21:40,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,170,126,,,181,132,DYSFUNCTION,ANEMIA,renal DYSFUNCTION.,170-164,116-126,"hemolytic ANEMIA,","Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction.",170,126,170,126,1,181,132,TWrex-cause,812859,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction",dysfunction,anemia
725373153,5/24/2015 20:27:07,1642760703,5/24/2015 20:26:55,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,170,126,,,181,132,DYSFUNCTION,ANEMIA,DYSFUNCTION.,170,126,"ANEMIA,","Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction.",170,126,170,126,1,181,132,TWrex-cause,812859,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction",dysfunction,anemia
725373153,5/24/2015 20:28:06,1642761017,5/24/2015 20:27:56,false,cointasker,1,21783324,NLD,,,31.151.239.133,170,126,,,181,132,DYSFUNCTION,ANEMIA,renal DYSFUNCTION.,164-170,99-116-126,"microangiopathic hemolytic ANEMIA,","Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction.",170,126,170,126,1,181,132,TWrex-cause,812859,"Diagnosis   Classically, TTP is defined by a pentad of clinical findings: fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal dysfunction",dysfunction,anemia
725373154,5/24/2015 20:28:31,1642761209,5/24/2015 20:28:19,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,76,11,,,83,17,ANXIETY,• PTSD,"ANXIETY,",76,11-13,• PTSD,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes.",76,11 13,76,11,1,83,17,TWrex-cause,814650,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes",anxiety,• PTSD
725373154,5/24/2015 20:33:07,1642762428,5/24/2015 20:32:52,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,76,11,,,83,17,ANXIETY,• PTSD,"ANXIETY,",76,11-13,• PTSD,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes.",76,11 13,76,11,1,83,17,TWrex-cause,814650,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes",anxiety,• PTSD
725373154,5/24/2015 20:59:13,1642770479,5/24/2015 20:59:01,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,76,11,,,83,17,ANXIETY,• PTSD,"ANXIETY,",76,11-13,• PTSD,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes.",76,11 13,76,11,1,83,17,TWrex-cause,814650,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes",anxiety,• PTSD
725373154,5/24/2015 20:59:18,1642770492,5/24/2015 20:59:06,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,76,11,,,83,17,ANXIETY,• PTSD,"ANXIETY,",76,11-13,• PTSD,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes.",76,11 13,76,11,1,83,17,TWrex-cause,814650,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes",anxiety,• PTSD
725373154,5/24/2015 21:01:48,1642771452,5/24/2015 21:00:52,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,76,11,,,83,17,ANXIETY,• PTSD,"depression or ANXIETY,",62-73-76,11-13,• PTSD,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes.",76,11 13,76,11,1,83,17,TWrex-cause,814650,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes",anxiety,• PTSD
725373154,5/24/2015 21:09:49,1642774264,5/24/2015 21:09:37,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,76,11,,,83,17,ANXIETY,• PTSD,"ANXIETY,",76,11-13,• PTSD,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes.",76,11 13,76,11,1,83,17,TWrex-cause,814650,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes",anxiety,• PTSD
725373154,5/24/2015 21:12:25,1642775058,5/24/2015 21:12:08,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,76,11,,,83,17,ANXIETY,• PTSD,"ANXIETY,",76,11-13,• PTSD,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes.",76,11 13,76,11,1,83,17,TWrex-cause,814650,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes",anxiety,• PTSD
725373154,5/24/2015 21:16:31,1642776329,5/24/2015 21:14:46,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,76,11,,,83,17,ANXIETY,• PTSD,"ANXIETY,",76,11-13,• PTSD,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes.",76,11 13,76,11,1,83,17,TWrex-cause,814650,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes",anxiety,• PTSD
725373154,5/24/2015 21:23:26,1642778307,5/24/2015 21:22:12,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,76,11,,,83,17,ANXIETY,• PTSD,"ANXIETY,",76,11-13,• PTSD,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes.",76,11 13,76,11,1,83,17,TWrex-cause,814650,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes",anxiety,• PTSD
725373154,5/24/2015 21:24:26,1642778560,5/24/2015 21:24:14,false,clixsense,1,26492726,GBR,C2,Halifax,2.103.117.226,76,11,,,83,17,ANXIETY,• PTSD,"ANXIETY,",76,11-13,• PTSD,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes.",76,11 13,76,11,1,83,17,TWrex-cause,814650,"Rationale: • PTSD may be underdiagnosed in patients reporting depression or anxiety, resulting in unsatisfactory treatment outcomes",anxiety,• PTSD
725373155,5/24/2015 21:19:26,1642777192,5/24/2015 21:19:03,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,145,119,,,154,122,CONFUSION,TTP,◊ Weakness ◊ CONFUSION Severe headaches Gastrointestinal symptoms,132-134-143-145-157-164-176-193,119,TTP,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,145,119,145,119,1,154,122,TWrex-cause,813078,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding,confusion,TTP
725373155,5/24/2015 21:33:46,1642781731,5/24/2015 21:33:12,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,145,119,,,154,122,CONFUSION,TTP,CONFUSION,145,119,TTP,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,145,119,145,119,1,154,122,TWrex-cause,813078,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding,confusion,TTP
725373155,5/24/2015 21:44:08,1642784700,5/24/2015 21:43:29,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,145,119,,,154,122,CONFUSION,TTP,CONFUSION,145,109-119,recurrent TTP,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,145,119,145,119,1,154,122,TWrex-cause,813078,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding,confusion,TTP
725373155,5/24/2015 22:09:20,1642792439,5/24/2015 22:09:06,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,145,119,,,154,122,CONFUSION,TTP,CONFUSION,145,119,TTP,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,145,119,145,119,1,154,122,TWrex-cause,813078,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding,confusion,TTP
725373155,5/24/2015 22:50:47,1642806708,5/24/2015 22:50:27,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,145,119,,,154,122,CONFUSION,TTP,CONFUSION,145,119,TTP,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,145,119,145,119,1,154,122,TWrex-cause,813078,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding,confusion,TTP
725373155,5/24/2015 22:56:34,1642808391,5/24/2015 22:56:09,false,clixsense,1,26770238,CAN,ON,Ilderton,209.183.157.27,145,119,,,154,122,CONFUSION,TTP,◊ Weakness ◊ CONFUSION Severe headaches Gastrointestinal,132-134-143-145-157-164-176,119-134-145-157-164-176-193-204-210-217-227-236-239-249,TTP Weakness Confusion Severe headaches Gastrointestinal symptoms Chest pain Dyspnea Bruising or excessive bleeding.,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,145,119,145,119,1,154,122,TWrex-cause,813078,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding,confusion,TTP
725373155,5/24/2015 22:57:07,1642808527,5/24/2015 22:56:21,false,points4rewards,1,28703583,USA,,,97.73.85.52,145,119,,,154,122,CONFUSION,TTP,recurrent TTP CONFUSION,109-119-145,109-119,recurrent TTP,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,145,119,145,119,1,154,122,TWrex-cause,813078,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding,confusion,TTP
725373155,5/24/2015 22:57:09,1642808557,5/24/2015 22:56:57,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,145,119,,,154,122,CONFUSION,TTP,CONFUSION,145,109-119,recurrent TTP,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,145,119,145,119,1,154,122,TWrex-cause,813078,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding,confusion,TTP
725373155,5/24/2015 22:57:46,1642808656,5/24/2015 22:57:22,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,145,119,,,154,122,CONFUSION,TTP,CONFUSION,145,109-119,recurrent TTP,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,145,119,145,119,1,154,122,TWrex-cause,813078,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding,confusion,TTP
725373155,5/24/2015 23:01:48,1642809628,5/24/2015 23:01:26,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,145,119,,,154,122,CONFUSION,TTP,◊ ◊ CONFUSION,132-143-145,109-119,recurrent TTP,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding.,145,119,145,119,1,154,122,TWrex-cause,813078,C]  Specific recommendation: • Inform patients that many different systemic symptoms may herald the onset of recurrent TTP such as: ◊ Weakness ◊ Confusion ◊ Severe headaches ◊ Gastrointestinal symptoms ◊ Chest pain ◊ Dyspnea ◊ Bruising or excessive bleeding,confusion,TTP
725373156,5/24/2015 19:57:43,1642753335,5/24/2015 19:57:24,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,46,28,,,61,31,HEMIHYPERTROPHY,BWS,HEMIHYPERTROPHY.,46,28,BWS,Individuals who do not have BWS can also have hemihypertrophy.,46,28,46,28,1,61,31,TWrex-cause,813300,Individuals who do not have BWS can also have hemihypertrophy,hemihypertrophy,BWS
725373156,5/24/2015 20:27:00,1642760678,5/24/2015 20:26:48,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,46,28,,,61,31,HEMIHYPERTROPHY,BWS,HEMIHYPERTROPHY.,46,28,BWS,Individuals who do not have BWS can also have hemihypertrophy.,46,28,46,28,1,61,31,TWrex-cause,813300,Individuals who do not have BWS can also have hemihypertrophy,hemihypertrophy,BWS
725373156,5/24/2015 20:30:58,1642761897,5/24/2015 20:30:47,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,46,28,,,61,31,HEMIHYPERTROPHY,BWS,HEMIHYPERTROPHY.,46,28,BWS,Individuals who do not have BWS can also have hemihypertrophy.,46,28,46,28,1,61,31,TWrex-cause,813300,Individuals who do not have BWS can also have hemihypertrophy,hemihypertrophy,BWS
725373156,5/24/2015 20:32:41,1642762263,5/24/2015 20:31:38,false,instagc,1,19740138,CAN,,,50.69.96.237,46,28,,,61,31,HEMIHYPERTROPHY,BWS,HEMIHYPERTROPHY.,46,28,BWS,Individuals who do not have BWS can also have hemihypertrophy.,46,28,46,28,1,61,31,TWrex-cause,813300,Individuals who do not have BWS can also have hemihypertrophy,hemihypertrophy,BWS
725373156,5/24/2015 20:55:10,1642769135,5/24/2015 20:54:56,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,46,28,,,61,31,HEMIHYPERTROPHY,BWS,BWS HEMIHYPERTROPHY.,28-46,28-46,BWS hemihypertrophy.,Individuals who do not have BWS can also have hemihypertrophy.,46,28,46,28,1,61,31,TWrex-cause,813300,Individuals who do not have BWS can also have hemihypertrophy,hemihypertrophy,BWS
725373156,5/24/2015 20:57:21,1642769806,5/24/2015 20:56:39,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,46,28,,,61,31,HEMIHYPERTROPHY,BWS,HEMIHYPERTROPHY.,46,28,BWS,Individuals who do not have BWS can also have hemihypertrophy.,46,28,46,28,1,61,31,TWrex-cause,813300,Individuals who do not have BWS can also have hemihypertrophy,hemihypertrophy,BWS
725373156,5/24/2015 20:57:38,1642769886,5/24/2015 20:57:02,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,46,28,,,61,31,HEMIHYPERTROPHY,BWS,HEMIHYPERTROPHY.,46,28,BWS,Individuals who do not have BWS can also have hemihypertrophy.,46,28,46,28,1,61,31,TWrex-cause,813300,Individuals who do not have BWS can also have hemihypertrophy,hemihypertrophy,BWS
725373156,5/24/2015 20:58:31,1642770253,5/24/2015 20:55:35,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,46,28,,,61,31,HEMIHYPERTROPHY,BWS,HEMIHYPERTROPHY.,46,28-46,BWS hemihypertrophy.,Individuals who do not have BWS can also have hemihypertrophy.,46,28,46,28,1,61,31,TWrex-cause,813300,Individuals who do not have BWS can also have hemihypertrophy,hemihypertrophy,BWS
725373156,5/24/2015 21:02:34,1642771704,5/24/2015 21:01:46,false,neodev,1,17426565,CAN,BC,Burnaby,70.79.18.187,46,28,,,61,31,HEMIHYPERTROPHY,BWS,HEMIHYPERTROPHY.,46,28,BWS,Individuals who do not have BWS can also have hemihypertrophy.,46,28,46,28,1,61,31,TWrex-cause,813300,Individuals who do not have BWS can also have hemihypertrophy,hemihypertrophy,BWS
725373156,5/24/2015 21:09:49,1642774254,5/24/2015 21:08:42,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,46,28,,,61,31,HEMIHYPERTROPHY,BWS,HEMIHYPERTROPHY.,46,28,BWS,Individuals who do not have BWS can also have hemihypertrophy.,46,28,46,28,1,61,31,TWrex-cause,813300,Individuals who do not have BWS can also have hemihypertrophy,hemihypertrophy,BWS
725373157,5/24/2015 20:33:54,1642762640,5/24/2015 20:33:40,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,95,48,,,103,55,GLAUCOMA,TIMOLOL,GLAUCOMA.,95,48,TIMOLOL,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma.",95,48,95,48,-1,103,55,TWrex-cause,804284,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma",glaucoma,timolol
725373157,5/24/2015 20:59:49,1642770715,5/24/2015 20:59:39,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,95,48,,,103,55,GLAUCOMA,TIMOLOL,GLAUCOMA.,95,48,TIMOLOL,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma.",95,48,95,48,-1,103,55,TWrex-cause,804284,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma",glaucoma,timolol
725373157,5/24/2015 21:00:01,1642770808,5/24/2015 20:59:49,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,95,48,,,103,55,GLAUCOMA,TIMOLOL,GLAUCOMA.,95,48,TIMOLOL,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma.",95,48,95,48,-1,103,55,TWrex-cause,804284,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma",glaucoma,timolol
725373157,5/24/2015 21:02:52,1642771815,5/24/2015 21:02:32,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,95,48,,,103,55,GLAUCOMA,TIMOLOL,GLAUCOMA.,95,48-95,TIMOLOL glaucoma.,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma.",95,48,95,48,-1,103,55,TWrex-cause,804284,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma",glaucoma,timolol
725373157,5/24/2015 21:10:25,1642774421,5/24/2015 21:10:16,false,prodege,1,31508822,CAN,AB,Calgary,206.75.77.133,95,48,,,103,55,GLAUCOMA,TIMOLOL,open angle GLAUCOMA.,84-89-95,48,TIMOLOL,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma.",95,48,95,48,-1,103,55,TWrex-cause,804284,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma",glaucoma,timolol
725373157,5/24/2015 21:13:13,1642775388,5/24/2015 21:13:02,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,95,48,,,103,55,GLAUCOMA,TIMOLOL,open angle GLAUCOMA.,84-89-95,48-56-60,TIMOLOL and epinephrine,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma.",95,48,95,48,-1,103,55,TWrex-cause,804284,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma",glaucoma,timolol
725373157,5/24/2015 21:19:27,1642777187,5/24/2015 21:18:14,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,95,48,,,103,55,GLAUCOMA,TIMOLOL,open angle GLAUCOMA.,84-89-95,39-48-56-60-72,Combined TIMOLOL and epinephrine therapy,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma.",95,48,95,48,-1,103,55,TWrex-cause,804284,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma",glaucoma,timolol
725373157,5/24/2015 21:25:06,1642778815,5/24/2015 21:24:57,false,clixsense,1,26492726,GBR,C2,Halifax,2.103.117.226,95,48,,,103,55,GLAUCOMA,TIMOLOL,GLAUCOMA.,95,48,TIMOLOL,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma.",95,48,95,48,-1,103,55,TWrex-cause,804284,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma",glaucoma,timolol
725373157,5/24/2015 21:25:42,1642779009,5/24/2015 21:25:23,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,95,48,,,103,55,GLAUCOMA,TIMOLOL,GLAUCOMA.,95,48,TIMOLOL,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma.",95,48,95,48,-1,103,55,TWrex-cause,804284,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma",glaucoma,timolol
725373157,5/24/2015 21:26:53,1642779341,5/24/2015 21:26:36,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,95,48,,,103,55,GLAUCOMA,TIMOLOL,open angle GLAUCOMA.,89-95-84,39-48,Combined TIMOLOL,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma.",95,48,95,48,-1,103,55,TWrex-cause,804284,"Knupp JA, Shields MB, Mandel AI et al. Combined timolol and epinephrine therapy for open angle glaucoma",glaucoma,timolol
725373158,5/24/2015 19:52:15,1642751540,5/24/2015 19:52:01,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,88,55,,,94,66,EMESIS,ONDANSETRON,EMESIS,88,55,ONDANSETRON,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy.",88,55,88,55,-1,94,66,TWrex-cause,804854,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy",emesis,ondansetron
725373158,5/24/2015 19:52:54,1642751695,5/24/2015 19:52:34,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,88,55,,,94,66,EMESIS,ONDANSETRON,Efficacy of oral ondansetron in the prevention of EMESIS in outpatients receiving cyclophosphamide - based chemotherapy.,38-47-50-55-67-70-74-85-88-95-98-110-120-136-137-143,38-47-50-55-67-70-74-85-88-95-98-110-120-136-137-143,Efficacy of oral ONDANSETRON in the prevention of emesis in outpatients receiving cyclophosphamide - based chemotherapy.,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy.",88,55,88,55,-1,94,66,TWrex-cause,804854,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy",emesis,ondansetron
725373158,5/24/2015 19:53:12,1642751795,5/24/2015 19:52:54,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,88,55,,,94,66,EMESIS,ONDANSETRON,EMESIS,88,55,ONDANSETRON,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy.",88,55,88,55,-1,94,66,TWrex-cause,804854,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy",emesis,ondansetron
725373158,5/24/2015 19:53:24,1642751919,5/24/2015 19:53:10,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,88,55,,,94,66,EMESIS,ONDANSETRON,EMESIS,88,55,ONDANSETRON,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy.",88,55,88,55,-1,94,66,TWrex-cause,804854,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy",emesis,ondansetron
725373158,5/24/2015 20:00:06,1642753920,5/24/2015 19:59:53,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,88,55,,,94,66,EMESIS,ONDANSETRON,EMESIS,88,50-55,oral ONDANSETRON,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy.",88,55,88,55,-1,94,66,TWrex-cause,804854,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy",emesis,ondansetron
725373158,5/24/2015 20:12:54,1642757392,5/24/2015 20:12:39,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,88,55,,,94,66,EMESIS,ONDANSETRON,EMESIS,88,55,ONDANSETRON,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy.",88,55,88,55,-1,94,66,TWrex-cause,804854,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy",emesis,ondansetron
725373158,5/24/2015 20:14:34,1642757886,5/24/2015 20:14:11,false,instagc,1,19740138,CAN,,,50.69.96.237,88,55,,,94,66,EMESIS,ONDANSETRON,EMESIS,88,50-55,oral ONDANSETRON,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy.",88,55,88,55,-1,94,66,TWrex-cause,804854,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy",emesis,ondansetron
725373158,5/24/2015 20:21:22,1642759385,5/24/2015 20:21:08,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,88,55,,,94,66,EMESIS,ONDANSETRON,EMESIS,88,50-55,oral ONDANSETRON,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy.",88,55,88,55,-1,94,66,TWrex-cause,804854,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy",emesis,ondansetron
725373158,5/24/2015 20:26:37,1642760551,5/24/2015 20:25:48,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,88,55,,,94,66,EMESIS,ONDANSETRON,EMESIS,88,55-50,oral ONDANSETRON,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy.",88,55,88,55,-1,94,66,TWrex-cause,804854,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy",emesis,ondansetron
725373158,5/24/2015 20:27:40,1642760883,5/24/2015 20:27:27,false,cointasker,1,21783324,NLD,,,31.151.239.133,88,55,,,94,66,EMESIS,ONDANSETRON,EMESIS,88,50-55,oral ONDANSETRON,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy.",88,55,88,55,-1,94,66,TWrex-cause,804854,"Beck TM, Ciociola AA, Jones SE et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy",emesis,ondansetron
725373159,5/24/2015 18:56:53,1642721860,5/24/2015 18:56:35,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,50,79,,,59,94,PNEUMONIA,YERSINIA PESTIS,PNEUMONIA,50,79-88,YERSINIA PESTIS.,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis.",50,79 88,50,79,1,59,94,TWrex-cause,810389,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis",pneumonia,yersinia pestis
725373159,5/24/2015 18:56:53,1642721864,5/24/2015 18:56:34,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,50,79,,,59,94,PNEUMONIA,YERSINIA PESTIS,Plague PNEUMONIA,43-50,79-88,YERSINIA PESTIS.,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis.",50,79 88,50,79,1,59,94,TWrex-cause,810389,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis",pneumonia,yersinia pestis
725373159,5/24/2015 18:56:54,1642721871,5/24/2015 18:56:35,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,50,79,,,59,94,PNEUMONIA,YERSINIA PESTIS,PNEUMONIA,50,79-88,YERSINIA PESTIS.,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis.",50,79 88,50,79,1,59,94,TWrex-cause,810389,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis",pneumonia,yersinia pestis
725373159,5/24/2015 18:58:36,1642722727,5/24/2015 18:58:04,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,50,79,,,59,94,PNEUMONIA,YERSINIA PESTIS,Plague PNEUMONIA disease,43-50-60,79-88,YERSINIA PESTIS.,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis.",50,79 88,50,79,1,59,94,TWrex-cause,810389,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis",pneumonia,yersinia pestis
725373159,5/24/2015 18:59:25,1642723122,5/24/2015 18:58:58,false,neodev,1,32456300,USA,CA,Laguna Niguel,216.177.129.227,50,79,,,59,94,PNEUMONIA,YERSINIA PESTIS,Cleri Vernaleo Lombardi et al: Plague PNEUMONIA disease caused by Yersinia pestis.,0-10-23-36-39-43-50-60-68-75-79-88,43-60-68-75-79-88-50,Plague pneumonia disease caused by YERSINIA PESTIS.,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis.",50,79 88,50,79,1,59,94,TWrex-cause,810389,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis",pneumonia,yersinia pestis
725373159,5/24/2015 19:02:17,1642724430,5/24/2015 19:01:31,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,50,79,,,59,94,PNEUMONIA,YERSINIA PESTIS,Plague PNEUMONIA disease,43-50-60,79-88,YERSINIA PESTIS.,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis.",50,79 88,50,79,1,59,94,TWrex-cause,810389,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis",pneumonia,yersinia pestis
725373159,5/24/2015 19:18:45,1642733206,5/24/2015 19:18:33,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,50,79,,,59,94,PNEUMONIA,YERSINIA PESTIS,Plague PNEUMONIA disease,43-50-60,79-88,YERSINIA PESTIS.,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis.",50,79 88,50,79,1,59,94,TWrex-cause,810389,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis",pneumonia,yersinia pestis
725373159,5/24/2015 19:21:47,1642737347,5/24/2015 19:21:35,false,pocketmoneygpt,1,32162555,CAN,BC,Vancouver,108.180.194.80,50,79,,,59,94,PNEUMONIA,YERSINIA PESTIS,PNEUMONIA,50,79-88,YERSINIA PESTIS.,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis.",50,79 88,50,79,1,59,94,TWrex-cause,810389,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis",pneumonia,yersinia pestis
725373159,5/24/2015 19:23:07,1642739039,5/24/2015 19:20:31,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,50,79,,,59,94,PNEUMONIA,YERSINIA PESTIS,Plague PNEUMONIA disease,43-50-60,79-88,YERSINIA PESTIS.,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis.",50,79 88,50,79,1,59,94,TWrex-cause,810389,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis",pneumonia,yersinia pestis
725373159,5/24/2015 19:24:05,1642739928,5/24/2015 19:23:53,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,50,79,,,59,94,PNEUMONIA,YERSINIA PESTIS,Plague PNEUMONIA,43-50,68-75-79-88-60,disease caused by YERSINIA PESTIS.,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis.",50,79 88,50,79,1,59,94,TWrex-cause,810389,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia disease caused by  Yersinia pestis",pneumonia,yersinia pestis
725373160,5/24/2015 18:59:44,1642723250,5/24/2015 18:59:18,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,21,81,,,26,89,FEVER,BORRELIA,FEVER,21,81,BORRELIA,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros.",21,81,21,81,1,26,89,TWrex-cause,810015,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros",fever,borrelia
725373160,5/24/2015 19:00:25,1642723588,5/24/2015 18:59:56,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,21,81,,,26,89,FEVER,BORRELIA,Tick borne relapsing FEVER,0-5-11-21,81,BORRELIA,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros.",21,81,21,81,1,26,89,TWrex-cause,810015,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros",fever,borrelia
725373160,5/24/2015 19:01:54,1642724200,5/24/2015 19:01:36,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,21,81,,,26,89,FEVER,BORRELIA,Tick borne relapsing FEVER (TBRF),0-5-11-21-27,81,BORRELIA,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros.",21,81,21,81,1,26,89,TWrex-cause,810015,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros",fever,borrelia
725373160,5/24/2015 19:02:01,1642724245,5/24/2015 19:01:31,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,21,81,,,26,89,FEVER,BORRELIA,Tick borne relapsing FEVER (TBRF),0-5-11-21-27,81,BORRELIA,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros.",21,81,21,81,1,26,89,TWrex-cause,810015,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros",fever,borrelia
725373160,5/24/2015 19:09:49,1642727978,5/24/2015 19:08:59,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,21,81,,,26,89,FEVER,BORRELIA,Tick borne relapsing FEVER (TBRF),0-5-11-21-27,81,BORRELIA,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros.",21,81,21,81,1,26,89,TWrex-cause,810015,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros",fever,borrelia
725373160,5/24/2015 19:21:15,1642736550,5/24/2015 19:21:01,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,21,81,,,26,89,FEVER,BORRELIA,Tick borne relapsing FEVER (TBRF),0-5-11-21-27,81,BORRELIA,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros.",21,81,21,81,1,26,89,TWrex-cause,810015,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros",fever,borrelia
725373160,5/24/2015 19:26:23,1642741053,5/24/2015 19:26:08,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,21,81,,,26,89,FEVER,BORRELIA,Tick borne relapsing FEVER,0-5-11-21,81,BORRELIA,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros.",21,81,21,81,1,26,89,TWrex-cause,810015,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros",fever,borrelia
725373160,5/24/2015 19:28:03,1642742030,5/24/2015 19:27:40,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,21,81,,,26,89,FEVER,BORRELIA,Tick borne relapsing FEVER (TBRF),0-5-11-21-27,81,BORRELIA,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros.",21,81,21,81,1,26,89,TWrex-cause,810015,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros",fever,borrelia
725373160,5/24/2015 19:29:56,1642742954,5/24/2015 19:28:01,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,21,81,,,26,89,FEVER,BORRELIA,Tick borne relapsing FEVER,0-5-11-21,59-69-77-81,different species of BORRELIA,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros.",21,81,21,81,1,26,89,TWrex-cause,810015,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros",fever,borrelia
725373160,5/24/2015 19:33:34,1642744828,5/24/2015 19:33:08,false,clixsense,1,6417722,USA,MI,Taylor,99.170.106.105,21,81,,,26,89,FEVER,BORRELIA,Tick borne relapsing FEVER,0-5-11-21,81,BORRELIA,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros.",21,81,21,81,1,26,89,TWrex-cause,810015,"Tick-borne relapsing fever (TBRF) is caused by at least 15 different species of  Borrelia , each of which is associated with a distinct member of the soft ticks of the genus  Ornithodoros",fever,borrelia
725373161,5/24/2015 20:34:12,1642762707,5/24/2015 20:33:55,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,58,3,,,77,11,LEUKOENCEPHALOPATHY,JC VIRUS,"LEUKOENCEPHALOPATHY,",58,3-6,JC VIRUS,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported.",58,3 6,58,3,1,77,11,TWrex-cause,811019,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported",leukoencephalopathy,jc virus
725373161,5/24/2015 21:00:03,1642770818,5/24/2015 20:59:50,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,58,3,,,77,11,LEUKOENCEPHALOPATHY,JC VIRUS,"LEUKOENCEPHALOPATHY,",58,3-6,JC VIRUS,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported.",58,3 6,58,3,1,77,11,TWrex-cause,811019,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported",leukoencephalopathy,jc virus
725373161,5/24/2015 21:00:20,1642770919,5/24/2015 21:00:04,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,58,3,,,77,11,LEUKOENCEPHALOPATHY,JC VIRUS,"LEUKOENCEPHALOPATHY,",58,3-6,JC VIRUS,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported.",58,3 6,58,3,1,77,11,TWrex-cause,811019,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported",leukoencephalopathy,jc virus
725373161,5/24/2015 21:13:25,1642775420,5/24/2015 21:13:08,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,58,3,,,77,11,LEUKOENCEPHALOPATHY,JC VIRUS,"LEUKOENCEPHALOPATHY,",58,3-6-12,JC VIRUS infection,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported.",58,3 6,58,3,1,77,11,TWrex-cause,811019,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported",leukoencephalopathy,jc virus
725373161,5/24/2015 21:13:46,1642775509,5/24/2015 21:13:14,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,58,3,,,77,11,LEUKOENCEPHALOPATHY,JC VIRUS,"multifocal LEUKOENCEPHALOPATHY,",47-58,0-3-6,1 JC VIRUS,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported.",58,3 6,58,3,1,77,11,TWrex-cause,811019,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported",leukoencephalopathy,jc virus
725373161,5/24/2015 21:20:04,1642777380,5/24/2015 21:19:28,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,58,3,,,77,11,LEUKOENCEPHALOPATHY,JC VIRUS,"progressive multifocal LEUKOENCEPHALOPATHY,",35-47-58,3-6-12,JC VIRUS infection,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported.",58,3 6,58,3,1,77,11,TWrex-cause,811019,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported",leukoencephalopathy,jc virus
725373161,5/24/2015 21:26:11,1642779158,5/24/2015 21:25:43,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,58,3,,,77,11,LEUKOENCEPHALOPATHY,JC VIRUS,"LEUKOENCEPHALOPATHY,",58,0-3-6-12,1 JC VIRUS infection,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported.",58,3 6,58,3,1,77,11,TWrex-cause,811019,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported",leukoencephalopathy,jc virus
725373161,5/24/2015 21:27:10,1642779401,5/24/2015 21:26:55,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,58,3,,,77,11,LEUKOENCEPHALOPATHY,JC VIRUS,"progressive multifocal LEUKOENCEPHALOPATHY,",35-47-58,3-6-12,JC VIRUS infection,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported.",58,3 6,58,3,1,77,11,TWrex-cause,811019,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported",leukoencephalopathy,jc virus
725373161,5/24/2015 21:45:31,1642785056,5/24/2015 21:44:29,false,neodev,1,17426565,CAN,BC,Burnaby,70.79.18.187,58,3,,,77,11,LEUKOENCEPHALOPATHY,JC VIRUS,"progressive multifocal LEUKOENCEPHALOPATHY,",35-47-58,3-6-12,JC VIRUS infection,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported.",58,3 6,58,3,1,77,11,TWrex-cause,811019,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported",leukoencephalopathy,jc virus
725373161,5/24/2015 21:57:30,1642788778,5/24/2015 21:56:10,false,neodev,1,31670127,USA,FL,Key West,162.233.108.112,58,3,,,77,11,LEUKOENCEPHALOPATHY,JC VIRUS,"multifocal LEUKOENCEPHALOPATHY,",58-47,0-3-6,1 JC VIRUS,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported.",58,3 6,58,3,1,77,11,TWrex-cause,811019,"1  JC virus infection resulting in progressive multifocal leukoencephalopathy, sometimes fatal, reported",leukoencephalopathy,jc virus
725373162,5/24/2015 19:53:23,1642751915,5/24/2015 19:53:08,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,80,94,,,82,120,TB,MYCOBACTERIUM TUBERCULOSIS,TB,80,94-108,MYCOBACTERIUM TUBERCULOSIS,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug.",80,94 108,80,94,1,82,120,TWrex-cause,810529,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug",TB,mycobacterium tuberculosis
725373162,5/24/2015 19:54:36,1642752310,5/24/2015 19:54:20,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,80,94,,,82,120,TB,MYCOBACTERIUM TUBERCULOSIS,TB,80,94-108,MYCOBACTERIUM TUBERCULOSIS,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug.",80,94 108,80,94,1,82,120,TWrex-cause,810529,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug",TB,mycobacterium tuberculosis
725373162,5/24/2015 19:54:38,1642752329,5/24/2015 19:54:22,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,80,94,,,82,120,TB,MYCOBACTERIUM TUBERCULOSIS,TB,80,94-108,MYCOBACTERIUM TUBERCULOSIS,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug.",80,94 108,80,94,1,82,120,TWrex-cause,810529,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug",TB,mycobacterium tuberculosis
725373162,5/24/2015 20:01:39,1642754274,5/24/2015 20:01:26,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,80,94,,,82,120,TB,MYCOBACTERIUM TUBERCULOSIS,TB,80,94-108,MYCOBACTERIUM TUBERCULOSIS,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug.",80,94 108,80,94,1,82,120,TWrex-cause,810529,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug",TB,mycobacterium tuberculosis
725373162,5/24/2015 20:06:39,1642755556,5/24/2015 20:06:02,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,80,94,,,82,120,TB,MYCOBACTERIUM TUBERCULOSIS,First - line agent for treatment of all forms of TB caused by Mycobacterium tuberculosis known or presumed to be susceptible to the drug.,33-38-39-44-50-54-64-67-71-77-80-83-90-94-108-122-128-131-140-143-146-158-161-165,33-38-39-44-50-54-64-67-71-77-80-83-90-94-108-122-128-131-140-143-146-158-161-165,First - line agent for treatment of all forms of TB caused by MYCOBACTERIUM TUBERCULOSIS known or presumed to be susceptible to the drug.,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug.",80,94 108,80,94,1,82,120,TWrex-cause,810529,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug",TB,mycobacterium tuberculosis
725373162,5/24/2015 20:22:59,1642759842,5/24/2015 20:22:36,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,80,94,,,82,120,TB,MYCOBACTERIUM TUBERCULOSIS,TB,80,94-108,MYCOBACTERIUM TUBERCULOSIS,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug.",80,94 108,80,94,1,82,120,TWrex-cause,810529,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug",TB,mycobacterium tuberculosis
725373162,5/24/2015 20:27:07,1642760707,5/24/2015 20:26:47,false,instagc,1,19740138,CAN,,,50.69.96.237,80,94,,,82,120,TB,MYCOBACTERIUM TUBERCULOSIS,TB,80,94-108,MYCOBACTERIUM TUBERCULOSIS,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug.",80,94 108,80,94,1,82,120,TWrex-cause,810529,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug",TB,mycobacterium tuberculosis
725373162,5/24/2015 20:27:59,1642760985,5/24/2015 20:27:44,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,80,94,,,82,120,TB,MYCOBACTERIUM TUBERCULOSIS,TB,80,94-108,MYCOBACTERIUM TUBERCULOSIS,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug.",80,94 108,80,94,1,82,120,TWrex-cause,810529,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug",TB,mycobacterium tuberculosis
725373162,5/24/2015 20:31:40,1642762063,5/24/2015 20:31:23,false,neodev,1,29074051,GBR,G5,Folkestone,80.6.67.18,80,94,,,82,120,TB,MYCOBACTERIUM TUBERCULOSIS,TB,80,94-108,MYCOBACTERIUM TUBERCULOSIS,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug.",80,94 108,80,94,1,82,120,TWrex-cause,810529,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug",TB,mycobacterium tuberculosis
725373162,5/24/2015 20:41:02,1642764363,5/24/2015 20:40:46,false,clixsense,1,23197581,NLD,11,Den Haag,82.217.5.55,80,94,,,82,120,TB,MYCOBACTERIUM TUBERCULOSIS,TB caused by Mycobacterium tuberculosis,80-83-90-94-108,94-108,MYCOBACTERIUM TUBERCULOSIS,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug.",80,94 108,80,94,1,82,120,TWrex-cause,810529,"100 ,   124 ,   126 ,   d ,   e  First-line agent for treatment of all forms of TB caused by  Mycobacterium tuberculosis  known or presumed to be susceptible to the drug",TB,mycobacterium tuberculosis
725373163,5/24/2015 21:03:56,1642772235,5/24/2015 21:03:41,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,77,44,,,80,52,DVT,WARFARIN,"acute proximal DVT,",62-68-77,44,WARFARIN,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT.",77,44,77,44,-1,80,52,TWrex-cause,803504,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT",DVT,warfarin
725373163,5/24/2015 21:04:34,1642772471,5/24/2015 21:04:23,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,77,44,,,80,52,DVT,WARFARIN,"DVT,",77,44,WARFARIN,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT.",77,44,77,44,-1,80,52,TWrex-cause,803504,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT",DVT,warfarin
725373163,5/24/2015 21:17:22,1642776551,5/24/2015 21:17:05,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,77,44,,,80,52,DVT,WARFARIN,"acute proximal DVT, and consider thrombolysis",62-68-77-82-86-95,28-32-40-44,Use heparin and WARFARIN,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT.",77,44,77,44,-1,80,52,TWrex-cause,803504,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT",DVT,warfarin
725373163,5/24/2015 21:30:34,1642780430,5/24/2015 21:30:11,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,77,44,,,80,52,DVT,WARFARIN,"acute proximal DVT,",62-68-77,44,WARFARIN,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT.",77,44,77,44,-1,80,52,TWrex-cause,803504,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT",DVT,warfarin
725373163,5/24/2015 21:34:04,1642781850,5/24/2015 21:33:11,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,77,44,,,80,52,DVT,WARFARIN,"acute proximal DVT,",62-68-77,44,WARFARIN,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT.",77,44,77,44,-1,80,52,TWrex-cause,803504,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT",DVT,warfarin
725373163,5/24/2015 22:07:04,1642791585,5/24/2015 22:06:42,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,77,44,,,80,52,DVT,WARFARIN,"acute proximal DVT,",62-68-77,44,WARFARIN,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT.",77,44,77,44,-1,80,52,TWrex-cause,803504,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT",DVT,warfarin
725373163,5/24/2015 22:45:31,1642805329,5/24/2015 22:45:16,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,77,44,,,80,52,DVT,WARFARIN,"DVT,",77,44,WARFARIN,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT.",77,44,77,44,-1,80,52,TWrex-cause,803504,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT",DVT,warfarin
725373163,5/24/2015 22:48:42,1642806202,5/24/2015 22:48:25,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,77,44,,,80,52,DVT,WARFARIN,"DVT,",77,44,WARFARIN,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT.",77,44,77,44,-1,80,52,TWrex-cause,803504,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT",DVT,warfarin
725373163,5/24/2015 22:50:11,1642806626,5/24/2015 22:49:19,false,neodev,1,24628757,CAN,,,107.179.231.99,77,44,,,80,52,DVT,WARFARIN,"acute proximal DVT, iliofemoral",62-68-77-126,44,WARFARIN,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT.",77,44,77,44,-1,80,52,TWrex-cause,803504,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT",DVT,warfarin
725373163,5/24/2015 22:52:26,1642807220,5/24/2015 22:51:49,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,77,44,,,80,52,DVT,WARFARIN,"acute proximal DVT,",62-68-77,44,WARFARIN,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT.",77,44,77,44,-1,80,52,TWrex-cause,803504,"DRUG THERAPY  Introduction  Use heparin and warfarin to treat acute proximal DVT, and consider thrombolysis for patients with iliofemoral DVT",DVT,warfarin
725373164,5/24/2015 18:57:07,1642722042,5/24/2015 18:56:54,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,14,47,,,25,52,PHARYNGITIS,GABHS,Streptococcal PHARYNGITIS,0-14,47,GABHS.,Streptococcal pharyngitis is usually caused by GABHS.,14,47,14,47,1,25,52,TWrex-cause,810336,Streptococcal pharyngitis is usually caused by GABHS,pharyngitis,GABHS
725373164,5/24/2015 18:57:06,1642722063,5/24/2015 18:56:54,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,14,47,,,25,52,PHARYNGITIS,GABHS,PHARYNGITIS,14,47,GABHS.,Streptococcal pharyngitis is usually caused by GABHS.,14,47,14,47,1,25,52,TWrex-cause,810336,Streptococcal pharyngitis is usually caused by GABHS,pharyngitis,GABHS
725373164,5/24/2015 18:58:48,1642722817,5/24/2015 18:56:54,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,14,47,,,25,52,PHARYNGITIS,GABHS,PHARYNGITIS,14,47,GABHS.,Streptococcal pharyngitis is usually caused by GABHS.,14,47,14,47,1,25,52,TWrex-cause,810336,Streptococcal pharyngitis is usually caused by GABHS,pharyngitis,GABHS
725373164,5/24/2015 18:59:06,1642722972,5/24/2015 18:58:38,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,14,47,,,25,52,PHARYNGITIS,GABHS,Streptococcal PHARYNGITIS,0-14,47,GABHS.,Streptococcal pharyngitis is usually caused by GABHS.,14,47,14,47,1,25,52,TWrex-cause,810336,Streptococcal pharyngitis is usually caused by GABHS,pharyngitis,GABHS
725373164,5/24/2015 18:59:41,1642723217,5/24/2015 18:59:26,false,neodev,1,32456300,USA,CA,Laguna Niguel,216.177.129.227,14,47,,,25,52,PHARYNGITIS,GABHS,Streptococcal PHARYNGITIS is usually caused by GABHS.,0-14-26-29-37-44-47,0-29-37-44-47-26,Streptococcal is usually caused by GABHS.,Streptococcal pharyngitis is usually caused by GABHS.,14,47,14,47,1,25,52,TWrex-cause,810336,Streptococcal pharyngitis is usually caused by GABHS,pharyngitis,GABHS
725373164,5/24/2015 19:03:08,1642724855,5/24/2015 19:02:19,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,14,47,,,25,52,PHARYNGITIS,GABHS,Streptococcal PHARYNGITIS,0-14,47,GABHS.,Streptococcal pharyngitis is usually caused by GABHS.,14,47,14,47,1,25,52,TWrex-cause,810336,Streptococcal pharyngitis is usually caused by GABHS,pharyngitis,GABHS
725373164,5/24/2015 19:19:04,1642733595,5/24/2015 19:18:48,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,14,47,,,25,52,PHARYNGITIS,GABHS,Streptococcal PHARYNGITIS,0-14,47,GABHS.,Streptococcal pharyngitis is usually caused by GABHS.,14,47,14,47,1,25,52,TWrex-cause,810336,Streptococcal pharyngitis is usually caused by GABHS,pharyngitis,GABHS
725373164,5/24/2015 19:23:58,1642739853,5/24/2015 19:23:12,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,14,47,,,25,52,PHARYNGITIS,GABHS,Streptococcal PHARYNGITIS,0-14,47,GABHS.,Streptococcal pharyngitis is usually caused by GABHS.,14,47,14,47,1,25,52,TWrex-cause,810336,Streptococcal pharyngitis is usually caused by GABHS,pharyngitis,GABHS
725373164,5/24/2015 19:24:24,1642740161,5/24/2015 19:24:06,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,14,47,,,25,52,PHARYNGITIS,GABHS,Streptococcal PHARYNGITIS,0-14,47,GABHS.,Streptococcal pharyngitis is usually caused by GABHS.,14,47,14,47,1,25,52,TWrex-cause,810336,Streptococcal pharyngitis is usually caused by GABHS,pharyngitis,GABHS
725373164,5/24/2015 19:25:02,1642740439,5/24/2015 19:24:53,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,14,47,,,25,52,PHARYNGITIS,GABHS,Streptococcal PHARYNGITIS,0-14,47,GABHS.,Streptococcal pharyngitis is usually caused by GABHS.,14,47,14,47,1,25,52,TWrex-cause,810336,Streptococcal pharyngitis is usually caused by GABHS,pharyngitis,GABHS
725373165,5/24/2015 21:02:23,1642771667,5/24/2015 21:02:04,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,105,30,,,118,38,ACNE VULGARIS,PEROXIDE,ACNE VULGARIS:,105-110,30,"PEROXIDE,","2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.",105 110,30,105,30,-1,118,38,TWrex-cause,800461,"2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients",acne vulgaris,peroxide
725373165,5/24/2015 21:02:59,1642771865,5/24/2015 21:01:36,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,105,30,,,118,38,ACNE VULGARIS,PEROXIDE,ACNE VULGARIS:,105-110,30,"PEROXIDE,","2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.",105 110,30,105,30,-1,118,38,TWrex-cause,800461,"2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients",acne vulgaris,peroxide
725373165,5/24/2015 21:15:02,1642775818,5/24/2015 21:14:43,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,105,30,,,118,38,ACNE VULGARIS,PEROXIDE,ACNE VULGARIS:,105-110,30,"PEROXIDE,","2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.",105 110,30,105,30,-1,118,38,TWrex-cause,800461,"2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients",acne vulgaris,peroxide
725373165,5/24/2015 21:15:43,1642776060,5/24/2015 21:15:18,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,105,30,,,118,38,ACNE VULGARIS,PEROXIDE,ACNE VULGARIS:,105-110,12-22-30,"Adapalene benzoyl PEROXIDE,","2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.",105 110,30,105,30,-1,118,38,TWrex-cause,800461,"2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients",acne vulgaris,peroxide
725373165,5/24/2015 21:28:32,1642779827,5/24/2015 21:28:18,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,105,30,,,118,38,ACNE VULGARIS,PEROXIDE,ACNE VULGARIS:,105-110,12-22-30,"Adapalene benzoyl PEROXIDE,","2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.",105 110,30,105,30,-1,118,38,TWrex-cause,800461,"2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients",acne vulgaris,peroxide
725373165,5/24/2015 21:28:33,1642779834,5/24/2015 21:28:09,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,105,30,,,118,38,ACNE VULGARIS,PEROXIDE,ACNE VULGARIS:,105-110,12-22-30,"Adapalene benzoyl PEROXIDE,","2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.",105 110,30,105,30,-1,118,38,TWrex-cause,800461,"2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients",acne vulgaris,peroxide
725373165,5/24/2015 21:28:41,1642779887,5/24/2015 21:28:05,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,105,30,,,118,38,ACNE VULGARIS,PEROXIDE,ACNE VULGARIS:,105-110,12-22-30,"Adapalene benzoyl PEROXIDE,","2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.",105 110,30,105,30,-1,118,38,TWrex-cause,800461,"2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients",acne vulgaris,peroxide
725373165,5/24/2015 22:00:19,1642789668,5/24/2015 22:00:11,false,neodev,1,31670127,USA,FL,Key West,162.233.108.112,105,30,,,118,38,ACNE VULGARIS,PEROXIDE,"the treatment of ACNE VULGARIS: a transatlantic, randomized,",88-92-102-105-110-120-122-137,8-12-22-30-40-42-49,"01 Adapalene benzoyl PEROXIDE, a unique fixed","2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.",105 110,30,105,30,-1,118,38,TWrex-cause,800461,"2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients",acne vulgaris,peroxide
725373165,5/24/2015 22:04:45,1642790862,5/24/2015 22:04:07,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,105,30,,,118,38,ACNE VULGARIS,PEROXIDE,ACNE VULGARIS:,105-110,12-22-30,"Adapalene benzoyl PEROXIDE,","2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.",105 110,30,105,30,-1,118,38,TWrex-cause,800461,"2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients",acne vulgaris,peroxide
725373165,5/24/2015 22:22:15,1642798056,5/24/2015 22:21:53,false,clixsense,1,30681680,NLD,11,Rotterdam,87.211.12.50,105,30,,,118,38,ACNE VULGARIS,PEROXIDE,"the treatment of ACNE VULGARIS: a transatlantic, randomized,",88-92-102-105-110-120-122-137,8-12-22-30-40-42-49,"01 Adapalene benzoyl PEROXIDE, a unique fixed","2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.",105 110,30,105,30,-1,118,38,TWrex-cause,800461,"2009-11-01  Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients",acne vulgaris,peroxide
725373166,5/24/2015 21:19:02,1642777060,5/24/2015 21:18:44,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,124,156,,,132,164,DIARRHEA,E. COLI.,traveler's DIARRHEA due to enterotoxigenic E. coli.[7],113-124-133-137-140-156-159,133-137-140-156-159,due to enterotoxigenic E. COLI.[7],"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",124,156 159,124,156,1,132,164,TWrex-cause,810766,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old",diarrhea,E. coli.
725373166,5/24/2015 21:33:11,1642781536,5/24/2015 21:32:35,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,124,156,,,132,164,DIARRHEA,E. COLI.,traveler's DIARRHEA,113-124,140-156-159-169,enterotoxigenic E. COLI.[7] A,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",124,156 159,124,156,1,132,164,TWrex-cause,810766,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old",diarrhea,E. coli.
725373166,5/24/2015 21:43:27,1642784541,5/24/2015 21:42:24,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,124,156,,,132,164,DIARRHEA,E. COLI.,traveler's DIARRHEA,113-124,140-156-159,enterotoxigenic E. COLI.[7],"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",124,156 159,124,156,1,132,164,TWrex-cause,810766,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old",diarrhea,E. coli.
725373166,5/24/2015 22:09:05,1642792349,5/24/2015 22:08:48,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,124,156,,,132,164,DIARRHEA,E. COLI.,traveler's DIARRHEA,113-124,140-156-159,enterotoxigenic E. COLI.[7],"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",124,156 159,124,156,1,132,164,TWrex-cause,810766,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old",diarrhea,E. coli.
725373166,5/24/2015 22:50:26,1642806644,5/24/2015 22:50:06,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,124,156,,,132,164,DIARRHEA,E. COLI.,traveler's DIARRHEA,113-124,137-140-156-159,to enterotoxigenic E. COLI.[7],"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",124,156 159,124,156,1,132,164,TWrex-cause,810766,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old",diarrhea,E. coli.
725373166,5/24/2015 22:56:07,1642808309,5/24/2015 22:55:38,false,clixsense,1,26770238,CAN,ON,Ilderton,209.183.157.27,124,156,,,132,164,DIARRHEA,E. COLI.,traveler's DIARRHEA due to enterotoxigenic,113-124-133-137-140,113-133-137-140-156-159-124,traveler's diarrhea due to enterotoxigenic E. COLI.[7],"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",124,156 159,124,156,1,132,164,TWrex-cause,810766,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old",diarrhea,E. coli.
725373166,5/24/2015 22:56:16,1642808343,5/24/2015 22:55:37,false,points4rewards,1,28703583,USA,,,97.73.85.52,124,156,,,132,164,DIARRHEA,E. COLI.,traveler's DIARRHEA,113-124,113-156-159-124,traveler's diarrhea E. COLI.[7],"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",124,156 159,124,156,1,132,164,TWrex-cause,810766,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old",diarrhea,E. coli.
725373166,5/24/2015 22:56:56,1642808472,5/24/2015 22:56:44,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,124,156,,,132,164,DIARRHEA,E. COLI.,traveler's DIARRHEA,113-124,156-159,E. COLI.[7],"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",124,156 159,124,156,1,132,164,TWrex-cause,810766,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old",diarrhea,E. coli.
725373166,5/24/2015 22:57:21,1642808599,5/24/2015 22:56:54,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,124,156,,,132,164,DIARRHEA,E. COLI.,traveler's DIARRHEA,113-124,140-156-159,enterotoxigenic E. COLI.[7],"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",124,156 159,124,156,1,132,164,TWrex-cause,810766,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old",diarrhea,E. coli.
725373166,5/24/2015 23:01:25,1642809552,5/24/2015 23:00:54,false,neodev,1,11659309,USA,KS,Derby,68.102.136.12,124,156,,,132,164,DIARRHEA,E. COLI.,traveler's DIARRHEA,113-124,140-156-159,enterotoxigenic E. COLI.[7],"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",124,156 159,124,156,1,132,164,TWrex-cause,810766,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with traveler's diarrhea due to enterotoxigenic E. coli.[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old",diarrhea,E. coli.
725373167,5/24/2015 19:55:01,1642752451,5/24/2015 19:54:49,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,141,92,,,162,101,CHRONIC RENAL FAILURE,CARBONATE,CHRONIC RENAL FAILURE.,141-149-155,92,CARBONATE,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure.,141 149 155,92,141,92,-1,162,101,TWrex-cause,800735,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure,chronic renal failure,carbonate
725373167,5/24/2015 19:56:25,1642752929,5/24/2015 19:56:12,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,141,92,,,162,101,CHRONIC RENAL FAILURE,CARBONATE,CHRONIC RENAL FAILURE.,141-149-155,92,CARBONATE,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure.,141 149 155,92,141,92,-1,162,101,TWrex-cause,800735,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure,chronic renal failure,carbonate
725373167,5/24/2015 19:56:32,1642752955,5/24/2015 19:56:19,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,141,92,,,162,101,CHRONIC RENAL FAILURE,CARBONATE,CHRONIC RENAL FAILURE.,141-149-155,92,CARBONATE,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure.,141 149 155,92,141,92,-1,162,101,TWrex-cause,800735,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure,chronic renal failure,carbonate
725373167,5/24/2015 20:10:13,1642756573,5/24/2015 20:09:44,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,141,92,,,162,101,CHRONIC RENAL FAILURE,CARBONATE,Hyperphosphatemia in Chronic Renal Failure (oral therapy) Calcium acetate and calcium carbonate are considered the salts of choice for CHRONIC RENAL FAILURE.,5-23-26-34-40-48-54-64-72-80-84-92-102-106-117-127-130-137-141-149-155-121,5-23-26-34-40-48-54-64-72-80-84-92-102-106-117-121-127-130-137-141-149-155,Hyperphosphatemia in Chronic Renal Failure (oral therapy) Calcium acetate and calcium CARBONATE are considered the salts of choice for chronic renal failure.,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure.,141 149 155,92,141,92,-1,162,101,TWrex-cause,800735,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure,chronic renal failure,carbonate
725373167,5/24/2015 20:25:48,1642760351,5/24/2015 20:25:34,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,141,92,,,162,101,CHRONIC RENAL FAILURE,CARBONATE,CHRONIC RENAL FAILURE.,141-149-155,84-92,calcium CARBONATE,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure.,141 149 155,92,141,92,-1,162,101,TWrex-cause,800735,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure,chronic renal failure,carbonate
725373167,5/24/2015 20:29:45,1642761645,5/24/2015 20:29:33,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.141,141,92,,,162,101,CHRONIC RENAL FAILURE,CARBONATE,CHRONIC RENAL FAILURE.,141-149-155,92,CARBONATE,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure.,141 149 155,92,141,92,-1,162,101,TWrex-cause,800735,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure,chronic renal failure,carbonate
725373167,5/24/2015 20:30:03,1642761722,5/24/2015 20:29:42,false,instagc,1,19740138,CAN,,,50.69.96.237,141,92,,,162,101,CHRONIC RENAL FAILURE,CARBONATE,CHRONIC RENAL FAILURE.,141-149-155,84-92,calcium CARBONATE,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure.,141 149 155,92,141,92,-1,162,101,TWrex-cause,800735,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure,chronic renal failure,carbonate
725373167,5/24/2015 20:33:34,1642762512,5/24/2015 20:33:17,false,neodev,1,29074051,GBR,G5,Folkestone,80.6.67.18,141,92,,,162,101,CHRONIC RENAL FAILURE,CARBONATE,CHRONIC RENAL FAILURE.,141-149-155,84-92,calcium CARBONATE,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure.,141 149 155,92,141,92,-1,162,101,TWrex-cause,800735,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure,chronic renal failure,carbonate
725373167,5/24/2015 20:52:58,1642768282,5/24/2015 20:52:12,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,141,92,,,162,101,CHRONIC RENAL FAILURE,CARBONATE,Hyperphosphatemia Chronic Renal Failure (oral therapy) Calcium acetate calcium carbonate salts CHRONIC RENAL FAILURE.,5-26-34-40-48-54-64-72-84-92-121-141-149-155,5-26-34-40-48-54-64-72-84-92-121-141-149-155,Hyperphosphatemia Chronic Renal Failure (oral therapy) Calcium acetate calcium CARBONATE salts chronic renal failure.,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure.,141 149 155,92,141,92,-1,162,101,TWrex-cause,800735,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure,chronic renal failure,carbonate
725373167,5/24/2015 20:54:30,1642768907,5/24/2015 20:53:54,false,clixsense,1,6450461,CAN,ON,North Bay,174.89.199.64,141,92,,,162,101,CHRONIC RENAL FAILURE,CARBONATE,CHRONIC RENAL FAILURE.,141-149-155,84-92,calcium CARBONATE,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure.,141 149 155,92,141,92,-1,162,101,TWrex-cause,800735,119  Hyperphosphatemia in Chronic Renal Failure (oral therapy)  Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure,chronic renal failure,carbonate
725373168,5/24/2015 21:04:27,1642772394,5/24/2015 21:03:57,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,207,79,,,231,96,TOXOPLASMA ENCEPHALITIS,TOXOPLASMA GONDII,TOXOPLASMA  ENCEPHALITIS.,207-218-219,79-90,TOXOPLASMA GONDII,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis.",207 218,79 90,207,79,1,231,96,TWrex-cause,811977,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis",toxoplasma encephalitis,toxoplasma gondii
725373168,5/24/2015 21:04:46,1642772531,5/24/2015 21:04:35,false,clixsense,1,24763049,GBR,Y8,Welshpool,81.135.56.139,207,79,,,231,96,TOXOPLASMA ENCEPHALITIS,TOXOPLASMA GONDII,TOXOPLASMA,207-218,79-90,TOXOPLASMA GONDII,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis.",207 218,79 90,207,79,1,231,96,TWrex-cause,811977,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis",toxoplasma encephalitis,toxoplasma gondii
725373168,5/24/2015 21:17:35,1642776570,5/24/2015 21:17:23,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,207,79,,,231,96,TOXOPLASMA ENCEPHALITIS,TOXOPLASMA GONDII,TOXOPLASMA  ENCEPHALITIS.,207-218-219,79-90,TOXOPLASMA GONDII,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis.",207 218,79 90,207,79,1,231,96,TWrex-cause,811977,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis",toxoplasma encephalitis,toxoplasma gondii
725373168,5/24/2015 21:30:57,1642780559,5/24/2015 21:30:35,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,207,79,,,231,96,TOXOPLASMA ENCEPHALITIS,TOXOPLASMA GONDII,TOXOPLASMA  ENCEPHALITIS.,207-218-219,79-90,TOXOPLASMA GONDII,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis.",207 218,79 90,207,79,1,231,96,TWrex-cause,811977,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis",toxoplasma encephalitis,toxoplasma gondii
725373168,5/24/2015 21:38:05,1642782930,5/24/2015 21:37:24,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,207,79,,,231,96,TOXOPLASMA ENCEPHALITIS,TOXOPLASMA GONDII,TOXOPLASMA  ENCEPHALITIS.,207-218-219,79-90,TOXOPLASMA GONDII,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis.",207 218,79 90,207,79,1,231,96,TWrex-cause,811977,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis",toxoplasma encephalitis,toxoplasma gondii
725373168,5/24/2015 22:07:22,1642791690,5/24/2015 22:07:05,false,clixsense,1,29688032,NLD,5,Heerlen,84.25.151.248,207,79,,,231,96,TOXOPLASMA ENCEPHALITIS,TOXOPLASMA GONDII,TOXOPLASMA  ENCEPHALITIS.,207-218-219,79-90,TOXOPLASMA GONDII,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis.",207 218,79 90,207,79,1,231,96,TWrex-cause,811977,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis",toxoplasma encephalitis,toxoplasma gondii
725373168,5/24/2015 22:45:42,1642805347,5/24/2015 22:45:31,false,instagc,1,26024737,GBR,H2,Preston,92.22.243.155,207,79,,,231,96,TOXOPLASMA ENCEPHALITIS,TOXOPLASMA GONDII,TOXOPLASMA  ENCEPHALITIS.,207-218-219,79-90,TOXOPLASMA GONDII,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis.",207 218,79 90,207,79,1,231,96,TWrex-cause,811977,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis",toxoplasma encephalitis,toxoplasma gondii
725373168,5/24/2015 22:49:03,1642806293,5/24/2015 22:48:43,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,207,79,,,231,96,TOXOPLASMA ENCEPHALITIS,TOXOPLASMA GONDII,TOXOPLASMA  ENCEPHALITIS.,207-218-219,79-90,TOXOPLASMA GONDII,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis.",207 218,79 90,207,79,1,231,96,TWrex-cause,811977,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis",toxoplasma encephalitis,toxoplasma gondii
725373168,5/24/2015 22:51:23,1642806930,5/24/2015 22:50:12,false,neodev,1,24628757,CAN,,,107.179.231.99,207,79,,,231,96,TOXOPLASMA ENCEPHALITIS,TOXOPLASMA GONDII,latent TOXOPLASMA  ENCEPHALITIS.,207-218-219-14,79-90,TOXOPLASMA GONDII,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis.",207 218,79 90,207,79,1,231,96,TWrex-cause,811977,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis",toxoplasma encephalitis,toxoplasma gondii
725373168,5/24/2015 22:53:11,1642807388,5/24/2015 22:52:27,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,207,79,,,231,96,TOXOPLASMA ENCEPHALITIS,TOXOPLASMA GONDII,reactivation and consequent TOXOPLASMA  ENCEPHALITIS.,191-195-207-218-219-178,79-90,TOXOPLASMA GONDII,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis.",207 218,79 90,207,79,1,231,96,TWrex-cause,811977,"Patients with latent toxoplasmosis, as indicated by serum antibodies (IgG) to  Toxoplasma gondii , receive TMP-SMX (in doses used to prevent  Pneumocystis  pneumonia) to prevent reactivation and consequent  Toxoplasma  encephalitis",toxoplasma encephalitis,toxoplasma gondii
725373169,5/24/2015 19:29:44,1642742848,5/24/2015 19:28:59,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,66,32,,,76,39,INFARCTION,ASPIRIN,myocardial INFARCTION,55-66,32,ASPIRIN,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack.",66,32,66,32,-1,76,39,TWrex-cause,800872,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack",infarction,aspirin
725373169,5/24/2015 19:47:03,1642750021,5/24/2015 19:45:42,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,66,32,,,76,39,INFARCTION,ASPIRIN,not reduce myocardial INFARCTION,44-48-55-66,15-24-32-40-44-48-55-66,"previous trials, ASPIRIN did not reduce myocardial infarction","In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack.",66,32,66,32,-1,76,39,TWrex-cause,800872,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack",infarction,aspirin
725373169,5/24/2015 19:47:12,1642750099,5/24/2015 19:46:40,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,66,32,,,76,39,INFARCTION,ASPIRIN,"In contrast to previous trials, aspirin did not reduce myocardial INFARCTION or death but lowered the incidence for ischemic stroke and transient ischemic attack.",0-3-12-15-24-32-40-44-48-55-66-77-80-86-90-98-102-112-116-125-132-136-146-155,0-3-12-15-24-32-40-44-48-55-66-77-80-86-90-98-102-112-116-125-132-136-146-155,"In contrast to previous trials, ASPIRIN did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack.","In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack.",66,32,66,32,-1,76,39,TWrex-cause,800872,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack",infarction,aspirin
725373169,5/24/2015 19:49:36,1642750903,5/24/2015 19:49:22,false,neodev,1,31743852,GBR,G5,Faversham,85.210.123.52,66,32,,,76,39,INFARCTION,ASPIRIN,aspirin did not reduce myocardial INFARCTION or death but,32-44-48-55-66-77-80-86-40,12-15-24-32-40-44-48-55-66,"to previous trials, ASPIRIN did not reduce myocardial infarction","In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack.",66,32,66,32,-1,76,39,TWrex-cause,800872,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack",infarction,aspirin
725373169,5/24/2015 19:49:51,1642750917,5/24/2015 19:49:28,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,66,32,,,76,39,INFARCTION,ASPIRIN,INFARCTION,66,32,ASPIRIN,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack.",66,32,66,32,-1,76,39,TWrex-cause,800872,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack",infarction,aspirin
725373169,5/24/2015 19:50:18,1642751115,5/24/2015 19:49:57,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,66,32,,,76,39,INFARCTION,ASPIRIN,INFARCTION,66,32,ASPIRIN,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack.",66,32,66,32,-1,76,39,TWrex-cause,800872,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack",infarction,aspirin
725373169,5/24/2015 19:50:52,1642751281,5/24/2015 19:50:35,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,66,32,,,76,39,INFARCTION,ASPIRIN,myocardial INFARCTION,55-66,32,ASPIRIN,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack.",66,32,66,32,-1,76,39,TWrex-cause,800872,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack",infarction,aspirin
725373169,5/24/2015 19:55:28,1642752611,5/24/2015 19:55:05,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,66,32,,,76,39,INFARCTION,ASPIRIN,myocardial INFARCTION,55-66,32,ASPIRIN,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack.",66,32,66,32,-1,76,39,TWrex-cause,800872,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack",infarction,aspirin
725373169,5/24/2015 20:06:16,1642755415,5/24/2015 20:05:53,false,neodev,1,30749660,USA,NC,Durham,24.211.188.217,66,32,,,76,39,INFARCTION,ASPIRIN,INFARCTION,66,32,ASPIRIN,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack.",66,32,66,32,-1,76,39,TWrex-cause,800872,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack",infarction,aspirin
725373169,5/24/2015 20:11:19,1642756896,5/24/2015 20:11:05,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,66,32,,,76,39,INFARCTION,ASPIRIN,INFARCTION,66,32,ASPIRIN,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack.",66,32,66,32,-1,76,39,TWrex-cause,800872,"In contrast to previous trials, aspirin did not reduce myocardial infarction or death but lowered the incidence for ischemic stroke and transient ischemic attack",infarction,aspirin
725373170,5/24/2015 18:56:34,1642721715,5/24/2015 18:56:10,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,57,28,,,71,35,OSTEOARTHRITIS,SULFATE,OSTEOARTHRITIS,57,28,SULFATE,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA.",57,28,57,28,-1,71,35,TWrex-cause,800212,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA",osteoarthritis,sulfate
725373170,5/24/2015 18:56:33,1642721716,5/24/2015 18:55:38,false,clixsense,1,6338946,CAN,QC,Montréal,174.138.212.81,57,28,,,71,35,OSTEOARTHRITIS,SULFATE,OSTEOARTHRITIS,57,16-28,chondroitin SULFATE,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA.",57,28,57,28,-1,71,35,TWrex-cause,800212,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA",osteoarthritis,sulfate
725373170,5/24/2015 18:56:34,1642721735,5/24/2015 18:56:15,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,57,28,,,71,35,OSTEOARTHRITIS,SULFATE,OSTEOARTHRITIS,57,16-28,chondroitin SULFATE,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA.",57,28,57,28,-1,71,35,TWrex-cause,800212,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA",osteoarthritis,sulfate
725373170,5/24/2015 18:58:01,1642722490,5/24/2015 18:57:35,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,57,28,,,71,35,OSTEOARTHRITIS,SULFATE,OSTEOARTHRITIS,57,16-28,chondroitin SULFATE,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA.",57,28,57,28,-1,71,35,TWrex-cause,800212,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA",osteoarthritis,sulfate
725373170,5/24/2015 18:58:57,1642722859,5/24/2015 18:57:56,false,neodev,1,32456300,USA,CA,Laguna Niguel,216.177.129.227,57,28,,,71,35,OSTEOARTHRITIS,SULFATE,been studied in OSTEOARTHRITIS without significant clinical,41-46-54-57-72-80-92,0-12-16-28-36-41-46,Glucosamine and chondroitin SULFATE have been studied,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA.",57,28,57,28,-1,71,35,TWrex-cause,800212,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA",osteoarthritis,sulfate
725373170,5/24/2015 19:01:29,1642724024,5/24/2015 19:01:03,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,57,28,,,71,35,OSTEOARTHRITIS,SULFATE,OSTEOARTHRITIS,57,16-28,chondroitin SULFATE,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA.",57,28,57,28,-1,71,35,TWrex-cause,800212,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA",osteoarthritis,sulfate
725373170,5/24/2015 19:18:32,1642732936,5/24/2015 19:18:19,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,57,28,,,71,35,OSTEOARTHRITIS,SULFATE,OSTEOARTHRITIS,57,16-28,chondroitin SULFATE,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA.",57,28,57,28,-1,71,35,TWrex-cause,800212,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA",osteoarthritis,sulfate
725373170,5/24/2015 19:20:23,1642735285,5/24/2015 19:19:42,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,57,28,,,71,35,OSTEOARTHRITIS,SULFATE,OSTEOARTHRITIS,57,16-28,chondroitin SULFATE,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA.",57,28,57,28,-1,71,35,TWrex-cause,800212,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA",osteoarthritis,sulfate
725373170,5/24/2015 19:21:34,1642736993,5/24/2015 19:21:17,false,pocketmoneygpt,1,32162555,CAN,BC,Vancouver,108.180.194.80,57,28,,,71,35,OSTEOARTHRITIS,SULFATE,OSTEOARTHRITIS,57,28,SULFATE,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA.",57,28,57,28,-1,71,35,TWrex-cause,800212,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA",osteoarthritis,sulfate
725373170,5/24/2015 19:23:51,1642739763,5/24/2015 19:23:35,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,57,28,,,71,35,OSTEOARTHRITIS,SULFATE,OSTEOARTHRITIS,57,16-28,chondroitin SULFATE,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA.",57,28,57,28,-1,71,35,TWrex-cause,800212,"Glucosamine and chondroitin sulfate have been studied in osteoarthritis without significant clinical benefit, and few data support their use in RA",osteoarthritis,sulfate
